University of Pennsylvania

ScholarlyCommons
Publicly Accessible Penn Dissertations
2015

Ef-G:trna Dynamics During the Elongation Cycle of Protein
Synthesis
Rong Shen
University of Pennsylvania, shenrong@sas.upenn.edu

Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Biochemistry Commons

Recommended Citation
Shen, Rong, "Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis" (2015). Publicly
Accessible Penn Dissertations. 1131.
https://repository.upenn.edu/edissertations/1131

This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/1131
For more information, please contact repository@pobox.upenn.edu.

Ef-G:trna Dynamics During the Elongation Cycle of Protein Synthesis
Abstract
During polypeptide elongation cycle, prokaryotic elongation factor G (EF-G) catalyzes the coupled
translocations on the ribosome of mRNA and A- and P-site bound tRNAs. Continued progress has been
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show good translocation activity in two different assays. In the smFRET work, by attachment of a
fluorescent probe at position 693 on EF-G permits monitoring of FRET efficiencies to sites in both
ribosomal protein L11 and A-site tRNA. The EF-G:L11 FRET efficiency is constant during the entire EF-G
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estimates of the timing of such changes. This EF-G:tRNA smFRET measurement was applied to
bifunctional rhodamine labeled EF-G derivatives (BR-EF-G) and comparable kinetic results were obtained.
FRET changes of BR-EF-G:Cy5-tRNA pair are larger if the BR group is located closer to the EF-G hinge
region, suggesting that parts of domain IV of EF-G, which penetrate to the decoding region of the
ribosome, move together with the A-site tRNA during translocation.
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ABSTRACT
EF-G:tRNA DYNAMICS DURING THE ELONGATION CYCLE OF
PROTEIN SYNTHESIS

Rong Shen
Barry S. Cooperman

During polypeptide elongation cycle, prokaryotic elongation factor G (EF-G)
catalyzes the coupled translocations on the ribosome of mRNA and A- and P-site bound
tRNAs. Continued progress has been achieved in understanding this key process,
including results of structural, ensemble kinetic and single-molecule studies. However,
most of work has been focused on the pre-equilibrium states of this fast process,
leaving the real time dynamics, especially how EF-G interacts with the A-site tRNA in
the pretranslocation complex, not fully elucidated.
In this thesis, the kinetics of EF-G catalyzed translocation is investigated by both
ensemble and single molecule fluorescence resonance energy transfer studies to further
explore the underlying mechanism. In the ensemble work, EF-G mutants were designed
and expressed successfully. The labeled EF-G mutants show good translocation activity
in two different assays. In the smFRET work, by attachment of a fluorescent probe at
position 693 on EF-G permits monitoring of FRET efficiencies to sites in both
ribosomal protein L11 and A-site tRNA. The EF-G:L11 FRET efficiency is constant

v

during the entire EF-G occupancy on the ribosome, while the EF-G:tRNA FRET
proceeds from high to intermediate to low FRET values. Transition from intermediate
to low is the rate-limiting step with a small FRET change, whereas transition from high
to intermediate is fast, showing a large FRET change. In total, we capture a ~12 Å
relative movement of A-site tRNA away from EF-G during translocation. This indicates
that EF-G:A-site tRNA distance increases progressively during translocation, with our
results providing the first good estimates of the timing of such changes. This EFG:tRNA smFRET measurement was applied to bifunctional rhodamine labeled EF-G
derivatives (BR-EF-G) and comparable kinetic results were obtained. FRET changes
of BR-EF-G:Cy5-tRNA pair are larger if the BR group is located closer to the EF-G
hinge region, suggesting that parts of domain IV of EF-G, which penetrate to the
decoding region of the ribosome, move together with the A-site tRNA during
translocation.
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CHAPTER I INTRODUCTION

1

1.1 The central dogma and ribosome-catalyzed translation
Nucleotides are ubiquitous molecules with high structural diversity. Their polymeric
forms, deoxyribonucleic acids (DNAs) and ribonucleic acids (RNA) are important in
storage and expression of genetic information. As determined by James Watson and
Francis Crick in 1953, the double helix structure of DNA is well known now. DNA in a
parent cell is replicated through its double helix, propagating genetic information to the
daughter cells (Watson et al., 1953a; Watson et al., 1953b). A great variety of enzymes
are involved in DNA replication. Single-stranded parental DNA is used as the template to
synthesize the complementary strand for both leading and lagging strands, with high
fidelity. As DNA strand can only be extended from 5’ to 3’, for the lagging strand, semidiscontinuous replication is performed and the DNA fragments are later joined together
by DNA ligase. DNA polymerases (Pol) catalyze DNA strand extension (Caruthers et al.,
2002). In E. coli, Pol I and Pol III have both polymerase and exonulcease activities, and
the latter functions as a proofreading mechanism which contributes to the high fidelity of
DNA replication, with only one mismatching occurring per 108 base pair replication
(Rothwell et al., 2005).
RNAs are classified according to their functions, including decoding RNA which is
messenger RNA (mRNA) and non-decoding RNA. mRNA serves as the template for
protein synthesis on the ribosome. Non-decoding RNA includes transfer RNA (tRNA),
ribosomal RNA (rRNA), small interfering RNA (siRNA), micro RNA (miRNA), small
nuclear RNA (snRNA), etc. tRNAs recognize the complementary triplet sequences of
mRNA through codon-anticodon interactions and deliver specific amino acids that
incorporate into nascent protein chains. tRNA has an L-shaped structure and is about 60

2

Å in length from its elbow region to the anticodon region (Fig 1.1). The amino acid is
covalently attached to the CCA- end of tRNA, in a reaction catalyzed by an aminoacyltRNA synthetase. There are two classes of aminoacyl-tRNA synthetases, denoted Class I
and Class II, with both a catalytic and an editing site to ensure the accuracy of this
process (Nureki et al., 1998). Another non-decoding RNA, denoted rRNAs account for ~
60% of the ribosome by weight.
According to the central dogma (Fig 1.2), the base sequences of DNA are copied into
mRNA during the transcription process (Crick et al., 1970). mRNA then directs protein
synthesis by having the ribosome translate its nucleotide sequence into an amino acid
sequence. The transcription of DNA is carried out by RNA polymerases using nucleotides
including adenine (A), cytosine (C), guanine (G) and uridine (U) (Cramer et al., 2002).
Unlike DNA replication, RNA synthesis is initiated at a specific site called the promoter
region and the single strand of mRNA is extended from 5’ to 3’. Posttranscriptional
processing alters certain features of the primary transcript and the transcripts are
subjected to several modifications, for instance, 5’ capping, poly (A) tail addition and
splicing for eukaryotic mRNA transcripts (Black. et al., 2003; Nishikura et al., 2006;
Wahl et al., 2009). The transcription process is rapid, with the in vivo rate of 20 to 50
nucleotides per second at 37 °C. However, the accuracy of transcription is one out of 10 4
mis-transcribed, which is much lower than replication. Three consecutive mRNA
nucleotides code for a particular amino acid. Protein synthesis is carried out on the
ribosome, which we will discuss in detail in Section 1.3.
1.2 Ribosome components
The ribosome is a ribonucleoprotein particle which is composed of a large and a
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small subunit. The ribosome is built of two-thirds rRNA and one third ribosomal proteins
(Table 1.). The E. coli ribosome, which has been extensively investigated, is a 2.5 MDa
ribonucleoprotein assembly with a diameter of ~ 250 Å and a sedimentation coefficient of
70S, where S stands for the Svedberg unit of sedimentation velocity. The complete 70S
ribosome is formed from 50S and 30S subunits (Kaltschmidt et al., 1970). The 30S
subunit consists of 16S rRNA (about 1500 nucleotides) together with 21 proteins. The
50S contains 23S rRNA (about 3000 nucleotides), 5S rRNA and 34 proteins. Their
eukaryotic counterparts are termed 60S and 40S, which together form an 80S ribosome.
1.3 The prokaryotic translation cycle
In bacteria, protein synthesis can be divided into three major stages including
initiation, elongation and termination, which requires correlated movements among
ribosomal proteins, rRNA, protein factors and tRNAs (Fig 1.3).
1.3.1 Initiation of protein synthesis
The initiation step requires mRNA, the initiator tRNA fMet-tRNAfMet and initiation
factors 1-3 (IF 1-3). In the initiation step, mRNA binds to the 30S subunit on the
ribosome at the anti Shine-Dalgarno (SD) sequence of 16S rRNA that is complementary
to an SD sequence in the mRNA. The initiator tRNA fMet-tRNAfMet, positioned in a Plike site of the 30S subunit, forms codon-anticodon interactions with the start codon. The
binding site of IF-1 partially overlaps with the decoding center, suggesting that IF-1 does
not only assist IF-3 binding but also prevents the aminoacyl tRNA binding at this
premature stage (Moazed et al., 1995). IF2 is a GTPase and it binds with GTP and fMettRNAfMet to form a ternary complex (Boelens et al., 2002; Tsai et al., 2012). IF3 helps to
dissociate vacant 70S ribosomes resulting from protein synthesis termination and
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prevents the premature docking of 50S subunit onto the 30S subunit. During the initiation
process, IF3 first binds to the 30S subunit, followed by the association of mRNA, IF1,
IF2, and initiator tRNA to form the 30S initiation complex (30SIC). The release of IF1
and IF3 promotes the 30SIC and 50S subunit joining to form the 70S initiation complex
(70SIC), followed by IF2 catalyzed GTP hydrolysis, Pi release, and IF2·GDP dissociation.
This results in the initiator tRNA fMet-tRNAfMet moving to the P-site of the 70S ribosome,
ready for the next stage of the elongation reaction.
1.3.2 Peptide elongation
The elongation cycle can be divided into three stages, including decoding, peptide
bond formation and translocation (Schmeing et al., 2009a). At the beginning of this cycle,
the ribosome contains a peptidyl-tRNA in the P-site, with an empty A-site. EF-Tu
delivers the cognate aminoacyl tRNA to the mRNA codon in the A-site of the ribosome in
the form of ternary complex (TC: aa-tRNA·EF-Tu·GTP) (Pape et al., 1998; Rodnina et
al., 1994). The TC complex first binds to the L7/L12 stalk and the anticodon of tRNA
penetrates into the decoding center on the 30S subunit with the acceptor arm and EF-Tu
interacting with the GTPase activation center on the 50S subunit (Schmeing et al.,
2009b). As a result, tRNA is said to be in the A/T state, in which it displays a distorted
conformation relative to the structure of tRNA bound within either a TC or free in
solution. The cognate codon-anticodon interaction at the decoding center triggers
conformational changes in both tRNA and the ribosome complex which are later
transmitted to the interface of EF-Tu and tRNA (Voorhees et al., 2010). After fast GTP
hydrolysis and Pi release, EF-Tu·GDP dissociates from the ribosome and the A/T tRNA is
accommodated into the A/A site. Decoding is followed by fast peptide bond formation,
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leaving deacylated-tRNA in the P site. Both structural work (Agirrezabala et al., 2008;
Fu et al., 2011) and kinetic studies, including ensemble measurements (Dorner et al.,
2006) and single molecule experiments (Blanchard et al., 2004b; Blanchard et al., 2004a;
Chen et al., 2011a; Fei et al., 2008) show that classic (A/A, P/P) and hybrid (A/P, P/E)
tRNA binding states interconvert reversibly prior to EF-G·GTP binding. EF-G binds to
the L7/L12 stalk on the ribosome, sharing the same binding site as EF-Tu (Gao et al.,
2009; Schmeing et al., 2009b). Upon EF-G·GTP binding, rapid GTP hydrolysis is
triggered, followed by Pi release. The energy generated from this process promotes
unidirectional movement of tRNAs, together with mRNA, from the A-, P- sites to the P-,
E-sites, in a process that proceeds via at least two intermediates (Pan et al., 2007). This
leaves an empty A-site, which is ready for the next cycle of elongation.
1.3.3 Termination of protein synthesis
The elongation cycle continues until a stop codon (UAA, UAG or UGA) moves into
the A-site, signaling translation termination. RF1 (Class 1 release factor, recognizing
UAA, UAG) or RF2 (Class 1 release factor, recognizing UAA, UGA) reads the stop
codon, resulting in conformational changes of conserved bases (G530, A1492 and A1493)
in the decoding center (Korostelev et al., 2008; Laurberg et al., 2008; Weixlbaumer et
al., 2008). The conserved GGQ motif on RFs is positioned in the PTC and promotes the
hydrolysis of peptidyl tRNA in the P-site, followed by peptide chain release from the
ribosome (Laurberg et al., 2008; Weixlbaumer et al., 2008). RF3, a Class II RF binds to
the ribosome in the GTP form and, accompanied by GTP hydrolysis (Zavialov et al.,
2002), destabilizes RF 1/2 binding, accelerating their dissociation from the ribosome.
Then RF3 dissociates, leaving inactive mRNA and deacylated tRNA bound to the
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ribosome. This inactive complex is recycled into 30S and 50S subunits, free mRNA and
tRNA, assisted by ribosome recycling factor (RRF) and EF-G (Franckenberg et al., 2012;
Hirashima et al., 1973). Then IF3 binds to the ribosome to the 30S subunit (Hirokawa et
al., 2008; Karimi et al., 1999), ready for the next round of translation.
1.4 Ribosome structure
Elucidation of ribosome structure is a daunting task due to its size and lack of
symmetry. The ribosome structure initially began to emerge via electron microcopy but
with a low resolution (Hall et al., 1959). An early view of single particle reconstruction
using cryo-EM came in 1986 (Frank et al., 1986) and structures with better resolution
(below 10 Å) were reported by Valle et al. in 2003. With advanced experimental
techniques and data refining methods, high resolution structure of 30S and 50S structures
at atomic resolution, determined by X-ray crystallography study (~ 3 Å), were first
reported in 2000 as the efforts from several groups (Ban et al., 2000; Carter et al., 2000;
Harms et al., 2001; Schluenzen et al., 2000; Wimberly et al., 2000). In 2001, Noller
group reported the first low resolution (5.5 Å) 70S ribosome structure from Thermus
thermophilus containing mRNA, A-, P- and E-site tRNAs (Yusupov et al., 2001),
showing that the core of the interface between 30S and 50S is mainly made up of RNA
with protein located at the periphery.
The 5’and 3’ domains of the 16S RNA are located in the body and head of the 30S
subunit, respectively, with the central domain located in the platform region (Fig 1.4).
There are three long helices in 30S subunits, h44, h16/17, and h7, with most of the small
ribosomal protein located on the exterior side. The primary role of 30S is to bind mRNA
and tRNA, providing the location for the decoding process, which occurs at the upper
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part of 30S body and lower part of the head (Ban et al., 2000; Schluenzen et al., 2000;
Wimberly et al., 2000) with nucleotides 1492 to 1498 and 1302 to 1408 of h44 forming
parts of the A- and P- tRNA sites. 50S has a stable core structure with a strong mobility
of the protuberances, for instance, the L7/L12 stalk and the L1 stalk (Fig 1.5, Fig 1.6).
The six domains of 23S RNA are interwoven and the 5S RNA is located in the center of
the protuberance (Harms et al., 2001). There are three tRNA binding sites on the
ribosome: the A site for the incoming aminoacyl-tRNA, the P site for peptidyl-tRNA and
the E site for the deacylated tRNA to exit from the ribosome after the elongation cycle
(Schmeing et al., 2009a; Yonath et al., 2010). The tRNA binds at the 30S:50S interface,
forming interactions with the decoding center of 30S and the peptidyl transferase center
(PTC) on the 50S subunit, and moves through a tunnel from the A site located close to the
L7/L12 stalk to the E site located close to L1 stalk in a stepwise manner during
translocation (Fig 1.6). mRNA binds to the small unit between the platform and the head
region with 5’ end of mRNA, forming contacts with the back of the platform, and wraps
around the neck of 30S to place the nucleotides into A, P and E sites (Yusupov et al.,
2001).
High resolution (~ 3 Å) structures of 70S ribosome were obtained successfully by
both Cate et al. and Ramakrishnan et al. in 2005 and 2006, separately (Schuwirth et al.,
2005; Selmer et al., 2006). Cate et al. reported two ribosome structures with a detailed
view of the interface of 50S and 30S as well as the conformation of the PTC. By defining
one structure as the standard, the comparison between the two structures indicated two
types of motions of the 30S subunit, including swivelling of the head of 30S ribosome ~
6° and the rotation movement of 30S relative to 50S subunit (Fig 1.7). The 2006 paper
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provided a detailed study of the ribosome interactions with mRNA, cognate A-, P- site
tRNAs and non-cognate E-site tRNA, suggesting that a metal ion stabilized kink structure
of mRNA is potentially important to prevent mRNA slippage. Since then, several high
resolution X-ray and cryo-EM structures have been reported, focusing on revealing
different aspects of translation, including mRNA decoding (Demeshkina et al., 2012;
Jenner et al., 2010), translocation (Agirrezabala et al., 2008; Connell et al., 2008; Frank
et al., 2007; Frank et al., 2000; Julián et al., 2008; Ratje et al., 2010) and termination
(Korostelev et al., 2008; Laurberg et al., 2008).
For mRNA decoding, by comparing the crystal structures of the ribosome with
uncharged cognate tRNA, or with a near-cognate tRNA, or without the A-site tRNA,
Yusupova and coworkers proposed a proofreading mechanism, suggesting that this
process begins with monitoring the tRNA anticodon loop, followed by the elbow region
of tRNA being examined by rRNA and ribosomal protein on the 50S subunit to decide if
the acceptor end of tRNA is to be accommodated or not.
During translocation, the ribosome undergoes a large scale conformational
rearrangement. Frank et al. (2000) reported a cryo-EM structure of 70S ribosome from E.
coli, showing that EF-G binding and GTP hydrolysis promote a ratchet-like rotation of
30S relative to 50S (Frank et al., 2000; Zhang et al., 2009). This movement of the
ribosome is believed to couple with the formation of hybrid state tRNAs but can be
decoupled with the addition of antibiotics, e.g., viomycin. The L1 stalk undergoes a
closure movement to form interactions with the deacylated P-site tRNA and such
interaction persists throughout translocation (Fei et al., 2008). A spontaneous ribosome
ratcheting movement (~ 8 to 10 degree) was observed with tRNAs in A/P, P/E hybrid
9

states by Julian et al. (2008) and Agirrezabala et al. (2008), separately. Ratje et al. (2010)
presented two cryo-EM structures of EF-G-ribosomes complex from Thermus
thermophilus and one of the characterized structures containing a partly translocated
tRNA. A swivelling movement of 30S head stabilized by Domain IV of EF-G, was
described and this movement was believed to be coupled with translocation and
unratcheting of the 30S body(Ratje et al., 2010). This result provides a new insight into
the structure of translocation intermediates.
Concerning the termination process, Laurberg et al. reported a structure of 70S
ribosome from Thermus thermophilus with release factor 1(RF1), P-, E- site tRNAs and
mRNA containing stop codon UAA at 3.2 Å resolution, suggesting that RF1 interaction
with the PTC is stabilized by the A-site of 30S, and repositioning of GGQ motif promotes
hydrolysis of peptidyl-tRNA (Laurberg et al., 2008). Noller and coworkers (2008)
obtained 70S ribosome with release factor 2 (RF2), P-, E- site tRNAs and mRNA
containing a UAA stop codon. This high resolution structure (3 Å) supports the idea that
the conformational changes transmitted from the decoding center to the PTC as the result
of recognition of the stop codon promote the docking of GGQ motif into the PTC to
catalyze peptidyl-tRNA hydrolysis (Korostelev et al., 2008).
1.5 Prior results of special pertinence to work presented in this thesis
Previous research has been heavily focused on the pre-equilibrium states of EF-G
catalyzed translocation, leaving the real time dynamics, especially how EF-G first
interacts with the A-site tRNA or with ribosomal protein in the GTPase associated center
(GAC) within the pretranslocation complex, not fully elucidated. In my work, we want to
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show how EF-G correlates its movements with tRNAs, and with ribosomal protein to
promote different sub-steps of translocation.
1.5.1 EF-G structures in solution or bound to the ribosome
Of particular interest is the structure of EF-G under different conditions, including
the structures of EF-G in solution (AEvarsson et al., 1994; al-Karadaghi et al., 1996;
Czworkowski et al., 1994; Hansson et al., 2005), EF-G bound to the ribosome (Brilot et
al., 2013; Chen et al., 2013b; Gao et al., 2009; Pulk et al., 2013; Ramrath et al., 2013;
Tourigny et al., 2013; Zhou et al., 2013; Zhou et al., 2014) and of EF-G-2, a homolog
of EF-G bound to the ribosome (Connell et al., 2008). In 1994, two crystal structures of
EF-G from Thermus thermophilus, either lacking any guanine nucleotide (AEvarsson et
al., 1994) or with GDP (Czworkowski et al., 1994) were reported separately. These two
papers provided the fundamental information of EF-G structure. EF-G has overall
dimensions of 50 × 60 × 118 Å and five domains. Its GTP binding domain has a core
structure which is similar to those of other GTPases. EF-G has a unique inserted domain
about 90 residues in length. The overall EF-G·GDP structure resembles the structure of
the ternary complex, with Domains I, II resembling EF-Tu in the GTP form and Domains
III, IV and V resembling tRNA. Al-karadaghi et al. reported another EF-G·GDP structure
and compared this structure with nucleotide-free EF-G structure. The results imply that
upon GDP release, the phosphate binding loop (P-loop) in the G domain of EF-G
undergoes a conformational change which can be transmitted to other parts of EF-G and
prepares EF-G for next round of GTP binding. Hansson et al., 2005 solved the structure
of the T84A EF-G mutant, which is located in the G domain, bound with nonhydrolysable GTP analogue GDPNP, providing the first structure of EF-G conformation
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in the GTP form. With the improved experimental techniques, some well-ordered
ribosome crystal structures were obtained and brought new insights into the structure of
ribosome-bound EF-G. EF-G binds to the ribosome subunit interface: Domain I binds to
the sarcin-ricin loop; Domains II and III bind to h15 of 16S rRNA and S12 of 30S;
Domain IV binds to h23 of 16S rRNA and the mRNA; Domain V binds to L11 stalk of
50S. Gao et al. (2009) presented a crystal structure of ribosome bound EF-G with the
antibiotic fusidic acid (FA) in the posttranslocation state at 3.6 Å resolution. In this work,
EF-G was trapped in an intermediate conformation between guanosine triphosphate and
guanosine diphosphate states with loops I and II on G domain in a conformation similar
to the GDP and GTP forms, respectively. In 2013, three ribosome-bound EF-G structures
were published in Science. Cate and coworkers reported an EF-G-ribosome complex with
non-hydrolyzable GTP analogue GDPCP at 3 Å. Binding of EF-G in the GDPCP state
orders the switch regions in the GTPase associated center (GAC) compared to GDP state.
Also, Domain II of EF-G moves about 7 Å toward Domain III and Domain IV is
positioned into the A-site decoding center but without contacts with the 30S head, such
that the presence of EF-G most likely precludes tRNA occupancy. EF-G-ribosome
structure with a non-hydrolyzable GTP analog GDPCP and P/E tRNA was obtained at 2.9
Å (Tourigny et al., 2013). Domain IV of EF-G was observed to be in an intermediate
conformation which was between ribosome free EF-G and EF-G-ribosome in the post
state. As was found by Pulk et al., an ordered structure stabilized by the sarcin-ricin RNA
loop of 50S in the GAC was obtained and the conformation of conserved residues in the
GTPase active site was different from both the ribosome-free and other ribosome-bound
structures. Fusidic acid bound to EF-G in a position that overlapped with switch loop I of
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G domain on EF-G in the GTP form and stabilized contacts between Domains I and II
(Zhou et al., 2013). Although all these high resolution structures provide a detailed view
of the ribosome bound EF-G structure, especially Domain I which catalyzes GTP
hydrolysis and Domain IV which extends to the decoding center, all of them lack the Asite tRNA and are from either the posttranslocation state or an intermediate state, leaving
the pretranslocation state not fully elucidated. Since 2013, two papers have been
published with EF-G-ribosome in a PRE-like state. Cryo-EM reconstruction of the
pretranslocation complex was obtained with viomycin (VIO) and FA to increase the
binding stability of the A-site tRNA. Although this structure is not of high resolution (7.6
Å), a distinct EF-G conformation which is different from all previously characterized EFG structures was observed, suggesting that EF-G undergoes a structural rearrangement
during translocation. Domain IV of EF-G is outside the A-site of 30S and the tip of
Domain IV makes an extensive contact with the anti-codon loop of the A-site tRNA.
Compared with EF-G-ribosome complex in the posttranslocation state (Gao et al., 2009),
the tip of Domain IV in this work is 20 Å farther from the A site, and a rotation about 20°
around the sarcin-ricin loop was observed to avoid a steric clash of Domain IV with the
A-site tRNA. A more recent published result (Zhou et al., 2014) improved the resolution
of the EF-G-ribosome structure in a PRE-like state to 3.8 Å, but in the presence of
antibiotics, with the deacylated P-site tRNA partly moving to a pe/E site and the A-site
peptidyl tRNA to an ap/ap state, revealing how the rearrangement of rRNA promotes
tRNA movements during translocation.
1.5.2 Structural analogs of the active EF-G-ribosome structure
As Domain IV of EF-G has a steric clash with the A-site tRNA, the stable structure
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of EF-G-ribosome in a pretranslocation state in the absence of antibiotics is not fully
characterized. Such a structure would be useful in choosing sites of fluorescent probe
introduction into EF-G for FRET studies. Here, we will briefly discuss EF-Tu-ribosome
and EF4-ribosome structures which can be considered as analogs of ribosome bound EFG.
1.5.2.1 EF-Tu-ribosome structure
EF-Tu is elongation factor Tu which delivers aminoacyl tRNA to the ribosome. EFTu has three domains. Domain I contains a nucleotide binding site and catalyzes GTP
hydrolysis. Domains II and III regulate the interaction of Tu with antibiotics and with EFTs which catalyzes the exchange between GDP and GTP on EF-Tu. Aminoacyl tRNA
binds to the interface of Domain I and II of EF-Tu, with the acceptor stem-loop
contacting Domains I and II and the T-stem contacting Domain III (Nissen et al., 1995).
In 2009, a high resolution (3.6 Å) EF-Tu-ribosome structure with kirromycin and
paramomycin was reported (Schmeing et al., 2009b). This structure shows a detailed
picture of the distortion of tRNA, which allows the tRNA to interact with both the
decoding center at the 30S subunit and the binding site on EF-Tu. Another high resolution
EF-Tu-ribosome structure (3.2 Å) was reported in 2010 with paramomycin and GDPNP
(Voorhees et al., 2010). EF-Tu is in an active conformation with the switch loop I
showing an ordered structure and the catalytic histidine positioned to attack the Ƴphosphate, which provides a mechanism for GTPase activation on the ribosome.
1.5.2.2 EF4-ribosome structure
EF4 (Lep A) is a highly-conserved GTPase which competes with EF-G for binding
to the PRE complex and leads to a transient inhibition of elongation (Liu et al., 2011; Liu
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et al., 2010; Qin et al., 2006). E. coli EF4 protein is made up of 599 amino acid residues
with a weight of 67 kDa. EF4 exhibits a strong similarity with EF-G in structure, and the
protein domains of EF4 are homologies of domains I, II, III, and V of EF-G, but neither
G’ or Domain IV is found in EF4. EF4 has a unique C-terminus which contains two βstrands and two helices. The lack of Domain IV makes the stable structure of the A site
tRNA and EF4 on the ribosome possible. In 2008, Spahn et al. and Steitz et al. reported
EF4 structure free of the ribosome (Evans et al., 2008) or bound to the ribosome
(Connell et al., 2008), separately. The direct comparison between EF-G and EF4
structure indicates that the orientations of Domains III and V in EF4 are different from
EF-G (~ 10° rotation relative to structure of H573A EF-G mutant), suggesting that the
hinge region of Domains III, IV, and V on EF-G undergoes a large movement during
translocation (Evans et al., 2008; Laurberg et al., 2000). With EF4, a tRNA state which
has not been characterized before was obtained and denoted A/L tRNA. The anticodon
loop of the A/L tRNA extends to the decoding center in a similar position as A/A tRNA.
However, it deviates from the A/A tRNA conformation, pivoting around the anticodon
loop with the largest distance displacement about 14 Å in T-loop and 13 Å in 5’-end
(Connell et al., 2008).
1.5.3 Ensemble kinetic studies of EF-G catalysis of translocation
Ensemble kinetic studies of the ribosome primarily rely on site-specific labeling of
different translation components. As translocation is of great importance to my work,
here we will focus on discussing the ensemble kinetic studies of the EF-G catalyzed
translocation process (Fig 1.8). The commonly used methods including introduction of
fluorescently labeled ribosome components, GTP hydrolysis assays, peptide formation
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assays and puromycin reactivity assays (Pan et al., 2007; Rodnina et al., 1997;
Savelsbergh et al., 2003). EF-G·GTP binds to L7/L12 stalk on the ribosome (Diaconu el
al., 2005), followed by a rapid GTP hydrolysis with a rate constant ~ 150 s-1. Addition of
the antibiotic viomycin, which inhibits translocation, does not slow down GTP hydrolysis,
suggesting that GTP hydrolysis precedes translocation. A slower step with a rate constant
of 25 s-1 measured by the fluorescence change of proflavin (prf) labeled A-site tRNA
which is attributed to ribosome conformational changes termed the unlocking process
(Savelsbergh et al., 2003) limits rates of mRNA-tRNA movement on the ribosome as
well as Pi release. The substitution of GTP with its non-hydrolysable analog (i.e.,
GDPNP) largely reduces the rate constant of this process (50 fold slower, Rodnina et al.,
1997; 6 fold slower, Zavialov et al., 2003; 5 fold slower, Pan et al, 2007). The intact
structure and flexibility of Domain IV is of crucial importance as EF-G variants with
Domain IV truncated, or with a Domain I-V cross-linked EF-G which limits the motions
of Domain IV, induce only slow translocation and catalyze only single turnover
(Savelsbergh et al., 2000). Although both mRNA-tRNA movement and Pi release are
limited by unlocking, these two processes are independent of each other. This is
confirmed by antibiotic studies, such as those showing that viomycin inhibits mRNAtRNA movement, but allows Pi release (Peske et al., 2000; Savelsbergh et al., 2003).
Both mRNA-tRNA movement and Pi release have to occur to allow subsequent steps,
including relocking of the ribosome before EF-G·GDP dissociation. The dissociation
process is important for multiple rounds of translocation. Substitution of GTP with
GDPNP only allows single round translocation by preventing EF-G dissociation.
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1.5.4 Single molecule FRET studies of elongation cycle
Protein synthesis is a highly dynamic process that involves multi-components.
Although as we discussed above, the ensemble measurement provides great insights
concerning the mechanism of translation, it is limited by ensemble averaging in bulk
solution which may make it difficult to detect important intermediates or conformational
changes of ribosome components. Measurement at the single molecule level provides a
powerful tool as it can reveal the population distribution for heterogeneous species
without averaging over all populations. As my work is based on single molecule
fluorescence studies, we will focus on discussing single molecule fluorescence or
fluorescence resonance energy transfer (FRET) results applied to the ribosome complexes
during translation. Single molecule fluorescence experiments can reveal the movements
of ribosome components or protein factors based on the fluorescence intensity differences
in different local environments. As well, changes in FRET efficiency between two
fluorophores attached to two ribosomal complex components can be used to monitor
relative movement between the two components.
In 2004, two papers were reported by Puglisi and coworkers, focusing on tRNA
dynamics on the ribosome. By using Cy3 labeled P-site fMet-tRNAfMet and Cy5 labeled
A-site Phe-tRNAPhe, direct tRNA - tRNA FRET was observed, showing three FRET
states, which are assigned to the codon recognition, GTPase-activated and accommodated
states. Comparisons of FRET values reveal differences in intermediate state sampling
upon cognate or near-cognate tRNA binding (Blanchard et al., 2004a). The same
fluorescent labels were introduced to elucidate tRNA dynamics. The A-site tRNA was
observed to fluctuate between the classic and hybrid states. Peptide bond formation
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modulates the fluctuation of tRNA between these two states, favoring the hybrid state
(Blanchard et al., 2004b). The effects of different experimental conditions (e.g., Mg2+
concentration, acylation or not of aminoacyl-tRNA in the A-site tRNA) on tRNA
equilibrium between classic and hybrid states were characterized, showing that when Asite tRNA is not acetylated, Mg2+ concentration does not shift the equilibrium, while if it
is acetylated, the classic state is stabilized by a high Mg2+ concentration (Kim et al.,
2007). A new hybrid intermediate state was identified by Blanchard and coworkers with
A/A, P/E site tRNAs and expanded previous reported tRNA states (Munro et al., 2007).
FRET studies of ribosome dynamics and correlating ribosome tRNA movements have
been carefully investigated since 2007. By engineering extended rRNA hairpins, which
allows site-specific hybridization of fluorescently labeled oligonuleotides, 30S and 50S
were labeled to monitor ribosome intersubunit rotations (Chen et al., 2013b; Marshall et
al., 2008b; Marshall et al., 2008a). L1 stalk motions during translocation were later
characterized. Interestingly, L1 stalk shows equilibrium between open and closed
conformations, and only interacts with the P/E site tRNA in the closed conformation. EFG binds to the hybrid state and shifts L1 equilibrium to favor the closed form,
collaborating allosterically with L1 to direct tRNA movements along the translocation
trajectories (Fei et al., 2009; Fei et al., 2008). In contrast to Fei’s results that EF-G only
binds to tRNAs in the hybrid state, Chen from our group monitored tRNA-tRNA and
tRNA-L11 FRET, and these FRET results suggest that EF-G binds to both hybrid and
classic tRNAs, which is later confirmed by work from Puglisi group in 2013. Chen et al.
(2011) also observed that translocation starting with classic tRNAs proceeds via a
transient intermediate hybrid state (lifetime~ 80 ms), in agreement with the ensemble

18

results of Pan et al. (2007).
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Figure 1.1 Overview of tRNA tertiary structure. (Adapted from Jenner et al., 2010)
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Figure 1.2 Central dogma of molecular biology. (Adapted from Crick et al., 1970).
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Ribosome/subunit
Molecular weight (kD)
rRNA components
Number of nucleotides in
rRNA
rRNA molecular weight
(kD)
Number of ribosomal
proteins
Protein molecular weight
(kD)

70S
2520

50S
1590

30S
930

23S, 16S 5S

23S and 5S

16S

4566

23S, 2904 nts
5S, 120 nts

16S, 1542 nts

1664

1104

560

55

34

21

857

487

370

Table 1.1 Components of E. coli ribosomes. This table is adapted from Voet et al., 2006

Figure 1. 3 Overview of bacterial translation. (Adapted from Schmeing et al., 2009).
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Figure 1.4 Stereo view of the tertiary structure of 16S RNA. H, head; Be, beak; N,
neck; P, platform; Sh, shoulder; Sp, spur; Bo, body. 3’ and 5’ domain are colored yellow
and red, respectively. (This figure is taken from Wimberly et al, 2000)

Figure 1.5 The tertiary structure of rRNA on the large ribosomal subunit. The
subunit particle is in its crown view. (This figure is taken from Ban et al, 2000)
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Figure 1.6 Overview of the ribosome structure. Ribosomal proteins and RNA of the
small subunit (blue and gray) and large (green and yellow) subunits are showed in
transparency. Three tRNAs (A-, P- E- site tRNAs) are colored in orange, red and blue.
(Adapted from Jenner et al., 2010)
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Figure 1.7 Overview of swiveling and ratcheting movements of 30S subunit. Two
intermediate states I (left) and II (right) of 70S-EF-G-GDP-FAcomplex. The 30S subunit
of intermediate states I and II (yellow) is compared with the 30S subunit of the POST
(gray, Gao, et al., 2009) by aligning the respective 50S subunits. Arrows with numbers
indicate the direction and magnitude of the head-swivel and inter-subunit rotation from
the non-rotated state to the intermediate states I and II. (Adapted from Ratje, et al., 2010)
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Figure 1.8 Kinetic model of EF-G catalyzed translocation. This figure is taken from
Savelsbergh et al., 2003.
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CHAPTER II MATERIALS AND METHODS
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2.1 Materials
2.1.1 Buffers
All of the following buffers were prepared and the pH was adjusted at 25°C. Unless
otherwise specified, experiments in Chapters 3-5 were performed in Buffers A (WB
buffer) and TAM15, respectively.
Buffer A (WB): 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 and
1 mM DTT.
TAM15 buffer: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 15 mM MgCl2 and
1 mM DTT.
Polyamine buffer: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 15 mM MgCl2 5
mM putrescine 1 mM spermidine and 1 mM DTT.
Buffer B: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2 and 1 mM
DTT, 100 μM GTP, 2 mM phosphoenolpyruvate, 100 μg/mL pyruvate kinase.
Buffer C: 20 mM Tris-HCl pH 7.6, 200 mM NH4Cl, 10 mM MgAc2.
IF3 lysis buffer: 50 mM Tris-HCl pH 8.0, 1 mM EDTA, 10 mM 2-mercaptoethanol, 0.2
mM PMSF.
IF3 purification buffer A: 10 mM Tris-HCl pH 8.0, 200 mM NaCl, 5% glycerol, 1 mM 2mercaptoethanol.
IF3 purification buffer B: 10 mM Tris-HCl pH 8.0, 500 mM NaCl, 5% glycerol, 1 mM 2mercaptoethanol.
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L11 dialysis buffer A: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 2mercaptoethanol, 10 mM NaCl.
L11 lysis buffer: 50 mM NaH2PO4 pH 8.0, 300 mM NaCl, 0.5 mM Imidazole, 0.5 mM 2mercaptoethanol
L11 purification buffer A: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 2mercaptoethanol, 10 mM NaCl, 10 mM MgCl2.
L11 purification buffer B: 20 mM Hepes-HCl pH 7.0, 0.5 mM EDTA, 6 M urea, 6 mM 2mercaptoethanol, 400 mM NaCl, 10 mM MgCl2.
L11 labeling buffer: 25 mM Tris-HCl pH 7.0, 100 mM NaCl, 2 mM EDTA.
EF-G washing buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl.
EF-G washing buffer A: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 5 mM Imidazole.
EF-G washing buffer B: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 125 mM Imidazole.
EF-G elution buffer: 50 mM Tris-HCl pH 8.0, 300 mM NaCl, 300 mM Imidazole.
EF-G labeling buffer (M-labeling buffer): 25 mM Tris-HCl pH 7.0, 100 mM NaCl, 2 mM
EDTA.
EF-G purification buffer A: 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 50 mM KCl, 0.5
mM EDTA.
EF-G purification buffer B: 50 mM Tris-HCl pH 7.5, 10 mM MgCl2, 1M KCl, 0.5 mM
EDTA.
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EF-G storage buffer: 50 mM Tris-HCl pH 7.5, 70 mM NH4Cl, 30 mM KCl, 7 mM MgCl2.
TBE buffer: 45 mM Tris-HCl pH=8.0, 45 mM H3BO3, 1 mM EDTA pH=8.0.
Hybridization buffer: 100 mM Tris-HCl pH 7.5, 1 M NaCl, 10 mM EDTA.
Aminoacylation buffer A: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2, 1 mM
EDTA (pH 8.0), 7 mM 2-mercaptoethanol, 10 mM KCl, 0.01 unit/μL thermostable
inorganic pyrophosphatase, 720 μM formyl donor (see section 2.2.2.1), 67 μM [35S]-fMet
stock, 0.75 mg/mL E. coli aminoacyl- tRNA synthetases.
Aminoacylation buffer B: 100 mM Tris-HCl pH 8.0, 10 mM ATP, 50 mM MgCl2, 2.5
mM EDTA (pH 8.0), 3 mM 2-mercaptoethanol, 200 μM [3H]-Phe, 3 mg/mL yeast
aminoacyl-tRNA synthetases.
Aminoacylation buffer C: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 5 mM MgAc2, 250 μM
EDTA (pH 8.0), 7 mM 2-mercaptoethanol, 150 μM [3H]-Phe, 1 μM E. coli Phe-tRNA
synthetase.
Aminoacylation buffer D: 100 mM Tris-HCl pH 8.0, 4 mM ATP, 20 mM MgCl2, 1 mM
EDTA (pH 8.0), 7 mM 2-mercaptoethanol, 0.005 unit/μL inorganic pyrophosphatase, 100
μM [3H]Val or 67 μM [3H]-Arg or 100 μM [3H]-Lys, 3 mg/mL E. coli aminoacyl-tRNA
synthetase.
Aminoacylation buffer E: 30 mM Hepes-HCl pH 7.0, 30 mM KCl, 15 mM MgCl2, 5 mM
DTT, 4 mM ATP, 100 μM [3H]-Val, 0.01 unit/μL thermostable inorganic pyrophosphatase,
3 mg/mL of E. coli aminoacyl-tRNA synthetase.
tRNA Phe purification buffer HPLC A: 20 mM NH4Ac (pH 5.0), 10 mM MgAc2 and 400
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mM NaCl.
tRNA Phe purification buffer HPLC B: 20 mM NH4Ac (pH 5.0), 10 mM MgAc2, 400
mM NaCl, 30% EtOH.
2.1.2 Reagents
All the aqueous solutions and buffers were prepared using either double-deionized
water (DDI) from Milli-A Water System (Millipore) and treated with a BioPak filter
(Millipore) to remove the DNase, RNase and protease or diethyl pyrocarbonate DEPCtreated water (Fisher BioReagentsTM). Unless otherwise specified, all the concentrations
mentioned are the final concentrations.
The following materials were purchased from the indicated suppliers: E. coli
tRNAfMet, E. coli tRNAPhe, E. coli tRNAVal, E. coli tRNAArg, E. coli tRNALys, and yeast
tRNAPhe (Chemical Block). Cy3/Cy5 maleimide dye and Cy3/Cy5 hydrazide dye (GE
Healthcare AmershamTM ); S. O. C. medium and Top 10 competent cells (Invitrogen);
Fusidic acid, IPTG, GTP, GDPNP, streptomycin, puromycin, glucose, phenylmethanesulfonylfluoride (PMSF), tris(2-carboxyethyl)phosphine hydrochloride (TCEP),
N-hydroxysuccinimide ester, folinic acid, glutathione and proflavin salt (Sigma Aldrich);
Talon Superflow Metal Affinity Resin, NAP-5 column and pETZ24a plasmid (GE
Healthcare); phosphoenolpyruvate (PEP), pyruvate kinase (PK), RNase T1, catalase and
bulk tRNA from E. coli. MRE600 cells (Roche); Phusion DNA polymerase and DpnI
(New England Biolabs); DNA purification kit and Ni-NTA Superflow resin (QIAGEN);
BL21(DE3) competent cells and QuickChange site-directed Mutagenesis Kit (Stratagene);
ampicillin and trichloroacetic acid (TCA) (Fischer Scientific); AG 50W-X8 cation
exchange resin(Bio-Rad); thermostable inorganic pyrophosphatase (New England
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BioLabs); PEG-succinimidyl valerate (Laysan Bio); Amicon Ultra ultrafiltration units,
Ultrafree centrifugal filter unit, and nitrocellulose filters (Millipore).
2.2 Methods of preparation
2.2.1 Proteins
The cloned E. coli His-tagged proteins IF3 (N-terminal His-tagged), EF-G (Cterminal His-tagged), EF-Tu (C-terminal His-tagged), and ribosomal protein L11 (Nterminal His-tagged) were prepared, purified and labeled as previously reported (Pan et
al., 2007; Seo et al., 2006).
2.2.1.1 Purification of IF3
All steps below were performed at 4 °C. 10 g of frozen BL21(DE3) IF3 cells were
kept on ice for 10 min, and then resuspended in 30 mL of IF3 lysis buffer followed by
French Press (12,000-14,000 psi) twice. The mixture was subject to centrifugation (10 K
rpm, 30 min and SS-34 rotor) to pellet the cell debris. The supernatant was loaded onto a
10 mL Ni-NTA column (18 mm in diameter, 15cm in height) which was pre-washed with
60 mL of water and pre-equilibrated with 60 mL of IF3 lysis buffer.
The column was then washed by 60 mL of IF3 purification buffer A followed by 30
mL of IF3 purification buffer B. IF3 protein was eluted by using a hyperbolic imidazole
gradient in IF3 purification buffer B (5 mM imidazole, 40 mL; 10 mM imidazole, 20 mL;
20 mM imidazole, 10 mL; 300 mM imidazole, 50 mL) and collected in fractions.
Fractions with large amounts of IF3 were identified by 15% SDS-PAGE gel and pooled
for dialysis against buffer A (Fig 2.1). IF3 was concentrated by an Amicon Ultra
ultrafiltration units [molecular weight cutoff (MWCO): 10,000] and the concentration
was determined by Bradford assay (Bradford et al., 1976).
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2.2.1.2 Purification and labeling of WT-L11 and L11 (C38S/S87C)
L11 protein was grown and purified as previously reported (Seo et al., 2006). Wildtype and (C38S/S87C) double mutant N-terminal E. coli His-tagged L11 cells were
grown in LB medium in the presence of 100 µg ampicillin/mL at 37 °C. 1mM final
concentration of IPTG was added to the medium and the cells were grown for another 4
hours. The cell pellet was harvested by (10 K rpm, SS-34 rotor) centrifugation at 4 °C for
20 minutes each cycle, then fast frozen and stored in a -80 °C refrigerator. 14 g of pellet
was dissolved in 20 mL of L11 lysis buffer with 3 μL of DNase I (2000 U/mg) for an hour.
Cells were broken by French press (12,000 - 16,000 psi) twice and centrifuged at 15 K
rpm, SS-34 rotor at 4 °C for 30 min twice. 12 mL of Ni-NTA Superflow resin (Qiagen)
were placed into a plastic flex column (18 mm in diameter, 15cm in height). After the
resin settled, the column was washed with water twice and pre-equilibrated with lysis
buffer. The supernatant was loaded onto prepared Ni-NTA column and washed with 50
mL each of L11 elution buffers A and B. Then L11 was eluted with 50 mL of elution
buffer C and the product was collected. These procedures were repeated once. Elution
product by buffer C was analyzed by 5-14% SDS-PAGE gel (Fig 2.2, Lane 5). The
product was dialyzed against L11 dialysis buffer at 4 °C overnight and purification buffer
A at 4°C for 3 hours. After concentration (1 mL) using Amicon Ultra ultrafiltration units
(MWCO Molecular weight cut-off: 10,000), crude L11 product was purified by a
MonoS™ (5/50 GL) FPLC column and pure L11 was eluted using a linear gradient from

L11 purification buffer A to L11 purification buffer B (Fig 2.2, Lanes 1 and 2). Then an
Amicon Ultra ultrafiltration unit (MWCO: 10,000) was used to remove the urea and
replace the buffer with L11 storage buffer to allow the proper folding of L11 protein. The
final concentration of L11 was determined by Bradford assay (Bradford et al., 1976) and
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adjusted by multiplying by 0.6 as the conversion factor (Congdon et al., 1993).
L11 labeling with either Cy3 or Cy5 was purified as reported (Chen et al., 2011a).
Nap-5 column (bed volume 500 μL) was used to exchange buffer from L11 storage buffer
to L11 labeling buffer. Nap-5 column was pre-washed by DDI water 6 times, then by L11
labeling buffer 6 times. 500 μL of L11 protein was loaded to the column and eluted by 1
mL of L11 labeling buffer. 100 μM L11 in 1 mL of labeling buffer was incubated with
300 μM fresh prepared TCEP for 40 min to free disulfide bonds formed by two cysteines,
followed by addition of 500 μM Cy3 or Cy5 maleimide and incubated at room
temperature in dark for 3 hours. The reaction was quenched with 3 μL of 14.3 βMe and
the mixture was loaded onto MonoS™ (5/50 GL, bed volume 500 μL, diameter 5 mm)
FPLC column for further dye protein separation and purification. Labeled L11 was eluted
by using a linear gradient from L11 purification buffer A to L11 purification buffer B.
Pure dye came out in the first 2 - 4 tubes and labeled product was washed out in later
fractions. Different FPLC fractions were pooled and determined by 5-14% SDS-PAGE
gel (Fig 2.3). Fractions 19 - 20 were collected and combined. An Amicon Ultra
ultrafiltration unit (MWCO: 10,000) was used to further concentrate the products. L11
concentration was determined by Bradford assay as described above and corrected by
multiplying a factor of 0.6. Dye concentration was determined by A550 for Cy3 and A650
for Cy5 (Extinction coefficients: 150,000 and 250,000 M-1 cm-1 for Cy3 and Cy5,
respectively). Typical dye/L11 ratio was 0.8 - 0.9.
2.2.1.3 Purification and labeling of EF-G and the derivatives
2.2.1.3.1 Purification of EF-G
EF-G protein and its variants were grown and purified as previously reported in
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published paper (Seo et al., 2006) and optimized conditions were explored. Expression
vectors for C-terminal His-tagged E. coli EF-G were based on the pET-21a vector. EF-G
plasmid (3 μL, 50-80 ng) was transformed into BL21 (DE3) competent cells (50 μL) and
incubated on ice for 30 min. The cells were then incubated at 42 °C for 30 s, 250 μL of
pre-warmed Super Optimal Broth (S.O.C.) medium were added, and the resulting mixture
was maintained at 37 °C for one hour. The cell cultures were plated onto LB-Agar plate
supplemented with 50 μg/mL of kanamycin and grown overnight at 37 °C. A single
colony on the plate was picked and transferred to 5 mL LB medium containing 50 μg/mL
kanamycin and incubated overnight at 37 °C. The cell culture was transferred to 100 mL
of LB medium, then to 1L of LB medium at 37 °C in the presence of 50 μg/mL
kanamycin (final concentration). Incubation was maintained until A600 was 0.4 larger than
the initial value (generally A600 is ~0.4 - 0.6), followed by addition of 1 mM IPTG to
induce over-expression of EF-G protein, and the incubation was continued for another 3
hours. The cell pellet was harvested by centrifugation at 4 °C for 20 min (7 K rpm, GS3
rotor). Cell pellets were fast frozen and stored at -80°C. 8 g of cell pellet was dissolved in
15 mL of EF-G elution buffer with 3 μL of lysozyme (50 units/mL) for an hour at 4 °C.
Cells were broken by two cycles of French press (12,000 - 16,000 psi) and centrifuged at
15 K rpm with SS34 rotor at 4 °C for 30 min twice.
The supernatant was loaded onto a prepared Ni-NTA column (18 mm in diameter
and 15 cm in height) and washed by 50 mL of EF-G elution buffers A and B. The EF-G
protein fractions eluted by 50 mL of elution buffer C were collected and this purification
procedure was repeated once. Sample was collected to run 5-14% SDS-PAGE gel (Fig
2.4, Lane 9) to confirm the presence of EF-G. The solution was dialyzed against EF-G
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purification buffer A without MgCl2 at 4 °C overnight and buffer A with MgCl2 at 4 °C
for four hours (MWCO Molecular weight cut-off dialysis membrane: 15,000). After
concentration using Amicon Ultra ultrafiltration units (MWCO Molecular weight cut-off:
30,000), EF-G was further purified by self packed Q-Sepharose FPLC column (bed
volume 1 mL). Purified EF-G protein was eluted using a linear gradient from EF-G
purification buffer A to purification buffer B (Fig 2.5). Fractions with EF-G band, as
determined by 5-14% SDS-PAGE (Fig 2.4, lanes 2 - 8), were pooled and dialyzed against
WB buffer overnight at 4 °C. After concentrating by Amicon Ultra ultrafiltration units
(MWCO Molecular weight cut-off: 30,000), EF-G concentration was measured by
Bradford assay without correction factor applied.
2.2.1.3.2 Labeling of EF-G
EF-G was labeled with Cy3 or Cy5 maleimide. Nap-5 column (bed volume 500 μL)
was used to exchange buffer from WB to EF-G labeling buffer and remove βMe which
reacted with maleimide dye. Nap-5 column was pre-washed with DDI water and with EFG labeling buffer 6 times separately. 500 μL of EF-G protein (334 μM) was loaded to the
column and eluted by 1 mL of labeling buffer. The protein concentration after buffer
exchange was measured by Bradford assay and diluted to 100 μM in 1 mL volume as the
final concentration, which was incubated with a 5-fold molar excess of Cy3 or Cy5
maleimide dye for 3 hours at 37 °C in dark and then quenched by 3 μL of 14.3 M βMe.
The mixture was further purified by self packed Q-Sepharose FPLC column as previously
described. Fractions were collected and examined by 5-14% SDS-PAGE (Fig 2.6).

Fractions containing EF-G were pooled and dialyzed against 1L of WB buffer overnight
at 4 °C (MWCO membrane: 15,000). Amicon Ultra ultrafiltration units (MWCO: 30,000)

36

were used to concentrate the EF-G protein and the final concentration was determined by
Bradford assay without any conversion factor applied. Dye concentration was determined
by A550 for Cy3 and A650 for Cy5 (Extinction coefficients: 150,000 and 250,000 M-1 cm-1
for Cy3 and Cy5, respectively). Typical dye/EF-G ratio was 0.5 - 0.9, depending on
which EF-G mutant was labeled.
2.2.1.3.3 Mutants of EF-G
2.2.1.3.3.1 PCR primer design
The Stratagene QuikChange site-directed mutagenesis kit was used to construct EFG variants. The primers were designed according to the following principles (adapted
from Stratagene QuikChange site-directed mutagenesis kit Manual):
1) Both of the mutagenic primers must contain the desired mutation and anneal to the
same sequence on opposite strands of the plasmid.
2) Primers should be between 25 and 45 bases in length, with a melting temperature (Tm)
of ≥78°C. Primers longer than 45 bases may be used, but using longer primers increases
the likelihood of secondary structure formation, which may affect the efficiency of the
mutagenesis reaction. The following formula is commonly used for estimating the Tm of
primers:
Tm=81.5 + 0.41(% GC) - 675/N-% mismatch
For calculating Tm:
• N is the primer length in bases
• Values for % GC and % mismatch are whole numbers
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For calculating Tm for primers intended to introduce insertions or deletions, use this
modified version of the above formula:
Tm=81.5 + 0.41(% GC) - 675/N
where N does not include the bases which are being inserted or deleted.
The designed primer sequences can be found in Fig 2.7 with the mutant sites colored in
red.
2.2.1.3.3.2 EF-G DNA purification
Wild type EF-G cell pellet was harvested as described above. Plasmid DNA was
purified by using the QIAprep Spin Miniprep Kit (QIAGEN). (Procedures were adapted
from QIAprep Miniprep Handbook)
1) Resuspend pellet bacterial cells in 250 μL Buffer P1 and transfer to a microcentrifuge
tube.
2) Add 250 μL Buffer P2 and mix thoroughly by inverting the tube 4 - 6 times.
3) Add 350 μL Buffer N3 and mix immediately and thoroughly by inverting the tube 4 - 6
times.
4) Centrifuge for 10 min at 13,000 rpm (~17,900 x g) in a table-top microcentrifuge.
5) Apply the supernatants from step 4 to the QIAprep spin column by decanting or
pipetting.
6) Centrifuge for 30 - 60 s. Discard the flow-through.
7) Recommended: Wash the QIAprep spin column by adding 0.5 mL Buffer PB and
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centrifuging for 30 - 60 s. Discard the flow-through.
8) Wash spin column by adding 0.75 mL Buffer PE and centrifuging for 30 - 60 s.
9) Discard the flow-through, and centrifuge at full speed for an additional 1 min to
remove residual wash buffer.
10) Place the QIAprep column in a clean 1.5 mL microcentrifuge tube. To elute DNA,
add 50 μL Buffer EB (10 mM Tris-Cl, pH 8.5) or water to the center of each QIAprep
spin column, let stand for 1 min, and centrifuge for 1 min. The concentration of purified
DNA is measured by A260 (1 A260=50 ng/ μL) and about 50 -80 ng/ μL was obtained.
2.2.1.3.3.3 PCR amplification
Mutant strand synthesis reactions were performed by Thermal Cycler using the
Stratagene QuikChange site-directed mutagenesis kit. 5 μL of 10× reaction buffer, 5 ng,
10 ng, 20 ng, 50 ng of wild type EF-G plasmid, 125 ng of primer 1, 125 ng of primer 2
(Fig 2.8), 1 μL of dNTP were mixed and double-distilled water (DDI H2O) was added to
a final volume 50 µL, followed by addition of 1 μL of 2.5 U/μL PfuTurbo DNA
polymerase. The PCR machine was programmed for two segments: 1) one cycle at 95 °C
for 30 sec; 2) eighteen cycles at 95 °C for 30 sec, at 55°C (or 60 °C, or 62 °C, 65 °C) for
1 min (annealing), and at 68 °C for 5.5 min (1min/kb of plasmid length). After the final
cycle, the reaction was stopped and kept at 4 °C overnight. DpnI was added to digest the
amplification products. 1 μL of 10 U/μL DpnI restriction enzyme, 4.5 μL of reaction
buffer 4 and 40 μL of PCR amplification product were gently mixed at 37 °C for 1 hour
to digest the parental supercoiled dsDNA. Nucleotides of dsDNA in EF-G were expected
to be 5.2 Kb in length and final products were confirmed by 1% DNA Agarose gel in
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TBE buffer, showing expected brand located between 5 Kb and 6 Kb (Fig 2.8). The
desired PCR products were sequenced. The DNA plasmids confirmed by sequencing
results were transformed and then purified as described in section 2.2.1.3.3.2.
2.2.1.4 Purification of EF-Tu
EF-Tu protein was expressed and purified as previous reported (Liu et al., 2014).
Expression vectors for C-terminal His-tagged E. coli EF-Tu variants were based on the
pET15b vector. EF-Tu plasmids (50 - 80 ng) were transformed into BL21(DE3)
competent cells, and the strains was grown in Super Optimal Broth (S.O.C.) medium at
37 °C for one hour. The cell cultures were plated onto LB-Agar plate with 100 μg/mL of
ampicillin and grown overnight at 37 °C. Single colony on the plate was inoculated into 6
mL of LB medium containing 100 μg/mL of ampicillin for overnight growth at 37 °C.
The cell culture was transferred into 1 L of LB medium with 100 μg/mL of ampicillin for
growth until A600 reached ~0.6 - 0.8. Protein expression was induced by addition of 1 mM
IPTG and continued for another 3 hours at 37 °C. The cell pellet was harvested by
centrifugation at 4 °C for 20 min each cycle (7 K rpm, GS3 rotor). The pellets were
resuspended in 25 mL of EF-Tu purification buffer A and the mixture was magnetically
stirred for 30 min at 4 °C. A second incubation at room temperature for 20 min was
performed after addition of 3 μL of lysozyme (50 units/mL). Cell was broken by French
press twice (12,000 - 14,000 psi) and centrifuged (4 °C, 20K rpm with SS34 rotor, 20 min)
to remove the cell debris. The supernatant was mixed with Co(II)-Sepharose (Talon) resin
(bed volume 3 mL), pre-washed twice with 30 mL of EF-Tu purification buffer A, and
shaken at 4 °C for 1 hour. Resin bound with EF-Tu was collected by centrifugation (4 °C,
5K rpm with SS34 rotor, 5 min), washed twice by 30 mL of EF-Tu purification buffer A,
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and transferred to a small gravity column (18 mm in diameter, 4 cm in height). The
column was washed with 10 mL of EF-Tu purification buffer A, 10 mL of EF-Tu
purification buffer B and 10 mL of EF-Tu purification buffer C, respectively. EF-Tu was
eluted by EF-Tu elution buffer and the collected fraction was examined by 5-14% SDSPAGE gel (Fig 2.9). Amicon Ultra ultrafiltration units (MWCO: 10,000) were used to
concentrate the samples and replace the elution buffer with EF-Tu storage buffer. EF-Tu
concentration was determined by Bradford assay without any conversion factor applied
for correction.
2.2.2 tRNAs
2.2.2.1 Preparation of formyl donor
Formyl donor was prepared as described (Dubnoff et al., 1971). 25 mg of folinic
acid was dissolved in 2.0 mL of 50 mM 2-mercaptoethanol, followed by addition of 1.0
M HCl 0.22 mL, and the mixture was reacted for 3 hours at room temperature. Some
precipitation can occur during the reaction, which could be re-dissolved on gentle heating
in a water bath set at 37 °C. Formyl donor concentration was determined by A355 (at 355
nm, 1 μmol/mL = 25 A355). The product was then aliquoted for storage at -80 °C. Before
being used for tRNAfMet aminoacylation, the pH of formyl donor was activated by
adjusting to its neutral pH with 1/4 volume of 1 M Tris-HCl, pH 8.0 and incubating at
room temperature for 15 min.
2.2.2.2 Formylaminoacylation of tRNAfMet
Wild type commercial E. coli tRNAfMet was formylated by formyl donor and charged
by bulk E. coli tRNA synthetase, synthetase S-100 (Kirillov et al., 1981). 7 μL of [35 S]Met was mixed with 21 μL of 670 μM non-isotopic labeled Met and DDI water to form
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Met stock in a total volume of 210 μL. 36 nmol of tRNAfMet was incubated in 2 mL of
aminoacylation buffer A (which contains formyl donor) at 37 °C for 45 min. The reaction
was quenched by 200 μL, 20% (w/w) KAc (pH=5.0), aliquoted in four tubes. The
reaction mixture was extracted with 1:1 (v/v) phenol (Tris-saturated, pH 4.3, Fisher) once
and 1:1 (v/v) chloroform once. Each time, the reaction mixture was centrifuged at 8 K
rpm for 5 min (Table centrifuge, Thermo Scientific Micro 17, 24×15/2.0 mL rotor) and
the upper aqueous layer was taken for EtOH precipitation. After addition of 50 μL of 20%
KAc (pH=5.0), 1400 mL of 99% ethanol was added to the reaction mixture, then stored at
-80 °C for 40 min and centrifuged at 13 K rpm for 25 min (Table centrifuge, Thermo
Scientific Micro 17, 24×15/2.0 mL rotor).
The formylaminoacylated tRNA pellet was suspended in 1 mL of tRNA FPLC buffer
A and further purified by FPLC using a self-packed column (bed volume, 1 mL) with QSepharose resin. The final product was eluted by a gradient from tRNA FPLC buffer A
(30 mL) to tRNA FPLC buffer B (30 mL) and the product was collected as determined by
both UV peak position and radioactivity. The pooled fMet-tRNAfMet fractions were
aliquoted in 500 μL, and 20% KAc pH 5.0 (50 μL) was added, followed by 1400 μL of
ethanol. The reaction mixture was stored at -80 °C for 40 min and centrifuged at 13 K
rpm for 25 min (Table centrifuge, Thermo Scientific Micro 17, 24×15/2.0 mL rotor). The
resulting precipitate was collected and dissolved in 60 μL DEPC-treated water. The
concentration of tRNA and charging efficiency was determined by A260 (1 unit A260 =1.8
μM) and radioactivity. Typical aminoacylation stoichiometry was 1100 - 1300 pmol/A260.
2.2.2.3 Aminoacylation of tRNAPhe
Commercial tRNAPhe from yeast and E. coli was aminoacylated in the similar
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procedures as in the preparation of fMet-tRNAfMet, except that for yeast tRNAPhe and E.
coli tRNAPhe, aminoacylation buffer A was replaced by aminoacylation buffers B and C,
respectively. Typical aminoacylation stoichiometries were 550 - 700 pmol/A260, for both
yeast and E. coli Phe-tRNAPhe.
2.2.2.4 Aminoacylation of E. coli tRNAArg, tRNAVal
Commercial tRNAArg and tRNAVal from E. coli was aminoacylated in the similar
procedures as above. Similar aminoacylation steps were applied expect that: 1) E. coli
tRNAArg, 2 mL of reaction mix was in aminoacylation buffer D and the typical
aminoacylation stoichiometry was 500 - 650 pmol/A260; 2) E. coli tRNAVal, 2 mL of
reaction mix was in aminoacylation buffer E and the typical aminoacylation
stoichiometry was 1000 - 1200 pmol/A260.
2.2.2.5 Proflavin labeling fMet-tRNAfMet
E. coli fMet-tRNAfMet was fluorescently labeled by proflavin followed the protocol
reported by Pan et al., 2007. The dihydrouridine residues on the D-loop of tRNA were
reduced by NaBH4 in 0.01 M KOH and replaced by proflavin. 32 nmol of uncharged
tRNA were incubated in 40 mM Tris-HCl pH 7.5 and rapidly mixed with 35.8 μL of 100
mg/mL NaBH4 (final concentration, 10 mg/mL). The reaction mixture was maintained on
ice for 1 hour, with H2 released every 10 min. The reduction reaction was quenched by
adding 60 μL of 6 M HAc dropwise and three EtOH precipitations were performed to
purify the tRNA pellet. After proper dilution, tRNA concentration was measured by A260
and stored at -80 °C. Formylmethionylation and purification were performed as described
above. Product pellet was resuspended in 100 μL of H2O and mixed with 1 mL of 0.52
mg/mL proflavin in 0.1 M HCOONa (pH 3.7) at 37°C for 45 min. After incubation, the
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solution was adjusted to pH 7.5 by addition of 1/10 volume of 1 M Tris, and extracted
twice with 1:1(v/v) phenol (Tris-saturated, pH 6.5). Labeled tRNA was EtOH precipitated
twice after addition of 1/10 volume of 20% KAc (pH 6.5). Charging and labeling
efficiencies were generally obtained as follows: 700 - 900 pmol/A260 and 0.9 - 1.1
prf/tRNA for tRNAfMet.
2.2.2.6 tRNAPhe labeling with Cy3 or Cy5
Yeast tRNAPhe was labeled with Cy3 (Pan et al., 2008; Pan et al., 2009) or Cy5
(Kaur et al., 2011) as reported. tRNAPhe was reduced and aminoacylated as described
above. Pellet from last EtOH precipitation was resuspended in 800 μL of HPLC buffer A
and purified by phenyl RP-HPLC (RP-C18 column, 4.6 × 250 mm, Alltech) with a
gradient of 0% to 30% ethanol in 20 mM NH4Ac (pH 5.0), 10 mM Mg(Ac)2 and 400 mM
NaCl. Pooled fractions were combined and EtOH precipitated with 20% KAc (pH 5.0).
The dried pellet was resuspended in 16 μL of 0.1 M HCOONa (pH 3.7) with 4.3 μL of
300 mM fluorescence dye in DMSO to make the final concentration of dye 60 mM which
was tested to be the best labeling condition. The reaction mixture was incubated at 37 °C
for 2 hours, followed by lyophilizing the samples. The resulting solid was dissolved in
100 μL of DEPC-treated water, and then 10 μL of 20% KAc (pH 6.5) was added followed
by ethanol precipitation. The solution-precipitation step was repeated a total of three
times. Phe-tRNAPhe (Cy3 or Cy5) was obtained with an aminoacylation efficiency of
~900 pmol/A260 and ~0.5 Cy3 or Cy5/tRNA.
2.2.3 mRNA 022
mRNA 022 was purified as reported (Pan et al., 2007). 100 µL of mRNA 022
plasmid ( 2.9 µg/µL) from Wei Liu was linearized by incubating with Hind III enzyme
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(30 µL, 100,000 units/mL), a type II restriction enzyme, 10 fold buffer 2, and DEPC
water, all from Hind III-HF kit (New England BioLabs), at 37 °C overnight. Linearized
mRNA plasmid was extracted once with 1:1 (v/v) phenol/chloroform and once with
chloroform, followed by EtOH precipitation with 1/10 volume of 20% KAc (pH 5.0). The
pellet was dried and dissolved by 100 μL of DEPC-treated water. Dilutions were
performed to allow concentration of mRNA to be determined by A260 (0.1 - 1.0). Plasmid
(9 µL, 150 ng/μL) was mixed with the following materials from the EPICENTRE
AmpliscribeT7-Flash Transcription Kit: 36 µL of NTPs (100 mM, initial concentration,
for each of ATP, CTP, GTP and UTP), 40 µL of DTT (100 mM, initial concentration), 40
µL of T7 enzyme (10,000 units/mL) and 127 μL RNase-free water in a total volume 400
μL. Following incubation of the mixture at 42 °C for 2 hours, 40 μL of DNase I (1
MBU/μL) was added and incubation was continued at 37 °C for 15 min. The reaction
mixture was extracted by 400 μL of 1:1(v/v) phenol/ chloroform once and 400 μL of
chloroform once. 400 μL of chilled 5 M LiCl was added to the upper aqueous layer and
left on ice for 1hour, followed by centrifugation at 15 K for 20 min (Thermo Scientific
Micro 17, 24×15/2.0 mL rotor in cold room). The mRNA pellet was resuspended in 200
μL of DEPC water and further purified by EtOH precipitation (99-100% ethanol). The
pellet was washed by 400 μL of 70% ethanol and subjected to centrifugation at 15 K rpm
for 5 min (Thermo Scientific Micro 17, 24×15/2.0 mL rotor in cold room). The purified
pellet was dried and resuspended by 200 μL of DEPC water, followed by another EtOH
precipitation and the final product was resuspended in 200 μL of DEPC water. The
concentration and purity of mRNA was determined by A260, assuming 0.04 mg/A260 and
electrophoretic analysis on 2% Agarose gel, respectively (Fig 2.10).
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2.2.4 70S ribosomal complexes
The mutant 70S ribosomes lacking L11 from E. coli AM77 cells and tight coupled
wild-type 70S ribosomes from E. coli MRE600 cells were prepared and purified as
previously reported (Liu et al., 2010; Pan et al., 2007).
2.2.4.1 Preparation of Cy3 or Cy5 labeled 70S ribosome
The reconstitution of 70S ribosomes containing L11Cy3 or L11Cy5 were performed as
described (Chen et al., 2011a). A two-fold molar excess of C38-L11Cy5 or C38S/S87CL11Cy5 was incubated with E. coli AM77 ribosome. 53 μL of 46 μM Cy5 labeled L11
(2400 pmol) and 64 μL of 19 μM AM77 70S (1200 pmol) were incubated separately at
37 °C for 5 min in WB buffer. Then the two solutions were mixed and continued
incubating at 37 °C for 15 min. MgCl2 was added to the mixture to increase the final
Mg2+ concentration to 20 mM, and the mixture was subject to centrifugation through a
sucrose cushion in WB buffer with 1.1 M sucrose, 1 mM DTT and 20 mM Mg2+
(SORVALL S120-AT2 rotor, 110K rpm, 40 min, 4 °C) to pull down the labeled 70S
ribosome. The pellet was resuspended in 100 μL of WB buffer. 70S concentration was
determined by A260 and dye concentration was determined by A550 for Cy3 or A650 for Cy5,
respectively. A typical labeling efficiency is 0.8 - 1.0 dye per 70S ribosome.
2.2.4.2 Preparation of initiation complex
For ensemble experiments, 70S initiation complex was formed by incubating 2 μM
WT or labeled ribosomes with 8 μM mRNA, 3 μM IF1, 3 μM IF2, 3 μM IF3, 1 mM GTP
and 3 μM [35S]-fMet-tRNAfMet or 3 μM [35S]-fMet-tRNAfMet (prf 20) for 25 min at 37°C
in WB buffer. The mixture was centrifuged through a sucrose cushion in WB buffer with
1.1 M sucrose and 1 mM DTT (SORVALL S120-AT2 rotor, 110K rpm, 40 min, and 4 °C)
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to pull down 70S initiation complex and get rid of all unbound protein factors. Initiation
complex concentration was determined by ribosome-bound [35S]-fMet-tRNAfMet. The
stoichiometry per ribosome of tRNA bound [35S]-fMet was typically ranged from 0.4-0.8,
depending on ribosome preparation.
For single molecule experiments, two unlabeled initiation complexes and two labeled
initiation complexes were prepared by mixing 1 μM WT or labeled ribosome with 4 μM
mRNA, 1.5 μM each of IF1, IF2, IF3, 1 mM GTP and 1.5 μM [35S]-fMet-tRNAfMet for 25
min at 37 °C in a total volume of 40 μL. IC-1 contains mRNA MVF and WT ribosomes;
IC-2 contains mRNA MFK and WT ribosomes; IC-3 contains mRNA MFK and
C38L11Cy5-ribosomes; IC-4 contains mRNA MFK and C38S/C87L11Cy5-ribosomes. The
initiation complex was subjected to centrifuge through a sucrose cushion in WB with 1.1
M sucrose and 1 mM DTT (SORVALL S120-AT2 rotor, 110K rpm, 40 min at 4 °C).
2.2.4.3 Preparation of ternary complex
Ternary complex was formed by incubating EF-Tu (4.5 - 6 μM) with 1 mM GTP, 1.5
mM phosphoenolpyruvate (Roche Diagnostics), 0.005 mg/mL pyruvate kinase (Roche
Diagnostics) in WB buffer for 5 min to activate EF-Tu. Then unlabeled or labeled PhetRNAPhe (3 μM), or unlabeled or labeled Val-tRNAVal, or unlabeled Arg-tRNAArg, or
unlabeled Lys-tRNALys (3 μM) was added and incubated for another 5 min at 37 °C in
WB buffer.
2.2.4.4 Preparation of PRE complex
PRE complex was formed as published preparation (Pan et al., 2007). Initiation
complex (1 µM, final concentration) and ternary complex (2 µM, final concentration)
were incubated at 37 ºC for 45 sec. The product was purified by ultracentrifugation
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through a 1.1 M sucrose cushion in WB buffer with 20 mM Mg2+( SORVALL S120-AT2
rotor, 110K rpm, 40 min, 4 °C). PRE complex concentration was determined from
ribosome-bound fMet-[3H]-Phe-tRNAPhe, which typically varied from 0.6 - 0.8/ribosome.
The stoichiometry per ribosome of tRNA bound [3H]-Phe was typically 0.6 - 0.7. In
single molecule experiments of the A-site tRNA and EF-G interaction, two PRE
complexes were used. PRE-I was formed by incubating IC-1 (0.4 - 1 pmol) with Cy5
labeled Val-tRNAVal ternary complex (0.8 - 2 pmol) on ice for 1 min. PRE-II was
prepared similarly by incubating IC-2 with Cy5 labeled Phe-tRNAPhe ternary complex.
For single molecule experiments measuring L11Cy5 and EF-GCy3 interaction, PRE-II38-Cy5
was formed by incubating C38L11Cy5-IC-3 with wild type Phe-tRNAPhe ternary complex
and labeled PRE-II87-Cy5 was formed by incubating Cy5 C38S/C87L11 labeled IC-4 with
wild type Phe-tRNAPhe ternary complex on ice for 1 min.
2.2.4.5 Preparation of POST complex
POST complex was prepared by incubation of initiation complex (1 µM) and ternary
complex (2 µM) at 37 ºC for 45 sec, followed by addition of 5 μM EF-G and 1 mM GTP
at 37 ºC for 10 min, and ultracentrifugation through a 1.1 M sucrose cushion (SORVALL
S120-AT2 rotor, 110K rpm, 40 min, 4 °C) in WB buffer. POST complex concentration
was calculated from the amount of ribosome-bound fMet-[3H]-Phe-tRNAPhe. The
stoichiometry per ribosome of tRNA bound [3H]-Phe was typically 0.6-0.7
2.2.5 Ensemble fluorescence measurements
All the ensemble experiments were measurements and associated incubation steps
were performed at 25.0 °C.
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2.2.5.1 Static fluorescence experiments
Steady-state fluorescence was measured on a photon-counting instrument
(Fluorolog-3 spectrofluorometer, Horiba Jobin Yvon). The Cy5 fluorophore was excited
at 600 nm wavelength and the emission spectrum from 610 - 740 nm wavelength was
recorded. The Cy3 fluorophore was excited at 514 nm wavelength and the emission
spectrum from 530 - 750 nm wavelength was recorded.
Solutions containing Cy3 labeled EF-G and wild type 70S or PRE complexes were
excited at 514 nm and the emission was monitored from 530 to 750 nm wavelength.
Solutions containing Cy3 labeled EF-G and L11Cy5-70S or L11Cy5-PRE complex were
excited at 514 nm and the emission was monitored from 530 to 750 nm wavelength.
Solutions containing wild type EF-G and L11Cy5-70S or L11Cy5-PRE complex were
excited at 600 nm and the emission was monitored from 610 - 740 nm wavelength. The
same wavelengths were utilized for experiments performed with fusidic acid. The four
samples in each case differ only in the presence or absence of the donor (Cy3) or acceptor
(Cy5) dyes, and they are designated D*A (donor-containing), D*A* (donor- and
acceptor-containing), DA* (acceptor-containing), and DA (a blank sample without donor
or acceptor dyes). Signal of DA was subtracted from those of D*A*, D*A and DA* to
correct

the

light

scattering

and

background

fluorescence.

Fluorescence

of

was subtracted from D*A* signal as a correction for donor leakage
in the acceptor channel. Then DA* signal upon 514 nm excitation was subtracted from
the corrected value of D*A* signal, yielding the extracted D*A (Cy5) fluorescence from
energy transfer (Seo et al., 2006).
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2.2.5.2 Kinetic experiments
2.2.5.2.1 Stopped-flow fluorescence experiments
Experiments were performed in an SX.18MV stopped-flow spectrofluorometer
(Applied Photophysics) with excitation ranging from 500 to 600 nm. The dead time is 1 2 ms, giving sufficient time resolution for most of the fluorescence or FRET changes
monitored. For the fluorescence experiments, Cy3 dye was excited at 530 nm and
monitored with a 570 ± 10 nm band pass filter. Proflavin was excited at 462 nm and
monitored with a 515 ± 15 nm band pass filter. For FRET experiments, Cy3 dye was
excited at 530 nm and monitored with 670 ± 10 nm band pass filter for Cy5 signal. Slit
widths were 2 nm for the excitation. For every independent experiment, signals from the
initial 2 to 3 shots were not collected to make sure the two chambers were filled with
reaction mixtures. Collected fluorescence signals were averaged from at least 5 traces to
make sure the abnormal traces were not counted and each experiment was repeated at
least twice to make sure the results were reproducible. Apparent rate constants (kapps)
were obtained by either single

or double exponential fitting
of each independent experiment using Origin 9.0

(OriginLab).
2.2.5.2.2 Puromycin assay
Puromycin (puro) experiments were designed as reported in Pan et al, 2007 and
optimized experimental condition was tested. Puromycin is an analog of 3’ end tyrosyltRNA which has a 3000 fold greater reactivity with the P-site peptidyl tRNA than the Asite peptidyl tRNA. All experiments were performed at 37 °C in WB buffer. For the
control group, 20 μL of PRE complex was incubated with 20 μL of puro for 10 sec and
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then quenched with 150 μL of 0.3 M NaAc (pH=5.2). In the real experiment, 20 μL of
PRE complex was incubated with 2 μM wild type EF-G or Cy3 labeled EF-G derivatives
for 20 s, followed by addition of 20 μL puro for 10 sec and quenched with 150 μL of 0.3
M NaAc (pH=5.2). The quenched products were extracted by 600 μL of ethyl acetate and
counted the radioactivity of [35 S]-fMet-tRNAfMet.
2.2.6 Single molecule FRET experiments
2.2.6.1 Temperature
Single molecule experiments were performed at 21 °C.
2.2.6.2 Microscope
Microscope was set up as described in (Chen et al., 2011a). A custom-built
objective-type total internal reflection fluorescence (TIRF) microscope was based on a
commercial inverted microscope (Eclipse Ti, Nikon) with a 1.49 N.A. 100×oil immersion
objective (Apo TIRF; Nikon, Tokyo, Japan). A Dual View splitter (Photometrics, Tucson,
AZ) was used to separate fluorescence intensities of Cy3 channel (550-620 nm) from Cy5
channel (660-720 nm). Cy3 fluorophore was excited by a 532 nm laser (CrystaLaser, Inc.)
and Cy5 fluorophore was excited by a 640 nm laser (Coherent, Inc.). The FRET signal
between Cy3 and Cy5 was measured by the corrected emission of Cy5 fluorophore.
Fluorescence signals were recorded with an electron multiplying charge-coupled device
(EM-CCD) camera (Cascade II, Photometrics) at either an 11 ms or a 35 ms integration
time, the 11 ms integration time was achieved by cutting the exposure area down to 128
pixels × 512 pixels without further binning and the 35 ms integration time was recorded
by using the whole area (512 pixels × 512 pixels).
Fluorescence data was collected and analyzed as described below (adapted from
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Chen et al., 2011). Collected movies were analyzed by a custom-made software program
developed as an Image J Plugin. Fluorescence spots were fitted by a two-dimensional
Gaussian function within 9 pixels × 9 pixels area, matching the donor and acceptor spots
using a variant of the Hough transform (Illingworth et al., 1988). The background
subtracted central intensity of the two-dimensional Gaussian peak was used as raw
fluorescence intensity I. Actual FRET efficiency was calculated by

(Equation 2.1)

where ID is raw fluorescence intensity of donor, IA is raw fluorescence intensity of
acceptor, and χ is the cross-talk of the donor emission into the acceptor channel.
accounts for the differences in quantum yield and detection efficiency between the donor
and the acceptor and is calculated as the ratio of change in the acceptor intensity (ΔIA) to
change in the donor intensity (ΔID) upon acceptor photobleaching and transition between
different FRET states (

.

2.2.6.3. Preparation of PEG-coated slides
PEG-coated slides were prepared as described in Chen et al, 2011. Glass slides and
coverslips (Fisher Scientific) were sonicated in acetone for 10 min at 40 °C, then washed
with water 3 times and the entire procedure was repeated once. The slides and coverslips
were sonicated in 200 mM KOH for 20 min at 40 °C and dried at room temperature.
Slides and coverslips were aminosilanized by 1% (v/v) 3-aminopropyltriethoxysilane
(United Chemical Technologies, Inc.) and 5% (v/v) acetic acid in methanol, and then the
containers were sealed in dark overnight under room temperature. The slides and
coverslips were washed by DDI water and EtOH five time each, followed by incubation
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with a polyethylene glycol mixture, which is 20% (w/v) 5000 MW PEG-succinimidyl
valerate (Laysan Bio) and 0.25% (w/v) 5000 MW biotin-PEG-succinimidyl valerate
(Laysan Bio) in 100 mM NaHCO3 solution for 3 hours in dark (Roy et al., 2008). The
prepared sides and coverslips were dried, sealed and stored in a -20 °C refrigerator.
2.2.6.4 Immobilizing the ribosome complex onto the slides
All the smFRET studies were carried out at 21 °C in TAM15 buffer unless otherwise
specified. 30 μL of 0.5 mg/mL streptavidin was added to the slides and the excess
material was washed away by TAM15 buffer. Initiation complexes (0.4 - 1 pmol)
containing a 5’-biotinylated mRNA (Dharmacon RNAi Tech) were mixed in a 1:2 ratio
with ternary complexes (0.8 - 2 pmol) in 30 μL of reaction buffer for 1 min on ice to form
PRE complexes, which were later immobilized onto a biotin/PEG-streptavidin coated
glass surface and washed with buffer to remove unbound complexes. The washing buffer
was composed of an enzymatic deoxygenation system of 3 mg/mL glucose, 100 μg/mL
glucose oxidase, 40 μg/mL catalase, 1.5 mM 6-hydroxy-2,5,7,8-tetramethyl-chromane-2carboxylic acid (Trolox, Sigma-Aldrich) and 1 mM GTP to diminish fluorophore
photobleaching and blinking. After quick injection of 5 to 10 nM Cy3 labeled EF-G
derivatives, real-time Cy3 and Cy5 fluorescence signals were collected for 1 min, then
the microscope was moved to another area of the slide for data collection.
2.2.6.5 Data analysis of single molecule experiments
2.2.6.5.1 FRET efficiency distribution
FRET efficiency distribution was plotted in the range of -0.2 to 1.2 by collecting all
the FRET traces and using 0.02 as the bin size. The FRET peaks were fitted by the
Gaussian function.

53

y=y0 + (

)

(Equation 2.2)

2.2.6.5.2 Dwell time distribution
Dwell time distribution was plotted in a range of 0 to 220 frames (35 ms per frame)
by collecting all the FRET traces and using 1 or 2 frames as the bin size, depending on
the number of traces collected. The dwell time distribution was fitted by either single
(Equation 2.3) or double exponential decay (Equation 2.4). The fitting result is mostly
contributed from the fast components of the FRET recordings as the best fit is obtained in
this region, whereas the slow component is not that well fitted. However, this fitting
strategy is reasonable, for the slow component is likely to be inactive ribosome
complexes, for instance, complexes with unchanged tRNA in the P-site or less active
PRE complexes. To simplify the term, we denote our fitting result as dwell time, but
precisely, it is the result of fitting the fast components of the FRET traces.

(Equation 2.3)

(Equation 2.4)
2.2.6.5.3 ΔFRET, Initial and Final FRET distributions
FRET events which lasted longer than 6 frames were selected. The initial and final
FRET was calculated as the averaged results of the first and last three frames,
respectively. The global fitting results suggested that for some experiments, fast FRET
change occurred soon after EF-G binding. For these events, only 4 frames were examined,
with the first frame value defined as initial FRET and the last three averaged as the final
FRET to avoid an averaging protocol that would miss the fast FRET change occurring
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early in the event. Results were plotted as a two-dimensional transition density contour
map. Similar selection criteria were applied and the transition density map was plotted by
mapping the initial FRET value along the x axis and final FRET value along the y axis
directly. In this way, the number of events with specific initial and final FRET values
could be counted from the map. The FRET difference distribution, which was calculated
by final FRET value minus initial FRET value, was plotted in the range of -0.8 to 0.8
using 0.02 as the bin size. The initial FRET and final FRET distributions were plotted in
the same way.
2.2.6.5.4 Postsynchronized analysis
Postsynchronized analysis was performed as reported in previous two papers (Chen
et al., 2012; Chen et al., 2011a) in order to reduce the noise of the data collected. All
FRET events were lined up at an identifiable trigger transition and averaged. To get equal
durations, all individual traces were extended at the prior and subsequent segment ends.
FRET traces were aligned at the beginning (pre-synchronization) or end (postsynchronization). The averaged results revealed the dynamics of the molecules leading up
to and following the transition and provided information which was previously hidden
due to the noise of the collected data (Fig 2.11). The lifetime of any given state is equal to
the reciprocal of transition rate of the given state and the apparent overall translocation
rate is the reciprocal of the summed lifetimes of all states in translocation. Two kinetic
models were built to study the transition rates by fitting the FRET efficiency. All the
results were fitted by Scientist 3.0 (MicroMath) and the detail programs are as follows:
Three-state model 1: Fitted by FRET
Define:
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T, time;
Y1, FRET efficiency of pre-synchronization trace;
Y2, FRET efficiency of post-synchronization trace;
k1, k2, k3: transition rates;
F1, F2, F3: FRET efficiencies of different complexes;
A, B, C: concentrations of different complexes in pre-synchronization analysis;
D, E, F: concentrations of different complexes in post-synchronization analysis.
// Simulations
IndVars: T
DepVars: Y1, Y2
Params: k1, k2, k3, F1, F2, F3
Y1=F1*A+F2*B+F3*C
A'=-k1*A
B'=k1*A-k2*B
C'=k2*B

Y2=F3*D+F2*E+F1*F
D'=-k3*D
E'=k3*D-k2*E
F'=k2*E
// Parameter values and constrains
//Initial conditions
T=0
A=1
B=0
C=0
D=1
E=0
F=0
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>
Two-state model: Fitted by FRET
Define:
T, time;
Y1, FRET efficiency of pre-synchronization trace;
Y2, FRET efficiency of post-synchronization trace;
k1, k2: transition rates;
F1, F2: FRET efficiencies of different complexes;
A, B: concentrations of different complexes in pre-synchronization analysis;
D, E: concentrations of different complexes in post-synchronization analysis.
// Simulations
IndVars: T
DepVars: Y1, Y2
Params: k1, k2, F1, F2

Y1=F1*A+F2*B
A'=-k1*A
B'=k1*A
Y2=F2*D+F1*E
D'=-k2*D
E'=k2*D
// Parameter values and constrains
//Initial conditions
T=0
A=1
B=0
D
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Figure 2.1 Electrophoretic analysis of IF3 by 15% SDS-PAGE gel. Protein
concentration measured by Bradford is 180 µM, IF3 (21 KD).
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Figure 2.2 Electrophoretic analysis of His-tagged L11 fractions. Lane 1, L11 (14.5
kDa) after FPLC, 3µL; Lane 2, L11 after FPLC, 9µL; Lanes 3 and 4, L11 pellet debris
after centrifugation and before Ni-NTA column purification; Lane 5, 2nd flow through of
L11 elution buffer C of Ni-NTA column purification; Lane 6, 1st flow through of L11
elution buffer A of Ni-NTA column purification; Lane 7, 2nd flow through of L11 elution
buffer A of Ni-NTA column purification; Lane 8, 1st flow through of L11 elution buffer B;
Lane 9, 2nd flow through of L11 elution buffer B of Ni-NTA column purification.
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Figure 2.3 Electrophoretic analysis of labeled L11 fractions after FPLC. Lanes 1 - 8
corresponded to FPLC fractions 16 - 23. Fractions 19 - 20 (lanes 4 and 5) were collected
and combined.
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Figure 2.4 Electrophoretic analysis of EF-G fractions of FPLC. Lane 1, EF-G (74
kDa) after final concentration by Amicon Ultra ultrafiltration units (after FPLC); Lanes 2
- 8, different FPLC fractions of EF-G; Lane 9, EF-G protein eluted by EF-G elution
buffer C after Ni-NTA column and before FPLC purification.
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Figure 2.5 FPLC buffer gradient of EF-G purification. The second red peak (24 - 37
mL) indicated the elution fraction of EF-G protein.
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Figure 2.6 Electrophoretic analysis of labeled EF-G. The labeled product was purified
product after FPLC.
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Figure 2.7 Designed EF-G primers
(The mutant sites were marked red).
Primer 1 S453C (32- number of nucleotides)
GG ACT GAC GAA GAA TGC AAC CAG ACC ATC ATC
GAT GAT GGT CTG GTT GCA TTC TTC GTC AGT CC
Primer 2 N454C (32)
CT GAC GAA GAA TCT TGC CAG ACC ATC ATC GCG
CGC GAT GAT GGT CTG GCA AGA TTC TTC GTC AG
Primer 3 Q455C (32)
GAC GAA GAA TCT AAC TGC ACC ATC ATC GCG GG
CC CGC GAT GAT GGT GCA GTT AGA TTC TTC GTC
Primer 4 T456C (33)
GAA GAA TCT AAC CAG TGC ATC ATC GCG GGT ATG
CAT ACC CGC GAT GAT GCA CTG GTT AGA TTC TTC
Primer 5 G484C (36)
GTT GAA GCG AAC GTA TGC AAA CCGCAG GTT GCT TAC
GTA AGC AAC CTG CGG TTT GCA TAC GTT CGC TTC AAC
Primer 6 K485C (33)
GAA GCG AAC GTA GGT TGC CCGCAG GTT GCT TAC
GTA AGC AAC CTG CGG GCA ACC TAC GTT CGC TTC
Primer Q487C (33)
CG AAC GTA GGT AAA CCG TGC GTT GCT TAC CGT G
C ACG GTA AGC AAC GCA CGG TTT ACC TAC GTT CG
Primer V488C (32)
GTA GGT AAA CCG CAG TGC GCT TAC CGT GAA AC
GT TTC ACG GTA AGC GCA CTG CGG TTT ACC TAC
Primer A489C (33)
GGT AAA CCG CAG GTT TGC TAC CGT GAA ACT ATC
GAT AGT TTC ACG GTA GCA AAC CTG CGG TTT ACC
Primer A690C (32)
CTG AAG TAT GAT GAA TGC CCG AGT AAC GTT GC
GC AAC GTT ACT CGG GCA TTC ATC ATA CTT CAG
Primer S692C (34)
G TAT GAT GAA GCG CCG TGC AAC GTT GCT CAG GCC
GGC CTG AGC AAC GTT GCA CGG CGC TTC ATC ATA C
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Primer N693C (31)
GAT GAA GCG CCG AGT TGC GTT GCT CAG GCC G
C GGC CTG AGC AAC GCA ACT CGG CGC TTC ATC
For 231 C-E (36)
GCA GCT GAA GCT TCT GAA GAG CTG ATG GAA AAA TAC
GTA TTT TTC CAT CAG CTC TTC AGA AGC TTC AGC TGC
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Figure 2.8 Electrophoretic analysis of PCR product of EF-G derivatives. This gel
contains 1% agarose. Lanes 1, 4 and 8, A690C-EF-G DNA with annealing temperatures
of 65 °C, 62 °C and 60 °C, respectively; Lanes 2 and 6, S692C-EF-G DNA with
annealing temperatures of 65 °C and 62 °C respectively; Lanes 3 and 7, N693C-EF-G
DNA with annealing temperatures of 65 °C and 62 °C respectively. Our experimental
results confirmed the presence of dsDNA encoding EF-G protein, as it is expected to be
5.2 kilobases in length.
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Figure 2.9 Electrophoretic analysis of wild type EF-Tu. Product was purified by
Co(II)-Sepharose resin and the presence of EF-Tu (43.2 kDa) is confirmed by 4-15%
SDS-PAGE gel.
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Figure 2.10 Electrophoretic analysis of mRNA. mRNA 022 (63 nucleotides) is labeled.
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Figure 2.11 Scheme of postsynchronized analysis. All FRET events are lined up at an
identifiable trigger transition and averaged. To get equal durations, all individual traces
are extended at the prior and subsequent segment ends. FRET traces are aligned at the
beginning (pre-synchronization, black) or at the end (post-synchronization, red).
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CHAPTER III EF-G MUTANT SCREENING AND ENSEMBLE
FLUORESCENCE STUDIES OF TRANSLOCATION
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Abstract
Ribosomes are large ribonucleic particles with three tRNA binding sites. The main
function of ribosomes is to carry out protein synthesis which can be divided into three
basic processes: initiation, elongation and termination. EF-G, one of the two conserved
translation elongation factors, catalyzes translocation of the A, P site tRNAs to the P, E
sites. In this work, 15 different EF-G mutants in which a Cys residue replaced a wild type
residue were designed with the help of two structural models, including EF-G bound to
the ribosome in the presence of fusidic acid (FA) (Gao et al., 2009) and EF4 bound to
the ribosome (Connell et al., 2008). Of these 15 EF-G derivatives, 7 were expressed
successfully and were labeled at the introduced Cys residue with 40 - 90 % labeling
efficiency (Fig 3.1). Each of these EF-G derivatives showed translocation activity in two
different assays, with apparent rate constants ranging from 1.4 - 2.5 s-1. In static
experiments, all Cy3-EF-G derivatives showed FRET with large ribosomal protein L11
(L11) in the presence of either FA and GTP or GDPNP, although the FRET efficiency was
different under these two experimental conditions. Different L11:EF-G FRET efficiencies
were also obtained in comparing vacant 70S ribosomes and pretranslocation (PRE)
complexes, suggesting the importance of the A-site tRNA in studies of EF-G function in
translocation. None of the Cy3-labeled EF-G variants studied showed significant FRET
changes in ensemble kinetic experiments in which EF-G was rapidly mixed with PRE
complex. However, in the presence of FA, sizable EF-G:L1138-Cy5 FRET changes were
observed for EF-G453-Cy3, EF-G655-Cy3, and EF-G693-Cy3, with apparent rate constants of
0.14 - 0.29 s-1, suggesting that FA traps EF-G on the ribosome in a state that follows
translocation. Preliminary single molecule fluorescence resonance energy transfer
(smFRET) studies were carried out on these three mutants. FRET with both the A-site
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tRNA and L11 was only observed for the EF-G693-Cy3 mutant, so this mutant was picked
to carry out the detailed smFRET studies described in Chapter 4.
3.1 Introduction
The detailed mechanism of EF-G catalyzed translocation during the elongation cycle
is still unclear. A well accepted model is that after the peptide bond formation, the A-site
tRNA oscillates between the classic (A/A) and hybrid states (A/P), and the 30S subunit is
rotated counterclockwise about 6° relative to the 50S subunit as the ratcheted movement
(Schuwirth et al., 2005; Zhang et al., 2009). EF-G.GTP first binds to the GTPase
associated center (GAC) and the mobile C terminal domain (CTD) of L7/12 reaches into
solution to promote this binding process. Compared to the isolated ribosome stalk, the
CTD of L7/12 is close to N-terminal domain (NTD) of L11 and bridges the interaction of
EF-G with L11 (Gao et al., 2009). EF-G hydrolyzes GTP immediately after binding to
the ribosome, the rate of which is at least 5 fold faster than the translocation rate
(Rodnina et al., 1997). By using a non-hydrolyzable GTP analogue GDPNP, a single
round of translocation is promoted with a slower rate (Pan et al., 2007; Rodnina et al.,
1997; Zavialov et al., 2003). The relative movements between Domains I, II and
Domains III, IV, V are of crucial importance as Domains I and V cross-linked EF-G was
inactive in both translocation and turnover on the ribosome (Peske et al., 2000). Domain
IV contains two loops at its tip region, loop I (496 - 509) and loop II (567 - 579) with two
conserved glycines (502 and 503) located on loop I to facilitate a tight turn which allows
loop I to be inserted into the minor groove (Gao et al., 2009). The Domain IV truncated
EF-G protein retained GTPase activity but only promotes single round of translocation
(Savelsbergh et al., 2000). Because of this great functional importance of Domain IV in
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translocation, when we selected potential sites on EF-G for fluorescent label introduction,
many positions within Domain IV were not considered, to avoid potential effects on EFG catalytic activity.
3.2 Results
3.2.1 Nomenclature
Cy3-labeled EF-G mutants H655C, Q669C, S453C, Q455C, Q487C, S692C, and
N693C are denoted EF-G655-Cy3, EF-G669-Cy3, EF-G453-Cy3, EF-G455-Cy3, EF-G487-Cy3, EFG692-Cy3, and EF-G693-Cy3, respectively. 70S ribosomes and pretranslocation complexes
containing Cy5 labeled L11 at position 38 are denoted 70S38-Cy5 or PRE-II38-Cy5,
respectively. PRE complexes containing Cy5 labeled A-site fMet-Phe-tRNAPhe(Cy5) are
denoted PRE-IItRNA-Cy5.
3.2.2 EF-G mutant screening
Potential mutant sites on EF-G for introduction of a fluorescent label should meet the
following criteria: 1) L11 or the A site tRNA are within FRET (Ro) range of a Cy3/Cy5
pair (about 50 Å); 2) the labeling site should be exposed to the solvent instead of buried
inside the structure; 3) the amino acid should not be conserved, and less likely to have
functional importance. As we have material stocks and developed matured labeling
strategies for position 38 on large ribosomal protein L11 and labeled tRNAs at the elbow
region, the site of EF-G labeling was selected based on its distance to these two sites
(Kaur et al., 2011; Seo et al., 2006). As there was no accessible structure of EF-G bound
to the ribosome with A site tRNA in presence when we started the mutant selection, two
structures were used to find proper mutant sites, including structure of EF-G bound
ribosome complex containing P/P and E/E site tRNAs in the presence of FA (Gao et al.,
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2009) and EF4 (Lep A) bound ribosome structure containing A/L, P/P, E/E site tRNAs,
and GDPNP (Connell et al., 2008). FA prevents EF-G release from the ribosome after
GTP hydrolysis. FA traps EF-G in a stable intermediate conformation as it locks switch II
of G domain in a conformation similar to the GTP form even after GTP hydrolysis. This
prevents the transmission of conformational changes to Domains III and IV while switch
I is in a conformation similar to the GDP form (Gao et al., 2009). EF4 competes with
EF-G for binding to the PRE complex and leads to a transient inhibition of elongation
(Liu et al., 2011; Liu et al., 2010; Qin et al., 2006). The protein domains of EF4 are
homologous of Domains I, II, III, and V of EF-G but with a unique C terminus (Fig 3.2).
The lack of Domain IV in EF4 allows formation of a stable complex in which the A-site
tRNA and EF4 are bound to the ribosome simultaneously (Fig 3.3). 3 mutant sites were
picked based on the first structure and another 12 mutants were selected based on the
latter one. Of these 15 EF-G derivatives, 7 were expressed successfully and with 60 - 90 %
labeling efficiency, except for Q669C-EF-G which showed a labeling efficiency of 40 %
(Table 3.1).
3.2.3 EF-G activity tests
3.2.3.1 Puromycin activity
Puromycin (Puro) is an analog of 3’ end tyrosyl-tRNA which has a 3000-fold greater
reactivity as a peptidyl acceptor when peptidyl-tRNA is bound in the P-site than when it
is bound in the A-site (Dorner et al., 2006; Pan et al., 2007; Semenkov et al., 1992;
Sharma et al., 2004). Therefore, formation of peptidyl-puromycin provides a quick way
to determine if the mutant is active or not for translocation, as posttranslocation (POST)
complexes have a much higher reactivity toward compared to PRE complexes. 70S
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initiation complex (70SIC), in which fMet-tRNAfMet is bound in the P-site while the Asite is empty, also shows a high activity toward transferring fMet to puro. PRE complex
in which peptidyl-tRNA occupies the A-site has a very low reactivity toward puro.
Reaction products on incubating PRE complex with wild type EF-G or Cy3-EF-Gs
should show comparable puro reactivity if the Cy3 labeled EF-G derivatives are fully
functional. As the labeling efficiencies of EF-Gs are 40 - 90 % and the reaction takes
about 30s, it is hard to determine if the reactivity toward puro reflects the real activity of
labeled EF-Gs or unlabeled species. However, all these mutants are confirmed to be
active. Experiments were performed as described in Chapter 2 and the same amount of
wild type EF-G was studied together with all the labeled EF-G mutants as the positive
control. In this assay puro reactivities of IC and of POST complex formed from PRE
complex by addition of WT-EF-G were approximately equal and ~3 to 4 fold greater than
PRE complex (Fig 3.4). POST complexes formed with each of seven labeled EF-Gs
showed equivalent reactivities to that seen with WT-EF-G. To simplify our descriptions
of experimental conditions, all concentrations mentioned for both static and kinetic
experiments are based on final concentrations after mixing.
3.2.3.2 Translocation rate constant
The previous assay only measured the stoichiometry of EF-G-induced translocation.
A more stringent test of EF-G derivative activity comes from measuring the rate of EF-G
catalyzed translocation. The kinetic activities of labeled EF-G were measured by a
translocation assay, monitored by using proflavin (prf) labeled tRNA programmed at the
ribosomal A site. Prf can be used to label dihydrouridines within the elbow region (Dloop) of tRNA. As reported by Pan et al., 2007, the prf fluorophore is sensitive to the
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local environment. Yeast fMet-Phe-tRNAPhe(prf), labeled at positions 16/17 shows an
increase in fluorescence intensity on translocation from the A- to the P-site and can be
used to monitor the kinetics of translocation (Fig 3.5). Upon rapid mixing of prf labeled
PRE complex with EF-Gs, all seven labeled EF-G mutants catalyzed translocation with a
rate constant 40 - 70 % of that of wild type EF-G catalyzed translocation. The
concentration of EF-G utilized (2 µM) is close to its Km value for translocation (Pan et
al., 2007; Savelsbergh et al., 2003), so that for the highly labeled EF-G variants (S453C,
Q455C, Q487C, S692C, N693C - see Table 3.1), the minor amounts of unlabeled EF-G in
the reaction mixtures would not have been sufficient to account for the rates observed.
However, the translocation rate constants for H655C-EF-G and Q669C-EF-G are
somewhat ambiguous. For these mutants, the labeling efficiencies were only 60 % and
40 %, respectively, so that the measured rates could reflect, at least in major part, the
activities of the unlabeled EF-G mutants.
3.2.4 Static FRET measurements
3.2.4.1 Static measurement of EF-G:L11 FRET
EF-G binds and dissociates from the ribosome dynamically even in the absence of
the A-site bound tRNA. To monitor FRET between EF-G and L11 at equilibrium, either
the antibiotic fusidic acid (FA) or GDPNP was added in order to trap Cy3-labeled EF-G
on the ribosome.
FA interacts with switch II of Domains I, II, III of EF-G and traps EF-G on the
ribosome by preventing EF-G release after GTP hydrolysis. Previous study indicated that
FA does not affect single-turnover GTPase but instead inhibits single-turnover Pi release
(Bodley et al., 1970). In contrast, Seo et al. (2006) showed that FA inhibits translocation
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moderately by a gradually halting translocation after a number of GTPase turnovers, with
higher concentrations of FA showing more marked effects. As we want to trap EF-G on
the ribosome to produce FRET with L11, we utilized a high concentration of FA (1 mM).
GDPNP is a non-hydrolyzable GTP analogue, which catalyzes translocation at lower
rate (50 fold slower, Katunin et al.; 6 fold slower, Zavialov et al., 2003; 5 fold slower,
Pan et al., 2007) compared to GTP but without Pi release. In the presence of GDPNP,
only single round translocation was promoted and there was, of course, no Pi release.
FA and GTP or GDPNP were added to study the interaction between Cy3-EF-Gs and
Cy5-L11 and determine if the Cy3-EF-G:Cy5-L11 pair was within the FRET distance. As
EF-G binds to the ribosome even in the absence of the A-site tRNA, both 70S38-Cy5 and
PRE-II38-Cy5 complexes were used to measure FRET with EF-G. To get an accurate
measurement of the FRET efficiency, four differently labeled samples were employed for
each EF-G mutant. They are designated D*A (donor-containing), D*A* (donor- and
acceptor-containing), DA* (acceptor-containing), and DA (a blank sample without donor
or acceptor dyes) and FRET efficiencies were calculated as described (Seo et al., 2006),
with corrections for the labeling efficiencies of both EF-G and L11. Briefly, signal of DA
was subtracted from those of D*A*, D*A and DA* to correct the light scattering and
background fluorescence. Fluorescence of

was subtracted from

D*A* signal as a correction for donor leakage in the acceptor channel. Then DA* signal
upon 514 nm excitation was subtracted from the corrected value of D*A* signal, yielding
the extracted D*A (Cy5) fluorescence from energy transfer.
FRET efficiencies for EF-G interactions with vacant ribosomes (Fig 3.6) are listed in
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Table 3.2. As the labeling efficiency of Q669C-EF-G was low, the mutant was not
included in our study. All Cy3-EF-G derivatives showed FRET with 70S38-Cy5 in the
presence of FA/GTP or GDPNP. For S453C-EF-G and N693C-EF-G, only minor FRET
efficiency differences were obtained for FA/GTP vs. GDPNP. In contrast, significant
decreases were seen for FA/GTP vs. GDPNP for EF-G655-Cy3 and EF-G692-Cy3 while EFG487-Cy3 showed a significant increase.
The A-site tRNA has a steric clash with the tip region of Domain IV on EF-G, making
it hard to obtain a stable structure with A-site tRNA and EF-G bound simultaneously. In
previous publications, EF-G bound to the A-site unoccupied ribosome was studied a lot to
decipher the information of EF-G interaction with PRE complexes (Gao et al., 2009;
Zhou et al., 2013). However, it turned out that the presence of the A-site tRNA may be of
great importance for EF-G and ribosome conformations. To further understand the effect
of the A-site tRNA on Cy3-EF-G:Cy5-L11 FRET pair, the static FRET of six Cy3-EFGs:PRE-II38-Cy5 pairs was studied in the similar way as described above in the presence of
either FA/GTP or GDPNP (Figure 3.7 and Table 3.3). Large FRET differences between
FA and GDPNP stabilized complexes were observed for EF-G655-Cy3, EF-G455-Cy3and EFG692-Cy3, with other EF-G derivatives showing no significant FRET efficiency differences.
With or without the A-site tRNA do bring a conformational difference between the
labeling sites on EF-G and L11. However, the effect was complicated as it is not in one
direction and both decreased (FRET efficiencies for EF-G487-Cy3 with 70S or PRE in the
presence of GDPNP are 0.25 and 0.17, respectively) and increased FRET (FRET
efficiencies for EF-G455-Cy3with 70S or PRE in the presence of FA/GTP are 0.13 and 0.33,
respectively) were obtained.
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For S692C and N693C on Domain V, the presence of the A-site tRNA increased the
FRET between Cy3-EF-G:Cy5-L11. For instance, FRET efficiencies in the presence of
FA/GTP for 70S or PRE are 0.4 and 0.25 respectively, and FRET efficiencies in the
presence of GDPNP for 70S or PRE are 0.22 and 0.07 for EF-G692-Cy3. Similar results
were obtained for EF-G693-Cy3, which seemed to contradict to our prediction as the
presence of the A-site tRNA should constrain EF-G movement toward the A-site and
push EF-G toward L11. The possible explanation would be that with the A-site tRNA,
EF-G had some inter-domain reorientation which resulted in a decreased FRET efficiency
of Cy3-EF-G:L1138-Cy5. To sum up, FA stabilizes EF-G on the ribosome in a different
confirmation compared to GDPNP. The occupancy of the A-site tRNA has an effect on
the relative distances between ribosome protein L11 and EF-G, which could be due to the
EF-G domain reorientation in the presence of the A-site tRNA.
3.2.4.2 Static measurement of EF-G:tRNA FRET
To monitor FRET between EF-G and tRNA at equilibrium, antibiotics FA and
viomycin (VIO) were added to trap both Cy3 labeled EF-G and Cy5 labeled A-site tRNA
on the ribosome. VIO is a cyclic peptide antibiotic that binds at the 16S and 23S
ribosomal RNA interface and inhibits translocation by stabilizing tRNAs in the A and P
sites (Modolell et al., 1977), although it does allow both EF-G binding and fast GTP
hydrolysis (Ermolenko et al., 2007; Stanley et al., 2010).
We confirmed that simultaneous addition of FA and VIO does not impair EF-G
binding, by measuring static FRET between EF-G693-Cy3 and 70S38-Cy5 (Fig 3.8), a result
that is in accord with recent published results of Salsi et al. (2014), which showed that
EF-G bound to PRE complexes in the presence of both FA and VIO by observing FRET
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between EF-G and protein S12 (Salsi et al., 2014).
Accordingly, we carried out static FRET experiments in which Cy3-labeled EF-Gs
were added to PRE-IItRNA-Cy5 in the presence of FA/GTP or of FA/GTP plus VIO (Fig 3.9),
in the expectation that a higher FRET signal would be seen in the presence of VIO than in
its absence. However, none of the experiments gave an observable FRET signal. When a
higher Mg2+ concentration (15 mM) was employed so as to increase the fraction of PRE
complex in the classic state (Chen et al., 2011a) which should decrease EF-G:tRNA
distance, still no FRET signal was obtained.
Our failure to detect FRET could result from neither of the two structures used for
mutant selection being good models for EF-G interaction with the A-site tRNA in PRE
state. As a result, the distances of labeled positions on A-site tRNA and EF-G would not
be in the FRET range. However, the most recently published high resolution structure by
Zhou et al. (2014) indicate that our selections are within FRET range to L11 and the Asite tRNA (Table 3.4). We think it more likely that the failure stems from slow
translocation occurring even in the presence of FA and VIO which we employ in our
experiments, although we cannot exclude the possibility that the presence of both FA and
VIO used in the work changes the confirmations of EF-G and/or ribosome and increases
the relative distances of Cy3-EF-G:Cy5-tRNA FRET pair.
3.2.5.1 Fast kinetic measurements of EF-G:L11 FRET
3.2.5.1.1 Experiments with vacant ribosomes and PRE complexes with EF-G·GTP in
the presence or absence of FA
As described above, in the static measurement, we observed FRET between Cy3-EFG:Cy5-L11 in the presence of either FA/GTP or GDPNP. The next step was to study the
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real time interaction between Cy3-EF-G:Cy5-L11 measured by stopped flow for six EFG derivatives. If position 38 of L11 is close enough to the labeled sites on EF-G used in
this work, when EF-G binds to the ribosome, a FRET signal should be observed. As
reported by Seo et al. (2006), the increase in FRET efficiency observed on addition of a
Cy3-EF-G labeled at position 216 in domain G’, quite far from the positions labeled in
this work, to vacant ribosomes containing Cy5-L11 was biphasic, with rate constants
equal to 20 ± 3 s-1 and 0.23 ± 0.02 s-1 and with the larger FRET change observed in the
fast phase. In the work by Seo, addition of FA/GTP did not change either the fast or slow
rate constants, but the overall magnitude of FRET change contributed from the slow
phase was enhanced.
We used the same PRE and EF-G concentration as reported by Seo, so if FRET
changes occurred they should have been observable within 0.5 s (fast phase) and/or 12 s
(slow phase). However, we observed little if any FRET change in this study over these
time scales when the Cy3-labeled EF-Gs were rapidly mixed with either 70S38-Cy5 (data
not shown) or PRE-II38-Cy5 (Fig 3.10).
In the presence of FA, anti-correlated fluorescence changes were observed when
three of Cy3-labeled EF-Gs, EF-G644-Cy3, EF-G453-Cy3, and EF-G693-Cy3 were rapidly mixed
with either 70S38-Cy5 (Fig 3.11) or PRE-II38-Cy5 (Fig 3.12) over 20 s time scale, however,
when we zoomed in the initial 0.5 s time scale, no FRET change was observed. The
FRET change occurred during 20 s time scale with apparent rate constants that varied
from 0.15 - 0.30 s-1 which are much lower than the apparent translocation rate constants
of 1.4 - 2.5 s-1 (Table 3.1). It is therefore likely that these FRET changes arise from slow,
FA-induced conformational rearrangements of EF-G that follow translocation, rather than
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from translocation itself.
3.2.5.1.2 Experiments with PRE complexes with GDPNP replacing GTP
Seo et al. (2006) found that on substitution of GDPNP for GTP, the increase in FRET
efficiency observed on addition of a Cy3-EF-G labeled at position 216 in domain G’, to
vacant ribosomes containing Cy5-L11, but that the rate constants of both the fast and
slow phases were reduced by about 100-fold and 30-fold to 0.20 ± 0.01 s-1 and 0.007 ±
0.001 s-1, respectively. However, when GDPNP was substituted for GTP we found no
evidence for FRET change out to 100 s on rapid mixing of each of the six Cy3-EF-G
labeled mutants with PRE-II38-Cy5 (data not shown).
The possible explanations for not observing FRET change in the real-time kinetic
measurement would be as follows: 1) FA traps EF-G on the ribosome in a state which is
not an intermediate of EF-G catalyzed translocation. Therefore, even FRET was obtained
in the static measurement, no FRET was observed in real time kinetic measurement, and
no FRET change could be observed accordingly; 2) As FRET events happened at
different times, at a single time point, only a small portion of EF-G bound to the
ribosome and contributed FRET signal. The scarcity of EF-G binding and the averaged
results in bulk solution covered the real FRET change signal. On the other hand, FA
enhanced binding of Cy3-EF-Gs to the ribosome and FRET change was observed only
with FA.
3.2.5.2 Fast kinetic measurements of EF-G:tRNA FRET
Although no FRET was observed between Cy3-EF-Gs and PRE-IItRNA-Cy5 in the
static experiments in the presence of FA ± VIO (Figure 3.9), fast kinetic measurement by
stopped flow were carried out to determine if an intermediate could be detected upon
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rapid mixing of Cy3-EF-Gs and PRE-IItRNA-Cy5 in the absence of any antibiotics. 2 µM
Cy3-EF-G was rapidly mixed with 0.1 µM PRE-IItRNA-Cy5 in TAM15 buffer and data was
collected over a 1 s time scale, as the translocation rate constant ranged from 1.43 ± 0.01
to 3.54 ± 0.02 s-1 as measured by prf labeled A site tRNA (Table 3.1). However, no FRET
change was obtained on this time scale. In addition, in an effort to decrease background
fluorescence which could make FRET detection difficult, the standard 2 µM Cy3-EF-G
was lowered to 0.4 µM and data was collected over a 5 s time scale instead of the 1 s time
scale used at 2 µM Cy3-EF-G. However, neither of these changes resulted in detectable
FRET changes.
3.3 Discussion
FA traps EF-G on the ribosome by preventing its dissociation and halts translocation
after a number of GTPase turnovers (Seo et al., 2006). GDPNP functions similarly, but
the effect is more stringent as only single turnover of translocation was allowed (Rodnina
et al., 1997). The equilibrium FRET results displayed in Table 3.2 show a clear between
the FA stabilized EF-G-70S structure and the GDPNP stabilized EF-G-70S structure,
which suggests that EF-G-ribosome complexes stabilized by FA or GDPNP are in two
different states. As the structure of the A-site tRNA bound to an EF-ribosome complex is
not stable, a lot of efforts have been made to characterize EF-G-ribosome structure with
an empty A-site to elucidate structural insights of the pretranslocation complex (Chen et
al., 2013b; Pulk et al., 2013; Ramrath et al., 2013). However, by comparing FRET
results in Tables 3.2 and 3.3, it is clear that the presence of the A-site tRNA does have
effects on EF-G and/or ribosome structures. Interestingly, for both EF-G692 and EF-G693
mutants, decreased FRET between EF-G and L11 was observed for PRE vs. 70S. As the
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presence of the A-site tRNA restricts the spatial movements of EF-G, FRET between EFG and L11 protein is expected to increase. The decreased FRET efficiency between EF-G
and L11 for PRE vs. 70S observed in our experiment suggests that reorientation of EF-G
occurred when the A-site tRNA bound.
The results obtained in the ensemble rapid kinetic experiments are summarized in
Table 3.5. FRET change was only observed under the experimental conditions of mixing
Cy3-EF-Gs with 70SCy5 or PRE-IICy5 and 1mM FA/GTP, but with a rate constant much
slower (0.15 - 0.30 s-1) than the translocation rate constant (3.5 s-1). A possible
explanation for not observing FRET change in the real-time kinetic measurement in the
absence of FA would be that during EF-G occupancy on the ribosome, EF-G has constant
FRET with L11 and tRNA. However, the single molecule FRET (smFRET) experiments
reported in Chapter 4 demonstrate changes in EF-G:tRNA FRET efficiency during
translocation. A more likely explanation, consistent with the smFRET results, is that at
any single time point, only a small portion of ribosomes contained bound EF-G capable
of producing a FRET change, which would be difficult to detect in an ensemble
experiment. The slow ensemble FRET change seen in the presence of FA is evidence that
FA traps EF-G on the ribosome in a state which is not an intermediate of EF-G catalyzed
translocation.

84

Figure 3.1 EF-G structure with mutant sites labeled. EF-G structure is adapted from
2WRI (PDB) (Thermus thermophilus) and the potential mutants are showed as sphere.
The number of the mutant sites is base on the sequence of EF-G protein in E. coli.
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A

B
…

Figure 3.2 Comparison of EF-G and EF4 structures. A. Structure of EF-G (colored
orange) bound with A-site tRNA (colored purple) and the structure of EF-G was
superimposed on the cryo-EM density of EF4 (gray mesh); B. EF4 structure with the
individual domains colored blue (I), green (II), yellow (III), orange (V) and red (CTD).

A

B

Figure 3.3 EF-G-ribosome and EF4-ribomse complexes. A. EF-G bound to the
ribosome with P/P E/E site tRNAs, mRNA, GTP and FA (Gao et al, 2009); B. EF4 bound
ribosome complex, containing A/L, P/P, E/E site tRNAs, mRNA and GDPNP (Connell et
al., 2008).
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Figure 3.4 Puromycin reactivity tests of Cy3-EF-Gs. All concentrations mentioned are
based on final concentrations after mixing. Background, no reactants was added; ICcomplex, 10 µL of 0.3 µM IC was mixed with 10 µL WB buffer and incubated with 5mM
puro at 37 °C for 20 sec and then quenched with 150 µL of 0.3 M NaAc (pH=5.2). PREcomplex, 20 µL of 0.3 µM PRE was incubated with 5mM puro at 37°C for 20 sec and
then quenched with 150 µL of 0.3 M NaAc (pH=5.2). WT or EF-GCy3, 20 µL of 0.3 µM
PRE was incubated with 2 µM wild type EF-G or Cy3-EF-Gs with 1 mM GTP for 1 min,
followed by incubation with 5mM puro for 20 sec and then quenched with 150 µL of 0.3
M NaAc (pH=5.2). All the quenched products were extracted by 600 µL ethyl acetate and
counted the radioactivity of [35S]-fMet-tRNAfMet. A second measurement was carried for
some mutants and the error bar is within 5% which confirms the reliability of our
measurement.
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Figure 3.5 EF-G derivatives catalyzed fast translocation as measured by stopped
flow fluorescence change. All the results were obtained by mixing 400 µL of 0.1 µM
prf-tRNA-PRE with 400 µL of 2 µM EF-G and 1mM GTP in WB buffer at 37 °C. The
latter concentration is close to the Km value for EF-G (Pan et al., 2007; Savelsbergh et al.,
2003). Both raw traces and fitted results of each trace are plotted.
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EF-G derivatives
(Domain)

Puromycin activity
(CPM)

Prf-tRNA
Labeling
translocation activity efficiency
(s-1)

WT
H655C(V)
Q669C(V)
S453C(III)
Q455C(III)
Q487C (III)
S692C (CTD)
N693C (CTD)

840 ± 25
780
820
810
850 ± 40
790 ± 20
880 ± 20
890

3.5 ± 0.8
1.7 ± 0.4
2.1 ± 0.4
2.2 ± 0.7
1.4 ± 0.3
2.0 ± 0.7
1.8 ± 0.5
2.5 ± 0.6

0.60
0.40
0.92
0.93
0.77
0.82
0.90

Table 3.1 Test of Cy3 labeled EF-G derivatives catalyzed fast translocation by
stopped flow. 400 µL of 0.1 µM prf-tRNA-PRE was rapidly mixed with 2 µM EF-G and
1mM GTP in the same volume in WB buffer at 37 °C. Two independent determinations
were performed to some mutants with the error listed.
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Figure 3.6 Static FRET of EF-GCy3:70S38-Cy5. Samples were prepared at 25 °C in WB
buffer, containing 70S (0.4 µM), EF-G (0.5 µM) and either 1 mM FA/GTP (left) or 1mM
of GDPNP (right) for all EF-G derivatives.
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EF-G
(Domain)

derivatives

H655C(V)
S453C(III)
Q455C(III)
Q487C (III)
S692C (CTD)
N693C (CTD )

Experimental
conditions

Labeling efficiency

70S, FA
70S, GDPNP
70S, FA
70S, GDPNP
70S, FA
70S, GDPNP
70S, FA
70S, GDPNP
70S, FA
70S, GDPNP
70S, FA
70S, GDPNP

0.60
0.60
0.92
0.92
0.93
0.93
0.77
0.77
0.82
0.82
0.90
0.90

EF-G:L11 FRET
efficiency
Ecorr
0.30
0.10
0.062
0.077
0.13
0.049
0.024
0.25
0.40
0.22
0.30
0.25

Table 3.2 Summary of static FRET of EF-GCy3:70S38-Cy5 pair. All static FRET
measurements were performed in WB at 25 °C. Samples were prepared containing 70S
(0.4 µM) with EF-G (0.5 µM) and either 1mM FA and GTP or 1mM of GDPNP. FRET
efficiencies are calculated as described in Seo et al., 2006.
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Figure 3.7 Static FRET of EF-GCy3:PRE38-Cy5. Samples were prepared at 25 °C in WB
buffer, containing PRE-II (0.4 µM), EF-G (0.5 µM) and either 1 mM FA/GTP (left) or
1mM of GDPNP (right) for all EF-G derivatives.
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EF-G derivatives Experimental
(Domain)
conditions

Labeling
efficiency

H655C(V)

0.60
0.60
0.92
0.92
0.93
0.93
0.77
0.77
0.82
0.82
0.90
0.90

S453C(III)
Q455C(III)
Q487C (III)
S692C (CTD)
N693C (CTD)

PRE, FA
PRE, GDPNP
PRE, FA
PRE, GDPNP
PRE, FA
PRE, GDPNP
PRE, FA
PRE, GDPNP
PRE, FA
PRE, GDPNP
PRE, FA
PRE, GDPNP

EF-G:L11
FRET
efficiency
Ecorr
0.29
0.09
0.09
0.11
0.33
0.03
0.11
0.17
0.25
0.07
0.10
0.06

Table 3.3 Summary of static FRET of EF-GCy3:PRE-II38-Cy5. All Static FRET
measurements were performed in WB at 25 °C. Samples were prepared containing PREII (0.4 µM) with EF-G (0.5 µM) and either 1mM FA/GTP or 1mM of GDPNP. FRET
efficiencies are calculated as described in Seo et al., 2006.
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Figure 3.8 Test of EF-G binding to the ribosome with both FA and VIO. Samples
were prepared at 25 °C in WB buffer, containing 70S38-Cy5 (0.4 µM), EF-G693-Cy3 (0.5 µM),
1 mM FA, 1 mM GTP and 5 µM viomycin.
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Figure 3.9 Static FRET of EF-GCy3:PRE-IItRNA-Cy5. Samples were prepared at 25 °C in
WB buffer, containing PRE-IItRNA-Cy5 (0.4 µM), Cy3-EF-G (0.5 µM), 1 mM FA/GTP and
with or without 5 µM viomycin.
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Structure
EF-G
H655C(V)
S453C(III)
Q455C(III)
Q487C (III)
S692C (V)
N693C (V)

Distances (Å)
L11
tRNA
24.8
80.3
53.9
66.6
53.9
71.4
51.5
67.3
48.4
54.9
51.0
55.7

Table 3.4 Summary of distances. Distances of EF-G mutants to L11 and tRNA were
calculated based on the ribosome structure containing ap/ap pe/E site tRNAs, mRNA,
GTP and FA. (Zhou et al., 2014)
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Figure 3.10 Fast kinetic of EF-GCy3 and PRE-II38-Cy5. Experiments were performed at
25 °C in WB buffer. All the results were obtained by mixing 400 µL of PRE-II38-Cy5 (0.5
µM) with 400 µL of EF-GCy3 (0.75 µM). Cy3 (left, red) and Cy5 (right, green) signal
collected from both short time (0.5 s) and long time scales (12 s) are plotted and no anticorrelated Cy3/Cy5 signals with comparable rate constants are obtained.
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Figure 3.11 Fast kinetic measurements of EF-GCy3 with 70S38-Cy5. Experiments were
performed at 25 °C in WB buffer. All the results were obtained by mixing 400 µL of
70S38-Cy5 (0.5 µM) with 400 µL of 0.75 µM Cy3-EF-G (EF-G453-Cy3, EF-G655-Cy3 or EFG693-Cy3), FA (1 mM) and GTP (1 mM). Cy3 (left, red) and Cy5 (right, green) signal
collected from both short time scale (0.5 s) and long time scale (20 s) are plotted and anticorrelated Cy3/Cy5 signals are obtained for results on 20 s time scale.
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Figure 3.12 Fast kinetic measurements of EF-GCy3 with PRE-II38-Cy5. Experiments
were performed at 25 °C in WB buffer. All the results were obtained by mixing 400 µL of
PRE-II38-Cy5 (0.5 µM) with 400 µL of 0.75 µM Cy3-EF-G (EF-G453-Cy3, EF-G655-Cy3 or
EF-G693-Cy3), FA (1 mM) and GTP (1mM). Cy3 (left, red) and Cy5 (right, green) signal
collected from both short time (0.5 s) and long time scale (20 s) are plotted and anticorrelated Cy3/Cy5 signals are obtained for results of 20 s time scale.
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Kinetic Exp
38-Cy5

Cy3-EF-G : 70S
(GTP)
0.5 s, 12s
Cy3-EF-G : 70S38-Cy5 (FA, GTP)

EF-G655-

EF-G453-

EF-G455-

EF-G487-

EF-G692-

EF-G693-

Cy3

Cy3

Cy3

Cy3

Cy3

Cy3

NO

NO
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NO

NO

YES
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NO

NO
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NO

YES

YES

NO

NO

NO

YES

NO

NO

NO

NO

NO

NO

NO

NO

NO

NO

NO

NO

0.5 s
Cy3-EF-G : 70S38-Cy5 (FA, GTP)
20 s
Cy3-EF-G : PRE-II38-Cy5 (GTP)
0.5 s
Cy3-EF-G : PRE-II38-Cy5 (FA,GTP)
20 s
Cy3-EF-G : PREII38-Cy5 (GDPNP)
5 s, 100 s
Cy3-EF-G : PREIItRNA-Cy5 (GTP)
1s

Table 3.5 Summary of ensemble rapid kinetic FRET experiments. Experiments were
performed at 25 °C in WB buffer. All the results were obtained by mixing 400 µL of
70S38-Cy5 (0.5 µM) or PRE-II38-Cy5 (0.5 µM) with 400 µL of 0.75 µM Cy3-EF-Gs, or
PRE-IItRNA-Cy5 (0.1 µM) with 400 µL of 2 µM Cy3-EF-Gs, with GTP (1 mM) or GDPNP
(1 mM) or GTP (1 mM) and FA (1 mM). Yes or No indicates whether FRET change was
observed over the time ranges indicated.
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CHAPTER IV SINGLE MOLECULE FRET STUDIES OF
TRANSLOCATION
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Abstract
Prokaryotic elongation factor G (EF-G) catalyzes the coupled translocations on the
ribosome of mRNA and A- and P-site bound tRNAs during the polypeptide elongation
cycle. However, the kinetic pathway of this important step has not been fully elucidated.
Here, we describe the application of single molecule fluorescence resonance energy
transfer (smFRET) to probe the mechanism of this key process in real time. Attaching a
fluorescent probe within domain IV of EF-G permits monitoring of FRET efficiencies to
sites in both ribosomal protein L11 and A-site tRNA. Two different sites on L11, position
38 or position 87, as well as two different A-site tRNAs, Phe-tRNAPhe or Val-tRNAVal,
were labeled with Cy5. The EF-G:L11 FRET efficiency is constant during EF-G
occupancy on the ribosome (300 - 400 ms), whereas EF-G:tRNA FRET proceeds from
high to intermediate to low FRET values. This indicates that the EF-G:A-site tRNA
distance increases progressively during translocation, with our results providing the first
good estimates of the timing of such changes. For both tRNAs, the EF-G:tRNA pair
spends most of its time in the intermediate FRET state, with shorter lifetimes in the high
and low FRET states. Each transition in the FRET value corresponds to a relative
distance change of about 5 to 7 Å, so in total, we capture a 12 Å relative movement of Asite tRNA away from EF-G during translocation. EF-G:A-site tRNA FRET is sensitive to
buffer conditions, with high Mg2+ and polyamines stabilizing the high FRET state. In
addition, the translocation inhibitors viomycin and spectinomycin block formation of the
low FRET state, although spectinomycin allows more movement between EF-G and
tRNA than viomycin.
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4.1 Introduction
Bacterial translation can be dissected into three major stages, including initial,
elongation and termination, which requires the correlated movements among the
ribosome, tRNAs, as well as important ribosomal factors, e.g., elongation factor G (EF-G)
and elongation factor Tu (EF-Tu) (Schmeing et al., 2009a). In the elongation cycle, EFG, a GTPase works dynamically on the ribosome, promoting translocation of tRNAs and
mRNA by precisely one codon. Continued progress has been achieved in understanding
this key process, including results of structural (Agrawal et al., 2000; Cate et al., 2013;
Tourigny et al., 2013; Zhou et al., 2013) ensemble (Dorner et al., 2006; Pan et al.,
2007; Savelsbergh et al., 2003; Wilden et al., 2006) and single-molecule studies (Chen
et al., 2011a; Chen et al., 2013a; Fei et al., 2009; Munro et al., 2010; Munro et al.,
2007). However, most of the work has been focused on the pre-equilibrium states of this
fast process, leaving the real time dynamics, especially how EF-G first interacts with the
A-site tRNA in the pretranslocation complex not fully elucidated (Scheme 4.1). In this
work, we studied how EF-G correlated its movement with tRNAs, ribosomal proteins to
promote different sub-steps of translocation.
EF-G comprises five domains, the overall structure mimics the structure of the
ternary complex, with Domains I-III resemble EF-Tu structure and Domain IV
corresponds to the anti-codon region of the tRNA (AEvarsson et al., 1994; Czworkowski
et al., 1994). After peptidyl transfer, a peptide chain is formed in the A-site, leaving a
deacylated tRNA in the P site. The A- and P-site tRNAs were observed to fluctuate
between the non-rotated (A/A, P/P) and rotated states (A/P, P/E), and adding EF-G
promoted translocation of the A, P-site tRNA to the P, E-sites respectively. While some
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previous studies showed that EF-G·GTP bound to the rotated state of the ribosome and
promoted translocation of tRNAs only from the hybrid states (Fei et al., 2008), the most
recent single molecule FRET experiments indicated that EF-G can bind to both rotated
and non-rotated ribosomes to promote translocation (Chen et al., 2011a; Chen et al.,
2013a). It was proposed that EF-G made its initial contact with the L7/L12 stalk and L10
protein which comprised EF-G binding sites on the large subunit (Savelsbergh et al.,
2005). While the intrinsic hydrolysis rate of EF-G·GTP is very low (less than 10-5 s-1),
binding to the ribosome largely enhances the hydrolysis activity of EF-G (at least 5 fold
faster than translocation) and the energy released from this process further drives tRNA
movements (Rodnina et al., 1997). Upon EF-G binding, it functions allosterically with
ribosomal protein L1, located near the exit tunnel, to control the delivery of tRNAs.
Domain IV of EF-G reaches out to the A-site decoding center (Gao et al., 2009),
preventing back movements of tRNAs, then EF-G finally dissociates from the ribosome
in the GDP form after translocation (Fei et al., 2009).
4.2 Results
4.2.1 The Design of the experiment
Two FRET pairs, EF-G:L11 and EF-G:tRNA, were studied in the experiment.
Ribosomal protein L11 or the A-site tRNA were labeled with Cy5 fluorescence dye. For
EF-G:L11 pair, L11Cy5-initiation complex (IC) was pre-incubated with WT-ternary
complex (TC) to form pretranslocation complex (PRE). For EF-G:tRNA pair, WT-IC was
incubated with tRNACy5-TC. Cy5 labeled PRE was then attached to the slide surface via a
single biotin labeled mRNA (Fig 4.1). As TAM15 buffer has been used extensively in
single molecule studies of ribosomes, both in our laboratory (Chen et al., 2011a) and
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others (Munro et al., 2010), we chose TAM15 as the standard buffer condition. Also, 100
nM next TC was added simultaneously with EF-GCy3 for two reasons. First, both PRE and
POST complexes (posttranslocation complex) were formed in our system and EF-G
bound to both complexes without showing a difference in the binding affinity. As we are
only interested in characterizing the EF-G interaction with PRE, we want to block EF-G
binding to the POST which blurs the results of PRE. TC shares the same binding site with
EF-G and competes with EF-G for binding to the POST. Therefore, 100 nM TC was
added. As POST complex had a higher affinity to TC compared to EF-G, and the
concentration of TC applied was 100 nM, which was about 10 to 20 fold of EF-G
concentration (5nM to 10 nM) used in the experiments, the addition of 100 nM TC
should effectively block EF-G binding to the POST. Second, in case EF-G binds, with
100 nM next TC, the second round of translocation would be promoted. The A-site
labeled tRNA would move to the E-site, which was far from EF-GCy3 after two cycles of
translocation. In this way, we were able to mitigate the contribution of FRET from the Psite labeled tRNA and focus on studying FRET of tRNA translocation from the A-site to
the P-site. Unless otherwise mentioned, all experiments were performed under the
standard experimental condition, which is TAM15 in the presence of 100 nM next round
TC. All single molecule experiments were performed at 21°C.
4.2.2 EF-G mutants
4.2.2.1 EF-G mutant selection
The relative movements between EF-G:tRNA and EF-G:L11 were studied to reveal
how EF-G works cooperatively with different ribosomal components. The potential
mutant sites on EF-G for introduction of a fluorescent label should meet the following
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criteria: 1) The distances between the mutant site and either ribosomal protein L11 or the
A site tRNA are within FRET (Ro) range of a Cy3/Cy5 pair (about 53 Å); 2) the site
should be exposed to the solvent instead of buried inside the structure; 3) the amino acid
should not be conserved, and less likely to have functional importance. As we have
material stocks and developed matured labeling strategies for both C38 and S87C on
large ribosomal protein L11 and labeled tRNAs at the elbow region, the site of EF-G
labeling was selected based on its distance to these three sites (Seo et al., 2006). As there
was no accessible structure of EF-G bound to the ribosome in the presence of A site
tRNA when we started the mutant selection, the EF4 (Lep A) bound ribosome structure
was used to find proper mutant sites. Here, cryo-EM structure of EF4, with A/L (Connell
et al., 2008) and P/P site tRNAs on ribosomes was selected as the structural model of
EF-G bound to PRE.
Three Cy3-labeled EF-G mutants, containing Cys at positions 453, 655, and 693,
show L11:EF-G FRET changes in the presence of FA (Section 3.2.5 ). Preliminary single
molecule FRET experiments were performed by adding each of these labeled mutants to
PRE-IItRNA-Cy5 in the absence of antibiotics. Only EF-G693-Cy3 showed an observable
FRET with the A-site tRNA. Accordingly, EF-G693-Cy3 was selected for detailed smFRET
studies on two FRET pairs, EF-G:L11 and EF-G:tRNA.
4.2.2.2 Ensemble FRET events confirmed the activity of EF-G693-Cy3
The kinetic activity of EF-G693-Cy3 was measured by a translocation assay, proflavin
(prf) labeled Phe-tRNAprf-Phe programmed at the ribosomal A site at 25 °C in WB buffer.
Prf substitution of dihydrouridine group was attached within the elbow region of the A
site tRNA and translocation of the A site tRNA to the P site leads to an increase of prf
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fluorescence intensity (Pan et al., 2007). Upon rapid mixing of prf labeled PRE with the
same concentration of WT-EF-G or EF-G693-Cy3 in stopped-flow, a single exponential
increase of prf fluorescence was observed in both experiments. In the presence of EFG693-Cy3, the fitted rate constant was 2.5 ± 0.6 s-1 at 25 °C, which was about 70% of rate
constant in the presence of WT-EF-G (3.5 ± 0.8 s-1 ), indicating the competency of Cy3
labeled EF-G693 in catalyzing fast translocation (see Section 3.2.3.2).
4.2.3 Characterization of EF-G:L11 FRET interaction
L1138-Cy5 or L1187-Cy5 IC was pre-incubated with WT-TC to form PRE and denoted
PRE-L1138-Cy5 or PRE-L1187-Cy5, followed by addition of EF-G693-Cy3. The experiment
was performed by using a total internal reflection fluorescence (TIRF) microscope as
described in Chapter 2 and green laser (532 nm) was illuminated to excite Cy3
fluorophore directly. The results in both cases are similar to one another, showing FRET
between PRE-L11Cy5 and EF-G693-Cy3 upon initial excitation. All the observed FRET
events presented an increase of Cy3 and Cy5 signals simultaneously, indicating that EF-G
binds to the ribosome with a conformation showing detectable FRET to the labeled sites
on L11 (Fig 4.2). Dwell time of the FRET events was about 200 - 400 ms with only one
fitted peak for both N-terminal (position C38) and C-terminal (position C87) labeled L11.
The FRET efficiencies were equal to 0.41 ± 0.01 and 0.67 ± 0.01 for PRE-L1138-Cy5 and
PRE-L1187-Cy5, respectively (Fig 4.3). All the FRET events lasted until EF-G693-Cy3
dissociation from the ribosome, with a simultaneous decrease of Cy3 and Cy5
fluorescence.
4.2.3.1 FRET efficiency between Cy3-labeled EF-G and Cy5-labeled L11
(C38S/S87C variant) is constant during EF-G occupancy of the ribosome
FRET events between EF-G693-Cy3 and C-terminal labeled L1187-Cy5 were collected
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and further analyzed. Dwell time was fitted by a single exponential function y = Aexp(kt), with a fitted value equal to 250 ± 5 ms under standard experimental condition (Fig
4.3). FRET efficiency was fitted by Gaussian function y=y0 + (

),

showing a single peak value of 0.67 ± 0.01. Averaged FRET values as a function of time
were calculated by lining up all FRET events either to the same starting time point or end
time point to generate one pre-synchronization trace and one post-synchronization trace
(Chen et al., 2012; Chen et al., 2011a). Synchronized FRET efficiency was plotted as a
function of time and showed a constant value for both pre-synchronization and postsynchronization (Fig 4.4, A), implying that there was only single FRET state over the
entire dwell time of EF-G on the ribosome.
This result was further confirmed by FRET difference distribution and transition
density map. FRET events which lasted longer than 6 frames with duration longer than
210 ms (35 ms per frame) were selected. The first and last three frames were averaged
separately, defined as initial and final FRET. Difference between the final and initial
FRET was calculated and the distribution was plotted, showing a symmetrical ΔFRET
distribution relative to x = 0 (Fig 4.4, B). Some FRET events showed an increased FRET
efficiency after translocation (located in the regions x > 0), while some showed decreased
efficiency (located in the regions x < 0), but the majority of events presented similar or
unchanged FRET efficiency. As similar numbers of events with increased or decreased
FRET were observed, it implied that those events showing changes were mostly due to
the noise, instead of being attributable to the relative distance changes between EF-G693Cy3

and L1187-Cy5 during EF-G residence on the ribosome. Additionally, the initial and

final FRET values were plotted as a transition density map. Events located on the
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diagonal line on the map presented exactly same initial and final FRET values. The
transition density contour map showed a symmetrical pattern relative to the diagonal line
with the majority of traces located in the region where ΔFRET was between -0.1 to
0.1(Fig 4.4 C), indicating that most events had similar initial and final FRET values.
4.2.3.2 FRET efficiency between Cy3-labeled EF-G and Cy5-labeled L11 (C38)
behaves similarly as Cy5-labeled L11 (C38S/S87C variant)
The FRET results between EF-G693-Cy3 and N-terminal domain labeled L1138-Cy5 are
similar to those of EF-G693-Cy3:L1187-Cy5 pair, with dwell time equal to 327 ± 5 ms and a
lower FRET efficiency of 0.41 ± 0.01 (Fig 4.3, C, D). A single FRET state was observed
during EF-G residence on the ribosome, as confirmed by postsynchronized analysis,
FRET difference distribution and transition density map (Fig 4.4 D, E, F). Protein L11 is
located at the base of the L7/L12 protein stalk and has significant structural flexibility on
the ribosome (Agrawal et al., 2000; Agrawal et al., 2001). Previous study showed that
C-terminal (CTD) and N-terminal domains (NTD) of L11 are connected by a linker
which is composed of two proline amino acids. Two L11 structures were compared
(Agrawal et al., 2001; Wimberly et al., 1999) and an inter-domain conformational
change by an approximate 7Å shift and 40° rotation between CTD and NTD was
observed, which is due to the movement in the linker region. Only a single FRET state
was obtained in our work for both N-terminal and C-terminal labeled EF-G, implying that
EF-G interacted with C-terminal and N-terminal domains of L11 in a similar manner and
that such interaction occurred without L11 inter-domain conformational change.
The EF-G693:L1138 and EF-G693:L1187 FRET efficiencies of 0.41 and 0.67,
respectively, correspond to approximate distances of 56 Å and 47 Å, respectively,
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assuming a Förster Ro value of 53 Å (Seo et al., 2006). These distances are in qualitative
accord with the coordinates from a recently published structure (Zhou et al., 2014) in
which EF-G and A-site peptidyl-tRNA are bound simultaneously to the ribosome, albeit
in the presence of fusidic acid and neomycin, in which the distances between Cβ of
N693C and Cβ of C38L11 or S87L11 are 51Å and 37Å, respectively (Fig 4.5). That the
FRET distances of EF-G with either L11 or tRNA measured in our work are somewhat
larger could be explained by three reasons: 1) the fluorophore-fluorophore distance
measured in our work could be considerably greater than α-C-α-C distances calculated
from the reported structure; 2) the structure was obtained from Thermus thermophilus and
our experiments were based on the ribosome from E. coli; 3) fusidic acid (FA) was
applied in the structural work which could result in a relative conformational change
between EF-G and the ribosome/tRNA (Sections 3.2.4.1 and 3.2.5.1).
4.2.4 Characterization of EF-G:tRNA FRET interaction showing relative distances
changes during translocation under standard conditions
4.2.4.1 Overview
To monitor the relative movements between EF-G and the A-site tRNA, the Cy3labeled EF-G mutant used in the previous L11 experiment, EF-G693-Cy3, was utilized. Two
different A-site tRNAs, Val-tRNAVal at dihydrouridine position 17 and Phe-tRNAPhe at
dihydrouridine positions 16/20 were labeled with Cy5 hydrazide dye (Kaur et al., 2011).
PRE-I contains Val-tRNAVal-Cy5 and PRE-II contains Phe-tRNAPhe-Cy5. By immobilizing
pretranslocation complexes onto the surface of the slide in a pre-incubation step, and then
quickly injecting Cy3 labeled EF-G together with 100 nM wild type next ternary complex,
the real-time kinetics of translocation can be monitored. The synchronization analysis of
all FRET events showed a small FRET decrease as a result of translocation, indicating
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that there were relative distance changes between EF-G693-Cy3 and the A-site tRNACy5
(Detailed discussion in section 4.2.4.3). In this section, both FRET and kinetic results are
described as follows: Sections 4.2.4.2 - 4.2.4.6, FRET results, including 4.2.4.2,
characterization of FRET; 4.2.4.3, FRET segmentation; 4.2.4.4, initial and final FRET
distributions; 4.2.4.5, FRET of POST complexes; 4.2.4.6, proposed explanations for two
different groups of traces. Section 4.2.4.7, kinetics of translocation for Group I trace.
4.2.4.2 EF-G693-Cy3: tRNA FRET characterization of all FRET results
Single molecule FRET experiments between Cy5 labeled PRE and EF-G693-Cy3 were
carried out under standard experimental conditions, as described above. Upon EF-G
binding, a simultaneous increase of Cy3 and Cy5 fluorescence was observed, similarly to
what was seen in the EF-G:L11 experiment, indicating that EF-G binding to the ribosome
gives rise to a detectable FRET signal (Fig 4.6). The dwell time of FRET for PRE-I was
424 ± 9 ms and FRET efficiency distribution was fitted by two peaks with values of 0.18
± 0.01 and 0.37 ± 0.02, respectively. Similarly, the dwell time for PRE-II was equal to
457 ± 8 ms and FRET distribution was fitted by two peaks, having values of 0.22 ± 0.01
and 0.36 ± 0.03 (Fig 4.7). Importantly, these average dwell times are consistent with the
overall ensemble rate constant for translocation of 2.5 ± 0.6 s-1, allowing for the
somewhat lower temperature at which the single molecule experiments are performed
(ensemble, 25 o C, smFRET, 21 o C).
4.2.4.3 Partial resolution of traces showing EF-G:tRNA FRET into two groups
More than one FRET state was observed over the entire FRET events, demonstrated
by the results of postsynchronized analysis, FRET difference distribution and transition
heat contour map. As discussed in Chapter 2, if there were no relative distance changes
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between two labeled positions, pre- and post- synchronization traces should show a single
constant FRET value, as what was observed in EF-G:L11 experiments. However, a
decrease of final FRET efficiency of EF-G:tRNA FRET pair was obtained, implying
there was more than one FRET state during translocation (Fig 4.8). The FRET difference
distribution of PRE-I was plotted to study the details of the changes. Interestingly,
although the majority of the events still presented no significant FRET changes during
translocation, the distribution was not symmetrical, in contrast to what was seen in the
EF-G:L11 interaction. A larger proportion of events was observed located in x < 0 region
with a negative FRET change (Fig 4.9, A). The transition heat contour map further
confirmed our observation by showing a large proportion of events under the line of
identity (Fig 4.9 B, C). To determine if these results suggested that the tRNA:EF-G
interaction was heterogeneous and could be further segmented by FRET efficiency
changes during translocation, a manually selected ΔFRET cutoff value (- 0.1 for PRE-I
and - 0.12 for PRE-II ) was applied to further segment the traces into two groups, without
confirming whether the two groups are really different from each other or not. For PRE-II,
essentially similar results were obtained from postsynchronized analysis, FRET
difference distributions and transition heat contour maps (Fig 4.8 B, Fig 4.9 D, E, F).
Traces with large decreased FRET changes (ΔFRET < - 0.1 for PRE-I and ΔFRET <
- 0.12 for PRE-II) were placed in Group I, and all other traces (ΔFRET > - 0.1 for PRE-I
and ΔFRET > - 0.12 for PRE-II) were placed in Group II. Group I traces constitute 15 40 % of the total population depending on different experimental conditions (Detailed
discussion in section 4.2.5). Dwell time analysis provided an indication that these two
groups represented two different types of EF-G:tRNA interactions. The dwell times
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averaged 555 ± 10 ms (PRE-I) and 543 ± 19 ms (PRE-II) for Group I, which were 1.25 1.5 fold longer than the dwell times of Group II (374 ± 13 ms, PRE-I; 435 ± 10 ms, PREII). Thus, these two Groups not only had different ΔFRET values during EF-G binding,
but also showed a difference in FRET signal duration (Fig 4.10). This suggested that the
two Groups were different and could be at least partially resolved.
4.2.4.4 Initial and Final FRET distributions for the EF-G:tRNA pair under standard
conditions
In this section we focused on FRET efficiencies measured between EF-G693-Cy3 and
the A-site tRNACy5 upon the first binding of EF-G to the PRE complex or just before EFG departing from the ribosome, as a prelude to the discussion of the kinetics of EFG:tRNA FRET efficiency changes during translocation (Section 4.2.4.7).
Initial and final FRET values were calculated as the average values of the first three
and last three frames of the FRET events, respectively. For PRE-I, the initial FRET
distribution showed two major peaks, with FRET efficiency values of 0.23 ± 0.01 and
0.42 ± 0.01, and relative areas of 0.45 and 0.55, respectively (Fig 4.11, top, left). The
initial FRET distribution was broad, which indicated that tRNAs were in a variety of
states when EF-G bound to the ribosome. The final FRET distribution also had two peaks
with approximately the same values as the initial FRET distribution (0.22 ± 0.01 and 0.41
± 0.01) but with very different relative areas (0.65 and 0.35, respectively) (Fig 4.11, top,
right), indicating that 36% ((0.55-0.35)/0.55=0.36) of the PRE complexes with an initial
high FRET efficiency successfully converted to the low FRET state.
The results for the PRE-II complex were qualitatively similar but, for the most part,
quantitatively different. The initial FRET distribution showed two major peaks, with
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FRET efficiencies of 0.27 ± 0.01 and 0.45 ± 0.05 and with relative areas of 0.70 and 0.30
(Fig 4.11, bottom, left). The corresponding final values were 0.25 ± 0.01 and 0.40 ± 0.04
for the FRET efficiencies and 0.80 and 0.20 for the relative areas (Fig 4.11, bottom,
right). One quantitatively similar result was obtained in the percentage of traces in PREII having initial high FRET efficiency that was successfully converted to the low FRET
state (33% vs. 36% in PRE-I).
As EF-G:L11 interaction indicated that the EF-G:L11 FRET pair only presented a
single FRET value, the differences in EF-G:tRNA FRET efficiencies and distributions
between PRE-I and PRE-II are likely due to differences in the binding of different
peptidyl-tRNAs [tRNAVal (PRE-I) vs. tRNAPhe (PRE-II )] at the A-site. PRE-I with ValtRNAVal-Cy5 showing a higher preference for the high FRET efficiency state compared to
PRE-II with A site Phe-tRNAPhe-Cy5, which is consistent with the results from Chen et al.
(2011).
It is reasonable to assume that the initial FRET distribution was determined by both
the equilibrium states of the A-site tRNA before EF-G binding and the binding affinity of
EF-G to the corresponding states. Chen et al. (2011) reported that at equilibrium in the
same buffer condition, the classic and hybrid populations of tRNAs in the absence of EFG were in 1:1 ratio for PRE-II complex. In our experiments, the relative populations of
high and low FRET states on EF-G addition, which correspond to class and hybrid tRNA
states (Detailed discussion in Section 4.2.6.1) was 0.3:0.7, implying the binding affinity
of EF-G to the hybrid FRET state was approximately two fold of that to the classic state.
The initial FRET distribution plots were broad for PRE-I and PRE-II, suggesting the
possibility that EF-G bound to different states of tRNAs which were located along the
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translocation trajectories between classic and hybrid states. This result is consistent with
Fischer et al. (2010) study which showed that while classic and hybrid tRNAs were the
two most abundant populations, tRNA possessed a number of different conformations
along the translocation trajectories that could be captured by EF-G (Fischer et al., 2010).
Initial FRET distributions of Group I and Group II were plotted separately for both
PRE-I and PRE-II (Figure 4.12). For Group I, most of the initial FRET events displayed
high FRET values for both PRE-I and II, but with a broad distribution (Fig 4.12 A, C).
This further supported that multiple high FRET states existed at the beginning of
translocation that could be captured by EF-G. For Group II, the initial FRET values were
dominated by the lower FRET values in both PRE complexes, but still a certain
proportion of high FRET state was observed. Since Group II is characterized by traces
showing similar initial and final FRET values, this distribution of initial FRET states
suggests that Group II includes both translocation events that start from low FRET states
and non-productive binding events to the high FRET states (Fig 4.12 B, D).
4.2.4.5 Binding of EF-G 693-Cy3 to POST Complex
Characterizations of FRET between EF-G693-Cy3 and PRECy5 were the focus of this
study. However, after one cycle of translocation, Cy5 labeled peptidyl tRNA in the P-site
gives rise to FRET signals with EF-G693-Cy3 that could affect the interpretation of our
results. Although 100 nM next TC was added to lessen such a FRET contribution, still
there is certain possibility that FRET between EF-G693-Cy3 with POSTCy5 were counted.
Therefore, binding of EF-G693-Cy3 to POSTCy5 complexes was studied as negative controls.
WT-EF-G was added to the pre-formed PRE to produce post translocation complex
(POST) in TAM15 buffer. POST complexes formed by PRE-I and PRE-II were denoted
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POST-I and POST-II, respectively. Each POST complex was formed after one cycle of
translocation and active peptidyl-tRNACy5 was translocated to the P site. POST was
attached to the slide surface by using the same single biotin labeled mRNA as previously
described, followed by addition of EF-G693-Cy3 in the absence of next TC. EF-G693-Cy3
bound and dissociated from the ribosome, resulting in a FRET between EF-G693-Cy3 and P
site peptidyl-tRNACy5. FRET efficiency distribution of POST-I had lower values
compared to the results of EF-G binding to the PRE complex, giving values of 0.14 ±
0.01 and 0.22 ± 0.01 (Fig. 4.13, A), which correspond to distances of 72 Å and 65 Å,
respectively. Zhou et al. (2014) reported tRNA in the pe/E site showing a distance of 88
Å to the position 693 on EF-G, which is larger but comparable to the calculated result of
72 Å. Therefore, 0.14 ± 0.01 may correspond to the FRET of Cy5-P-site tRNA: Cy3-EFG pair and 0.22 ± 0.01 may be attributed to FRET between the inactive tRNA in the A/P
site and EF-G. Also, the dwell time of the POST complex was 301 ± 6 ms, significantly
shorter than for EF-G interaction with the PRE complex (Fig. 4.13, B). A single FRET
state over the entire duration was obtained, demonstrated by postsynchronized analysis
which showed only one constant value for both pre- and post-synchronizations, indicating
that, unlike in PRE, there were no relative distance changes between the P-site tRNACy5
in POST-I and EF-G693-Cy3 (Fig 4.13, C). The ΔFRET distribution of POST-I further
confirmed this conclusion (Fig 4.14). Unlike in PRE, the distribution of delta FRET for
POST showed a symmetrical pattern relative to x = 0. The Group I population was
largely suppressed in POST-I complexes, suggesting that Group I can be attributed to
translocation, which involves movements of tRNAs and mRNA by one codon. Similar
results were obtained for POST-II complexes. FRET efficiencies were equal to 0.16 ±
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0.01 and 0.29 ± 0.02, respectively with a dwell time of 275 ± 3 ms (Fig. 4.13, D, E). A
constant FRET value was obtained in postsynchronized analysis and Group I traces were
again not present (Fig. 4.13, F and Fig 4.14).
4.2.4.6 Proposed explanations of Group I and Group II traces
Previous studies showed that EF-G binding to the ribosome could be both productive,
catalyzing active translocation, and non-productive, with EF-G dissociation occurring
prior to translocation (Chen et al., 2013a; Munro et al., 2010). For the reasons cited
above (longer residence time of EF-G, reflecting the longer time needed to complete the
translocation process, and decreases in FRET during the residence time, expected as a
result of peptidyl-tRNA movement from the A- to the P-site ) we conclude that Group I
traces reflect largely productive, translocation events. On the other hand, we believe that
Group II traces comprised both translocation events starting from lower FRET states and
non-productive binding events during which EF-G binds and dissociates from the same
state without completing translocation. Here, it is noteworthy that high FRET events (E >
0.4) in Group II had much shorter dwell times (112 ± 2 ms for PRE-I and 169 ± 6 ms for
PRE-II) than events started with high FRET in Group I (Fig 4.15)
4.2.4.7 Translocation kinetics of Group I
Synchronization analysis was applied to extract FRET efficiencies and durations of
FRET events in Group I and characterize the kinetics of tRNA translocation (Chen et al.,
2011a). The postsynchronized traces were calculated from the averaged FRET values as a
function of time. All FRET events were lined up at an identifiable trigger transition and
averaged. To get equal durations, all individual traces were extended at the prior and
subsequent segment ends. FRET traces were aligned at the beginning (pre123

synchronization) or end (post-synchronization). The fitted results of synchronization
analysis of Group I traces showed three FRET states, with the conversion of the
intermediate FRET state to the low FRET state constituting the rate limiting step.
4.2.4.7.1 Group I traces show three FRET states
PRE and post synchronization traces were each fitted with a single exponential
function. The apparent overall translocation rate is the reciprocal of the summed lifetimes
of all the states. Both two- and three- state models were applied to the two PRE
complexes. The three state model turn out to show better fitting results to the raw data for
both PRE complexes (Fig 4.16, Fig 4.17). Therefore, the three-state model will be applied
in our following kinetic analysis.
For PRE-I, FRET events started with a high FRET value of 0.47 ± 0.01, via an
intermediate FRET 0.25 ± 0.01, and finally disappeared with a low FRET of 0.24 ± 0.01,
corresponding to a distance change from about 54.1 Å to 63.6 Å and then to 64.2 Å.
These values agree reasonably well with the average distance between Cβ of N693C in
EF-G and C4 of positions 16/20 of the A-site bound N-acetyl-Val-tRNAVal in the recent
structure of Zhou et al. (2014). The transitions from 0.47 to 0.25 and 0.24 to zero
proceeded with rate constants of 18.0 ± 0.4 s-1, 18.4 ± 1.8 s -1 respectively, while the
conversion from 0.25 to 0.24 was slower, with a rate constant of 1.8 ± 0.1 s-1 (Table 4.4
and Fig 4.17, A). For PRE-II, essentially similar results were obtained. FRET events
started with a high FRET value of 0.49 ± 0.01, via an intermediate FRET of 0.31 ± 0.01,
and finally disappeared with a low FRET of 0.26 ± 0.01, corresponding to a distance
change from about 53.7 Å to 60.6 Å and then to 63.1 Å. The transitions from 0.49 to
0.31 and 0.26 to zero proceeded with rate constants of 24.4 ± 1.1 s-1, 12.6 ± 1.1 s-1 and
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the conversion from 0.31 to 0.26 proceeded more slowly, with a rate constant of 1.6 ± 0.1
s-1 (Table 4.4 and Fig 4.17, B).
4.2.4.7.2 Transition from INT to Low is the rate determining step
As described above, for both PRE complexes, transition from intermediate FRET
(INT) to low FRET (Low) is the rate limiting step but with a small FRET change, and
from high FRET (High) to intermediate FRET (INT) is not rate limiting but shows a large
FRET change. As Group II also contains active translocation events which only give rise
to a small FRET change, it is likely that transition from INT to Low FRET is included in
Group II. Such transitions should have a longer duration as they correspond to the ratelimiting step in translocation. To further examine this point, the timing of translocation
events with an initial FRET value of 0.35 to 0.27 and final FRET of 0.27 to 0.21 in Group
II was analyzed. The average dwell time of this group for PRE-I complexes was
determined to be 670 ± 43 ms (Fig 4.18, A), considerably longer than the dwell time of
the total population 424 ± 9 ms (Fig 4.7), consistent with the notion that FRET
conversion from INT to Low was the rate determining step. Similar results were found
for PRE-II, with an average dwell time of the selected traces equal to be 630 ± 30 ms (Fig
4.18, B), suggesting that different tRNAs have similar translocation trajectories.
4.2.4.7.3 Choosing different FRET cutoffs does not substantially alter the kinetics
of Group I traces
By definition, Group I and Group II are two types of events with different ΔFRET
values. As the 0.1 cutoff value was selected somewhat arbitrarily, several different cutoff
values were applied to test the robustness of our interpretation of the results (Table 4.2).
We want to examine how many traces were placed in Group I when different cutoff
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values applied, but the noise was counted in our measurement which complicated the
results. To get rid of the noise, the number of traces in corresponding positive ΔFRET
regions was used as the benchmark value of noise (for instance, number of traces with
FRET > + 0.10 was counted as noise for the traces with FRET < - 0.10), for the noise
should present a normal distribution as a function of ΔFRET. Therefore, a larger cutoff
value (absolute value) would reduce noise counted in Group I (for instance, for PRE-I
complexes, the numbers of traces with FRET > + 0.10 and FRET > + 0.20 were 522
and 67, respectively). Global fitting was applied to Group I with different cutoff values to
test the robustness of our results. Transition rates were fitted with the cutoff values
between - 0.12 and - 0.20. The fitted transition rates were little affected, confirming the
robustness of the three-state model. Similar results were found for PRE-II (Table 4.2 a, b).
4.2.5 Characterization of EF-G:tRNA FRET interaction showing relative distances
changes during translocation under non-standard conditions
4.2.5.1 Ternary complex concentration effect on translocation kinetics
Elongation factor Tu (Tu) is believed to bind to the ribosome at L7/L12, sharing the
same binding site with EF-G. As there are two copies of L7/L12 dimer per E. coli
ribosome, it is possible, even likely, that Tu and EF-G could bind to the ribosome
simultaneously at some point. Therefore, ternary complex (TC) binding may have three
possible effects on EF-G catalyzed translocation: 1) binding to the A-site - expected to be
codon dependent; 2) binding to L7/L12 - expected to be codon independent 3) uncharged
tRNA (present within TC preparations) binding to the E-site - expected to be codon
independent (Lill et al., 1987). As explained above, we added 100 nM of the next
cognate TC as part of the standard reaction mixture for studying EF-G:peptidyl-tRNA
interaction during translocation. To further examine the effect of TC complex on
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translocation, here we examine the effects of either eliminating the next cognate TC (0
nM TC) or of increasing the TC concentration to 500 nM. TC was added along with EFG693-Cy3 to both PRE-I and PRE-II. As compared with adding 100 nM TC, eliminating TC
did not alter FRET efficiency distribution, while adding 500 nM TC shifted the high
FRET peak to an even higher value for both PRE-I and PRE-II (Fig 4.19). The total dwell
time of FRET events was unchanged for PRE-I and was shorter for PRE-II in the absence
of TC. Interestingly, the total dwell time was reduced to half of its value with the addition
of large concentration (500 nM) TCs (Table 4.4) for both PRE-I and PRE-II. Further
analysis was applied to Groups I and II traces, respectively. For PRE-I, a similar trend of
dwell time change at different TC concentrations was observed for Groups I and II, with
unchanged dwell time at 0 nM TC and half reduced dwell time at 500 nM TCs. For PREII, under 0 nM TC, dwell time of both Groups I and II was reduced and similar reduction
in dwell time was obtained for 500 nM TCs condition. To test whether this effect was
codon dependent or not, 500 nM non-cognate Arg-tRNAArg was applied and showed a
similar dwell time reduction (Total dwell times are 202 ± 4 ms for PRE-I and 249 ± 5 ms
for PRE-II), implying that this effect was not codon dependent and could be attributed to
either the binding effect of EF-Tu to L7/L12 on the 50S subunit or of deacylated tRNA to
the E-site. Either of these possibilities could decrease the affinity of EF-G on the
ribosome and promote its release. While eliminating TC did not change the transition
rates for PRE-I, 500 nM TC did reduce the transition rate from High to INT (k1 from 18.1
± 0.4 s-1 to 15.7 ± 1.2 s-1 for PRE-I and from 24.4 ± 1.1 s-1 to 12.8 ± 0.5 s-1 for PRE-II)
and increased the dissociation of EF-G (k3 from 18.4 ± 1.8 s-1 to 38.6 ± 18.7 s-1 for PRE-I
and from 12.6 ± 1.1 s-1 to 20.9 ± 3.6 s-1 for PRE-II ), leaving the transition rate constant
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from INT to Low unchanged (Table 4.4). The possible explanation for the decreased
transition rates from High to INT for PRE-I and PRE-II would be that with high
concentration of TC complexes, uncharged tRNA within the TC preparation, bound to the
E-site non-specifically, favoring the classic state position for A-site tRNA and extending
the life-time of the high FRET state.
4.2.5.2 Buffer effect on translocation kinetics
Our standard conditions employed 15 mM Mg2+ in the absence of polyamines. We
determined the effects of both reducing Mg2+ and adding polyamines on translocation
kinetics, as reflected in the measurement of FRET values, dwell times and kinetics (Table
4.6, Fig 4.21 and Fig 4.22). For PRE-I, the high FRET proportion was increased in both
polyamine buffer and by reducing Mg2+ to 7 mM, with the effect being more marked in
the presence of polyamine. By contrast, for PRE-II the overall FRET efficiency
distribution was essentially unchanged by reduced Mg2+ concentration or addition of
polyamine (Table 4.5).
Decreasing Mg2+ from 15 mM to 7 mM resulted in shorter dwell times for both PREI and PRE-II, with reduced values for both Groups I and II. For PRE-I, the transition rate
constant (k1) from High to INT was slightly increased (from 18.1 ± 0.4 s-1 to 21.6 ± 1.1
s-1), while the rate constants from INT to Low (k2) was increased by a factor of two (from
1.8 ± 0.1 s-1 to 3.9 ± 0.1 s-1). Similar fitting results were obtained for PRE-II, except that
the transition rate constants from Low to dissociation was unchanged and from High to
INT was slightly decreased (Table 4.6).
Addition of polyamines did not much change overall dwell times. For PRE-I, a
decrease in the dwell time of Group II was offset by an increase on the dwell time of
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Group I, while for PRE-II added polyamine had little effect on either overall dwell time
or the dwell times for Groups I and II. For PRE-I, adding polyamine significantly
decreased the transition rates (from 18.1 ± 1.8 s-1 to 10.2 ± 0.5 s-1 for k1, from 1.8 ± 0.1 s-1
to 1.1 ± 0.3 s-1 for k2, and from 18.4 ± 0.1 s-1 to 9.2 ± 1.2 s-1for k3). For PRE-II adding
polyamine had only minor effects, slightly decreasing k1 and k3 and having little effect on
k2. Added polyamine also increased the percentage of Group I traces from 29.8 % to 37.7 %
for PRE-I and from 19.0 % to 25.1 % for PRE-II (Table 4.6).
In summary, added polyamine stabilized high FRET states in PRE I and II by both
reducing the transition rate from High to INT and increasing the portion of tRNA starting
translocation from a high FRET state.
4.2.6 Antibiotics effect on EF-G:tRNA FRET interaction
Many biochemical and structural studies have revealed that a diverse array of
antibiotics function during translocation to inhibit protein synthesis. Fusidic acid (FA)
binds to Domains G, II and III of EF-G, prevents EF-G conformational changes
following GTP hydrolysis, but does not inhibit translocation (Gao et al., 2009). Viomycin
(VIO) decouples the movements between EF-G and the A-site tRNA, blocking the
effective translocation of the A-site tRNA and stabilizing the ribosome in both ratcheted
and unratched states (Ermolenko et al., 2007; Peske et al., 2004; Stanley et al., 2010;
VAZQUEZ et al., 1977). Spectinomycin (Spc) binds to helix 34 of the small subunit
head domain on the ribosome and inhibits translocation after GTP hydrolysis and Pi
release (Munro et al., 2010; Peske et al., 2004).
4.2.6.1 Viomycin perturbs EF-G:tRNA FRET state transitions
PRE-I and II interactions with EF-GCy3 were carried out in the presence of 100 µM
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VIO under standard experimental conditions. The FRET distribution was shifted to
higher values on VIO addition with peak values of 0.27 ± 0.01, 0.42 ± 0.01 for PRE-I
[compare Fig 4.23, middle left (+VIO) with Fig. 4.21B (-VIO)] and 0.31 ± 0.01, 0.52 ±
0.02 for PRE-II [compare Fig 4.23, middle right (+VIO) with Fig. 4.21E (-VIO)].
Previous studies suggest that VIO blocks translocation of the A-site tRNA to the P site
and stabilizes tRNAs in both A/A classic and A/P hybrid states. Therefore, the 0.27 and
0.42 FRET states are attributed to the EF-G:A/P tRNA and EF-G:A/A tRNA structures
for PRE-I. Similarly, 0.31 and 0.52 FRET states are attributed to the EF-G:A/P tRNA and
EF-G:A/A tRNA structures for PRE-II . In the absence of VIO, FRET conversions from
High to INT and to Low efficiencies were observed. Added VIO suppressed these FRET
conversions, demonstrated by both synchronization analysis and ΔFRET distribution.
Postsynchronized analysis showed constant values for both pre and post synchronization
traces, indicating that there were no FRET efficiency changes during the entire residence
time of EF-G on the ribosome (Fig 4.24 A, B). Similarly, added VIO completely
suppressed Group I traces as plotted in Fig 4.24 C, D.
The same experiments were repeated under different buffer conditions described
above (Section 4.2.5.2). Adding polyamine at 15 mM Mg2+ led to an increases in the
fraction of PRE complex in the high FRET state (E ≈ 0.5) which was more pronounced
for PRE-II than for PRE-I, suggesting that high Mg2+ and polyamine concentrations
stabilize a classic-like state (Fig 4.23). To sum up, these findings together revealed that
EF-G:A/A site tRNA revealed a high FRET value ~ 0.5, and EF-G:A/P hybrid tRNA
showed an intermediate FRET value ~ 0.3, while the low FRET state (0.23 for PRE-I and
0.26 for PRE-II ) was not observed in the presence of VIO. This indicates that low the
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FRET state observed in the absence of antibiotics is attributable, at least in part, be
contributed by tRNAs in the late steps of translocation, which were not populated in the
presence of VIO.
4.2.6.2 Spectinomycin (Spc) inhibits complete translocation
PRE-I and II interactions with EF-GCy3 were repeated in the presence of 5 mM Spc.
Added Spc suppressed the population of traces showing a complete FRET change as
what was observed with no antibiotics, but still allowed some FRET changes. In the
presence of Spc, the FRET distribution was shifted to lower values compared to that seen
with added VIO and shifted to higher values compared to the experiments lacking
antibiotic, with peak values of 0.19 ± 0.01 and 0.38 ± 0.02 for PRE-I, and 0.23 ± 0.01 and
0.45 ± 0.01 for PRE-II (Fig 4.25). This indicated that Spc hindered translocation in a later
step compared to VIO, in accord with published results (Pan et al., 2007, Munro et al.,
2010). Interestingly, with Spc, we captured a smaller FRET change, demonstrated by
synchronization analysis, and the transition was a one step process with no intermediate
FRET state observed. Also, Group I traces were observed in ΔFRET distribution but the
population was smaller compared to that in the absence of antibiotics (Fig 4.26 B, D and
Fig 4.14 A, C). Taken together, these data suggested that Spc allowed the initial EF-G to
engage in the GTPase activation center and A-site tRNA conformational change, but
inhibited a later step of translocation. Similar global fitting analysis was applied here to
the traces with large FRET change. Two FRET states were obtained for both PRE-I and
PRE-II complexes. For the PRE-I complex, transition rate constants from the High (0.53
± 0.01) to the Low FRET state (0.26 ± 0.01) and from Low FRET state to dissociation are
5.7 ± 0.2 s-1 and 3.3 ± 0.1 s-1, respectively. Similar results were calculated for PRE-II,
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with efficiencies for both FRET states equal to 0.53 ± 0.01 and 0.27 ±0.01 and transition
rates of 5.7 ± 0.1s-1 and 4.5 ± 0.1 s-1 (Fig 4.27). The results suggest that in the presence of
Spc, the lowest FRET state, which was observed in the absence of antibiotic, was not
populated, and that EF-G dissociated from an intermediate state, with a FRET value
similar to that of a hybrid state, without catalyzing the complete translocation.
4.3 Discussion
Comparing our results with previous smFRET studies using labeled EF-G
smFRET studies have the potential to elucidate reaction mechanism by identifying
the important intermediates that may be too short-lived or weakly populated to be
detected in the ensemble FRET measurements. Since 2007, several smFRET studies have
been published focusing on different aspects of the role of EF-G in translocation. Wang in
our group first reported smFRET studies measuring FRET between position 231 in the G’
domain of EF-G, which is far from residue 693, the labeling position most utilized in our
work, and the NTD of L11 (C38) on a ribosome engaged in poly Phe synthesis, showing
that two FRET states can be identified, with efficiencies of 0.3 and 0.6 respectively
(Wang et at., 2007). However, due to the low time resolution of the experiment, no dwell
time or transition rates were reported in this work. In 2010, Munro et al. reported another
smFRET work of translocation. Cy3 labeled tRNAfMet (U8) and Cy5 labeled L1 (S55C)
construct were used to study the formation of the unlocked state. Cy3-fMet-Phe-tRNAPhe
(U47) and Cy5-EF-G were used to study the EF-G interaction with the A site tRNA. But
in this work, EF-G was enzymatically labeled via the Sfp phosphoantetheinyl transferase
reaction to a peptide (12 aa in length) fused at the C terminus. As a result, the dye could
be far away from EF-G protein, making questionable utilizing the FRET signal to
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monitor the relative movements between EF-G and A-site tRNA. This work focused on
the ribosome spontaneous movement which results in an unlocked state, suggesting that
this intrinsic conformational change of the ribosome determines the rate of translocation.
They observed FRET between EF-G and the A-site tRNA with a dwell time of 385 ms,
which matches the dwell time of total FRET events in our work (424 ± 9 ms, PRE-I; 457
± 8 ms, PRE-II). However, at the time resolution used in Munro’s work, transition rates
between FRET states could not be accurately determined (Munro e al., 2010). Chen et al.
(2013) correlated the composition and conformation of the ribosome during translocation
and focused on elucidating the ratcheting and back ratcheting motions of the ribosome by
using Cy3 labeled 30S and quencher labeled 50S. They reported dwell times for
translocation of 122 ms at 5 mM Mg2+ increasing to 270 ms at 15 mM Mg2+, somewhat
shorter than our results for translocation. However, in their measurement, dwell time is
based on measuring multiple cycles of translocation. In contrast, our result is obtained
from the first round of translocation, which is believed to be longer than translocation
occurring in the later cycles (Chen et al., 2011b). The most recently published EF-G
translocation work (Salsi et al., 2014) followed the movement of Domain IV on EF-G
(either position 538 or 541) by measuring FRET between labeling sites on Domain IV of
EF-G and small ribosomal protein S12, which is the only protein located at the subunit
interface near the A-site. By comparing FRET measured in the presence of different
antibiotics which are believed to stabilize either PRE or POST complexes, this work
describes a nice picture of EF-G Domain IV moving toward the A-site to facilitate the
movement of peptidyl-tRNA from the A site to the P site. However, due to weak EF-G
binding, all the results are obtained with antibiotics FA and/or VIO, no real-time
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translocation with dwell times and transition rates characterized.
Here, we monitor FRET between fluorophores attached to EF-G693 and ribosome
protein L11 or the A site tRNA to directly observe the relative distance changes between
EF-G:L11 and EF-G:tRNA. Our work provides the first good estimation of translocation
kinetics with rate constants of each transition accurately determined and coupled
movements between EF-G:tRNA and EF-G:L11.
EF-G:L11 shows constant FRET during translocation
For the EF-G:L11 pair, constant FRET was obtained for both a N-terminal domain
(NTD) labeled residue (C38) and a C-terminal domain (CTD) labeled residue (C87). L11
has a flexible structure with a linker region that is composed of two proline amino acids.
A comparison between EF-G bound ribosome with EF-G free ribosome structures reveals
that the NTD of L11 undergoes a large conformational change and large rearrangements
upon EF-G binding, with the EF-G binding regions on the NTD and the CTD moving
toward each other (Wimberly et al., 1999; Agrawal et al., 2001). In addition, during
translocation, Domains III-V of EF-G are believed to undergo large distance
displacements (Agirrezabala et al., 2009; Tourigny et al., 2013; Zhou et al., 2013),
Despite these results from structural studies, we observe no FRET efficiency changes
between EF-G and either NTD or CTD labeled L11 during the entire occupancy of EF-G
on the ribosome, as demonstrated by synchronization analysis. This implies that L11
internal conformational changes that are induced by EF-G binding occur prior to
translocation, and that, during translocation, either L11 moves together with EF-G or that
the labeled positions of EF-G (CTD) and L11 do not move, which seems less likely.
Group I traces measure the translocation trajectory
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A significant fraction of traces for the EF-G:tRNA FRET pair, denoted Group I
traces, showed decreased FRET efficiency during translocation and had a longer EF-G
residence time on the ribosome than traces showing little FRET change (Fig 4.9, Fig
4.10). We propose that the FRET efficiency changes in Group I traces reflect changes in
EF-G:tRNA distance during translocation, based on the following considerations. EFG693-Cy3 is active in translocation confirmed by fluorescence increase of prf labeled tRNA
programmed at the ribosomal A-site (Fig 3.5). The residence time of EF-G693-Cy3 for
Group I traces is similar to the overall rate of translocation measured in rapid kinetic
ensemble experiments, considering a) the measured ensemble rate constant in this work
at 2 µM EF-G concentration is 2.5 ± 0.6 s-1 for EF-G693-Cy3 mutant and the measured EFG residence time of Group I in smFRET is ~0.5 s, corresponding to a rate constant of 2 s1

; b) the Km for EF-G in Pan et al. (2007) is ~ 1.14 - 1.6 µM, so the saturated ensemble

rate would be about 4.5 s-1; c) the smFRET experiments are performed at 21 o C and the
ensemble experiments are performed at 25 o C. Increasing the temperature by 4 ° C, it is
likely to raise the smFRET rate by 1.5 - 2 fold which is about 3 - 4 s-1, and matches the
results of ensemble measurements both in our work and Pan’s work in 2007.
EF-G interactions with POST were also studied. PRE complex (about 10 ~ 30 nM)
was pre-incubated with fully active wild type EF-G (~ 3 µM) to form the POST complex.
The direct comparison of ΔFRET distributions between EF-G:POST and EF-G:PRE
suggests that, unlike in PRE complex, Group I traces are not present in POST complex
(Fig 4.14). The result is further supported by the postsynchronization analysis as a
constant FRET efficiency is obtained (Fig 4.13 C, F), suggesting that there are no relative
distance changes between EF-G and POST complex bearing Cy5 labeled tRNA in the P
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site. This result suggests that Group I traces report on those A-site tRNAs which undergo
translocation to the P site.
This suggestion is further supported by results that measure PRE complex
interactions with EF-G in the presence of viomycin (VIO) or spectinomycin (Spc). VIO is
a cyclic peptide antibiotic that binds at the 16S and 23S ribosomal RNA interface and
inhibits translocation by stabilizing tRNAs in the A and P sites (Modolell et al., 1977),
while allowing both EF-G binding and fast GTP hydrolysis (Ermolenko et al., 2007,
Stanley et al., 2010). Translocation is completely inhibited by 100 µM VIO, the
concentration used in our experiment. The ΔFRET distribution of PRE bearing Cy5
labeled A-site tRNA in the presence of VIO shows that Group I traces are fully
suppressed (Fig 4.24), indicating that Group I traces are attributable to translocation of
the A-site tRNA to the P-site. Spc binds to h34 of 30S neck region and disturbs
translocation by inhibiting swivelling of the head of the 30S subunit, but does not block
the movements of tRNAs in 50S subunit (Pan et al., 2007). In our experiments, Spc
suppresses the population of traces showing a complete FRET change. Moreover, global
fitting of the results with PRE-II clearly show that, in the presence of Spc, good fits can
be obtained by using a two-state model (Fig 4.27), while without Spc, a three-state model
is required for a good fit (4.17). This result suggests that, with Spc, EF-G dissociates in
an intermediate state without finishing catalyzing the complete translocation process.
This conclusion is in agreement with Pan et al. (2007) who reported that Spc stabilizes a
kinetically competent intermediate state of EF-G induced translocation, with puromycin
activity falling between that of PRE and POST complexes. Combining all the
aforementioned evidence leads to the conclusion that Group I traces arise from A-site
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tRNA translocation.
Translocation kinetics of EF-G:tRNA
Unlike EF-G:L11 which shows a constant FRET value during the whole EF-G
duration on the ribosome, EF-G:tRNA interaction possesses heterogeneous properties.
The previous view raised by Gonzalez and coworkers in 2008 suggested that EF-G only
binds to the hybrid state of tRNAs and shifts the equilibrium of the ribosome to the
ratcheted state. In 2011, Chen et al. demonstrated that EF-G binds to both rotated and
non-rotated states of the ribosome, by studying the tRNA: tRNA FRET and tRNA:L11
FRET. This idea was later confirmed by Chen et al. (2013) as EF-G binding to both
rotated and nonrated states was observed with Cy3 labeled 30S and quencher labeled 50S.
In our work, by measuring the dynamics of FRET interaction between the EFG:tRNA pair, we are able to directly characterize how EF-G samples tRNAs states. The
initial FRET distribution is broad and implies that EF-G samples tRNAs in various states
located along the translocation trajectory. To further understand what these FRET states
structurally correspond to, the EF-G:tRNA FRET pair is studied under 100 µM VIO
which traps tRNAs in both classic and hybrid states with a higher portion staying in the
hybrid state in the TAM15 buffer used in this work (unpublished results from Chunlai
Chen). It reveals that FRET between EF-G and classic or hybrid tRNAs are 0.42 ± 0.01
and 0.27 ± 0.01 for PRE-I and 0.52 ± 0.02 and 0.31 ± 0.01 for PRE-II, respective (Fig
4.23, middle). The initial FRET distributions (Fig 4.11, left) suggest that EF-G could
sample tRNAs in both classic and hybrid states with Val-tRNA preferring the classic state
and Phe-tRNA preferring to stay in the hybrid state.
EF-G can catalyze translocation of both classic and hybrid state tRNAs. Group II
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traces, which our results suggest include hybrid state tRNAs, show a FRET efficiency
which is close to that seen for EF-G:P-site tRNA FRET (Fig 4.13 A, D). This explains
why a significant portion of EF-G:tRNA FRET pairs corresponding to tRNAs
translocating from hybrid states, show no large FRET changes during translocation. On
the other hand, Group I traces, which we assign to translocation events starting from the
classic state, show large FRET changes during translocation. Specifically, the PRE-II
complex has an initial FRET efficiency of 0.49 ± 0.01, proceeds to 0.31 ± 0.01 to 0.26 ±
0.01. For PRE-I, the intermediate and final states have similar FRET efficiencies.
However, based on the PRE-II results, we used a three-state model to give a good fit to
our results, showing FRET values proceeding from 0.47 ± 0.01 to 0.25 ± 0.01 to 0.24 ±
0.01. These results suggest that EF-G:tRNA FRET proceeds from classic to hybrid to
POST-like FRET. The transition from hybrid state to POST-like state is the rate limiting
step, but proceeds with only a small FRET change, whereas the transition from classic
state to hybrid state is not rate limiting but shows a large FRET change. While Group I
traces are made up mostly of translocation events that start with A-site tRNAs in a classic
state, Group II traces reflect a more complex mixture of states, containing unproductive
bindings as well as translocation events starting from hybrid states. If the transition from
hybrid state to POST-like state is the rate-limiting step as observed in Group I,
translocation events in Group II should present a longer dwell time than non-productive
binding events. The dwell time of translocation events with an initial FRET value of 0.35
to 0.27 and final FRET of 0.27 to 0.21 in Group II was analyzed. The average dwell time
of this group for PRE-I and PRE-II are 670 ± 43 ms and 630 ± 30 ms (Fig 4.18, A),
respectively, which are considerably longer than the dwell times of the total Group II
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populations (374 ± 13 ms and 434 ± 10 ms, respectively, Fig 4.10 B, D), confirming the
notion that FRET conversion from hybrid state to POST-like state is the rate determining
step.
Combining all the aforementioned results, we propose a kinetic model of EF-G
catalyzed translocation. EF-G samples both classic and hybrid state tRNAs. EF-G
binding to the classic state shows a high FRET efficiency, and then tRNAs quickly move
to the hybrid states revealing an intermediate FRET with EF-G. The transition from
hybrid state constitutes the rate-limiting step for translocation with a rate constant about
10 fold slower than the transition rate from classic state to hybrid state. After hybrid state
tRNA translocating to the P-site, EF-G quickly dissociates from the ribosome (Fig 4.28).
On the other hand, the inter-domain movements of L11 occur before translocation, and
during translocation L11, if it moves at all, moves together with the C-terminal domain of
EF-G, showing no relative distance changes.
4.4 Conclusion
A simultaneous increase of Cy3 and Cy5 fluorescence intensities was observed for
two FRET pairs, indicating that EF-G binds to the ribosome in a conformation revealing
detectable FRET with both L11 and tRNA. For the EF-G:L11 FRET pair, a constant
FRET value was obtained over the entire EF-G residence time for both N-terminal and Cterminal labeled L11. In contrast, a decreasing FRET efficiency was observed for EFG:tRNA interaction. Our data provides evidence that tRNAs behave heterogeneously
during translocation. We are able to formulate a detailed kinetic scheme for translocating
complexes that show large negative FRET efficiency changes, suggesting that EFG:tRNA FRET proceeds from High to INT to Low FRET values. The transition from INT
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to Low is the rate-limiting step with a small FRET change, whereas the transition from
High to INT is rapid and displays a large FRET change. Both high concentration of the
next ternary complex (500 µM) and high Mg2+ with polyamine favor the High FRET state.
By comparing the FRET efficiencies obtained with VIO, we propose that High, INT and
Low FRET states correspond to peptidyl-tRNAs in A/A, A/P and near P-site like states as
translocation proceeds.
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Scheme 4.1 EF-G catalyzed translocation of A, P site tRNAs to P, E sites. Distinct
tRNAs and ribosome states are labeled: State 7, PRE complex with tRNAs in their classic
states (A/A, P/P); State 8, PRE complex in an intermediate state of ratcheting, with
tRNAs in A/A, P/E sites; State 9: PRE complex with a larger relative rotation between
50S and 30S and tRNAs in A/P, P/E sites; State 10: PRE complex with EF-G bound in
GTP form; State 11: PRE complex with EF-G bound in GDP·Pi form; 0 state, POST
complex with P/P, E/E site tRNAs (Frank and Gonzalez, 2010).
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Figure 4.1 Cartoon of single molecule experimental setup. PRE complex containing
tRNACy5 or L11Cy5 was attached to the slide surface via a single biotin labeled mRNA.
Then Cy3 labeled EF-G was injected into the system. A 532 nm laser was illuminated to
excite Cy3 fluorophore.
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Figure 4.2 Representative FRET traces of PRE-L11Cy5:EF-G693-Cy3 pair. Experiment
was performed in TAM15 buffer with 100 nM next TC. Cy3 fluorescence (Green) and Cy5
fluorescence (blue) showed a simultaneous increase for all FRET events. The initial
appearance and final disappearance of FRET are indicated by black dashed lines.
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Figure 4.3 FRET analysis of EF-G693-Cy3:L11Cy5. EF-G693-Cy3 interactions with L1187-Cy5
(top) or L1138-Cy5 (bottom) were studied in TAM15 buffer with 100 nM next TC. A, C.
FRET efficiency distributions are fitted by Gaussian function y=y0 + (
B, D. Dwell time distribution is fit by single exponential decay y = Aexp(-kt).
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Figure 4.4 FRET state analysis of EF-G693-Cy3:L11Cy5. EF-G693-Cy3 interaction with
L1187-Cy5 (top) or L1138-Cy5 (bottom) was studied in TAM15 buffer with 100 nM next TC.
A, D. Postsynchronized traces are obtained by aligning all FRET events at the beginning
(black) or at the end (red) and plotted as a function of time. B, E. FRET events which last
longer than 6 frames (210 ms, 35 ms per frame) are selected. The first and last three
frames are averaged separately, defined as initial and final FRET. The differences
between final and initial FRET are calculated and delta FRET distributions are plotted. C,
F. Initial and final FRET are plotted as a transition density map with the number of events
in each region indicated.
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Figure 4.5 Structure of pretranslocation complex. A. 70S ribosome with tRNAs bound
in classical A/A and P/P states with FA and mRNA. B. Translocation intermediate
complex, containing ap/ap and pe/E site tRNAs, EF-G mRNA and FA (Zhou et al., 2014).
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Figure 4.6 Representative FRET traces of PREtRNA-Cy5:EF-G693-Cy3 pair. Experiment
was performed in TAM15 buffer with 100 nM next TC. Cy3 fluorescence (green) and Cy5
fluorescence (blue) showed a simultaneous increase for all FRET events. The initial
appearance and final disappearance of FRET are indicated by black dashed lines.
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Figure 4.7 FRET analysis of EF-G693-Cy3:PREtRNA-Cy5. EF-G693-Cy3 interactions with
PRE-ItRNA-Cy5 (top) or PRE-IItRNA-Cy5 (bottom) were studied in TAM15 buffer with 100 nM
next round TC. A, C. FRET distribution plot and two peak values are fitted to a Gaussian
function. B, D. Dwell times are each fit by a single exponential decay.
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Figure 4.8 Synchronization analysis of EF-G693-Cy3:PREtRNA-Cy5. EF-G693-Cy3
interaction with PRE-ItRNA-Cy5 (left) or PRE-IItRNA-Cy5 (right) for total events was studied
in TAM15 buffer with 100 nM next round TC. Postsynchronized traces are obtained by
aligning all FRET events at the beginning (black) or at the end (red) and plotted as a
function of time.
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Figure 4.9 FRET state analysis of EF-G693-Cy3:PRECy5. EF-G693-Cy3 interaction with
PRE-ItRNA-Cy5 (top) or PRE-IItRNA-Cy5 (bottom) was studied in TAM15 buffer with 100 nM
next round TC. FRET events which last longer than 6 frames (210 ms) are selected. The
first and last three frames are averaged separately, defined as initial and final FRET. A, D.
Delta FRET distribution of EF-G:tRNA. The differences between final and initial FRET
are calculated and delta FRET distributions are plotted. B, E. Initial and final FRET are
plotted relative to each other. C, F. Initial and final FRET values are plotted as twodimensional transition density contour maps.
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Figure 4.10 FRET distribution and dwell time distribution of EF-G693-Cy3:PREtRNACy5
. EF-G693-Cy3:PRE-ItRNA-Cy5 (top) or EF-G693-Cy3:PRE-IItRNA-Cy5 (bottom) was studied in
TAM15 buffer with 100 nM next round TC. Dwell time distributions of traces of Group I
(red), II (green) are fitted by a single exponential decay. A, B. FRET distribution of
Group I (red) and Group II (Green) of PRE-I. C, D. FRET distribution of Group I (red)
and Group II (Green) of PRE-II.
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Figure 4.11 Initial and Final FRET distributions of EF-G693-Cy3:PREtRNA-Cy5 pair. EFG693-Cy3:PRE-ItRNA-Cy5 (top) and EF-G693-Cy3:PRE-IItRNA-Cy5 (bottom) were studied under
TAM15 buffer with 100 nM next round TC. Percentages of two FRET states are labeled
separately in red (cutoff FRET value: E=0.3 for PRE-I and E=0.4 for PRE-II). Fitted
FRET peak values are labeled in black.
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Figure 4.12 Initial FRET distributions of EF-G693-Cy3:PREtRNA-Cy5 for Groups I and
II. EF-G693-Cy3:PRE-ItRNA-Cy5 (top) and EF-G693-Cy3: PRE-IItRNA-Cy5 (bottom) were studied
in TAM15 buffer with 100 nM next round TC. Distribution of initial FRET values for
Groups I and II traces are plotted with peak values labeled separately. The detailed fitting
results, including standard deviations of the peak values and percentages of high FRET
state are listed in Table 4.1.
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Fitted Peak of Initial

Complex

MVF

Peak1=0.23±0.01c

1=

0.06

Peak2=0.42±0.01

2=

0.17

Peak1=0.37±0.01

1=

0.06

Peak2=0.52±0.01

2=

0.14

Group

Peak1=0.22±0.01

1=

0.06

II

Peak2=0.40±0.02

2=

0.16

Peak1=0.27±0.01

1=

0.08

Peak2=0.45±0.04

2=

0.18

Peak1=0.41±0.01

1=

0.10

Peak2=0.63±0.06

2=

0.18

Group

Peak1=0.26±0.01

1=

0.08

II

Peak2=0.41±0.04

2=

0.17

Group I

Total

PRE-II
MFK

σ(SD)

FRET distribution

Total

PRE-I

a

Group I

b

High FRET

55%

73%

32%

30%

41%

20%

Table 4.1 FRET result summary of EF-G693-Cy3:PREtRNA-Cy5. Results of initial FRET
distributions of EF-G693-Cy3:PRE-ICy5 and EF-G693-Cy3:PRE-IICy5 are summarized. The
experiments were performed under TAM15 buffer with 100 nM next round TC. The initial
FRET information of total events, Group I and Group II are summarized separately.
a
SD of FRET distribution
b
The intersect FRET value of the two Gaussian fitted curve (E = IS) is obtained. High
FRET percentage is calculated by using the number of events (E > IS) divided by the
number of total events.
c
Standard error of the fitted peak value
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Figure 4.13 FRET analysis of EF-G693-Cy3:POSTtRNA-Cy5. EF-G693-Cy3 interaction with P
site fMet-Val-tRNAVal-Cy5 (top) or fMet-Phe-tRNAPhe-Cy5 (bottom) in TAM15 buffer was
studied in the absence of next TC. A, D. FRET distributions are fitted by Gaussian
function. B, E. Dwell times are fitted by a single exponential decay. C, F.
Postsynchronized traces are obtained by aligning all FRET events at the beginning (black)
or at the end (red) and plotted as a function of time.

155

Figure 4.14 Comparison of ΔFRET distribution between PRE and POST. FRET
events which lasted longer than 6 frames are selected. The first and last three frames are
averaged separately, defined as initial and final FRET, respectively. The differences
between final and initial FRET are calculated and ΔFRET distributions are plotted. A.
ΔFRET distribution of EF-G: PRE-ItRNA-Cy5. B. ΔFRET distribution of EF-G: POST-ItRNACy5
. C. ΔFRET distribution of EF-G: PRE-IItRNA-Cy5. D. ΔFRET distribution of EF-G:
POST-IItRNA-Cy5.
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Figure 4.15 Dwell time distributions of high FRET traces (E > 0.4) in Group II. EFG693-Cy3:PRE-ICy5 (left) and PRE-IICy5 (right) were studied in TAM15 buffer with 100 nM
next round TC. Dwell time distributions are each fitted by a single exponential y = Aexp(kt).
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Figure 4.16 Synchronization analysis of EF-G693-Cy3:PRE-ItRNA-Cy5. EF-G693-Cy3
interaction with PRE-ItRNA-Cy5 was performed in TAM15 buffer with 100 nM next round
TC. Post-synchronization traces are fitted by a two-state model (left) or a three-state
model (right).

Figure 4.17 Synchronization analysis of EF-G693-Cy3:PRE-IItRNA-Cy5. EF-G693-Cy3
interaction with PRE-IItRNA-Cy5 was performed in TAM15 buffer with 100 nM next round
TC. Post-synchronization traces are fitted by a two-state model (left) or a three-state
model (right).
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Figure 4.18 Dwell time distribution of certain traces in Group II. EF-G693-Cy3:PREItRNA-Cy5 (left) and PRE-IItRNA-Cy5 (right) were obtained in TAM15 buffer with 100 nM next
round TC. Traces with initial FRET (0.35 to 0.27) and final FRET (0.27 to 0.21) in Group
II are selected. Dwell time distributions of these traces are fitted by a single exponential y
= Aexp(-kt).

159

Delta FRET cutoff
values
PRE-I

<-0.10

<-0.12

<-0.14

<-0.16

<-0.18

<-0.2

Number of events

2359

2075

1845

1638

1452

1296

100%

88%

78%

69%

62%

55%

Rate constant
(Global fitting)

k1=18.1±0.4
k2=1.8±0.1
k3=18.4±1.8

k1=22.1±0.9
k2=1.8±0.1
k3=8.9±0.8

-----

-----

-----

k1=22.4±1.2
k2=1.8±0.1
k3=6.4±0.6

FRET Efficiency

F1=0.47±0.01
F2=0.25±0.01
F3=0.24±0.01

F1=0.49±0.01
F2=0.27±0.01
F3=0.24±0.01

-----

-----

-----

F1=0.54±0.01
F2=0.27±0.01
F3=0.22±0.01

>0.1

>0.12

>0.14

>0.16

>0.18

>0.20

Number of events

522

346

229

155

110

67

Ratio

100%

66%

44%

30%

21%

13%

Percentage

1

Delta FRET values

Table 4.2a Global fitting results summary using different ΔFRET cutoff values of
PRE-I. EF-G693-Cy3 interaction with PRE-ItRNA-Cy5 and 100 nM next TC was studied in
TAM15 buffer.
1
Global fitting results are based on traces with decreased FRET changes
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Delta FRET cutoff
values
PRE-II

<-0.12

<-0.14

<-0.16

<-0.18

<-0.2

Number of events

1207

1017

865

730

610

100%

84%

72%

60%

50%

Percentage

Rate constant
(Global fitting)

k1=24.4±1.1
k2=1.6±0.1
k3=12.6±1.1

k1=23.1±1.2
k2=1.6±0.2
k3=10.4±0.5

FRET Efficiency

F1=0.49±0.1
F2=0.31±0.1
F3=0.26±0.1

F1=0.53±0.01
F2=0.33±0.01
F3=0.28±0.01

1

Delta FRET values

>0.12

>0.14

>0.16

>0.18

>0.20

Number of events

481

345

252

184

134

Ratio

100%

72%

52%

38%

28%

Table 4.2b Global fitting results summary using different ΔFRET cutoff values of
PRE-II. EF-G693-Cy3 interaction with PRE-IItRNA-Cy5 and 100 nM next TC was studied in
TAM15 buffer.
1
Global fitting results are based on traces with decreased FRET changes
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Figure 4.19 FRET distribution of EF-G693-Cy3:PREtRNA-Cy5 under different next TC
concentrations. EF-G693-Cy3 interaction with PRE-ItRNA-Cy5 (top) and PRE-IItRNA-Cy5
(bottom) was studied in TAM15 buffer with 0, 100, 500 nM next TC. FRET distribution is
plotted and two peak values are fitted by Gaussian function. The detailed fitting results,
including standard deviations of the peak values and the percentage of high FRET state
are listed in Table 4.3.
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Fitted Peak of Total

Complex

MVF

100
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0

PRE-II
MFK

σ(SD)

FRET distribution

0

PRE-I

b
a

100

500

High FRET
percentage

Peak1=0.18±0.01c

1=

0.07

Peak2=0.36±0.02

2=

0.16

Peak1=0.18±0.01

1=

0.07

Peak2=0.37±0.02

2=

0.17

Peak1=0.18±0.01

1=

0.07

Peak2=0.40±0.01

2=

0.19

Peak1=0.21±0.01

1=

0.08

Peak2=0.35±0.04

2=

0.14

Peak1=0.22±0.01

1=

0.08

Peak2=0.36±0.03

2=

0.15

Peak1=0.23±0.01

1=

0.09

Peak2=0.45±0.02

2=

0.20

22%

20%

41%

27%

19%

30%

Table 4.3 Summary of FRET distributions of EF-G693-Cy3:PREtRNA-Cy5 at different
next TC concentrations. The experiments were performed under TAM15 buffer with 0,
100, 500 nM next round TC.
a
SD of FRET distribution
b
The intersect FRET value of the two Gaussian fitted curve (E = IS) is obtained. High
FRET percentage is calculated by using the number of events (E > IS) divided by the
number of total events.
c
Standard error of the fitted peak value
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Complex

TC

d

Transition rate (s-1 )

Dwell time (ms)

Concentration
k

k
1

PRE-I
MVF

PRE-II
MFK

01

a

100 nM 1

k
2

3

b

c

Dw2=336+9

18.7±0.5

1.8±0.1

18.6±2.0

Dw=424±9

Dw1=555±10

Dw2=374±13

18.1±0.4

1.8±0.1

18.4±1.8

500 nM 1

Dw=199±3

Dw1=288±8

Dw2=185±3

15.7±1.2

1.8±0.1

38.6±18.7

03

Dw=291±6

Dw1=394±14

Dw2=278±7

22.9±1.5

2.1±0.1

13.8±1.4

100 nM 2

Dw=457±8

Dw1=573±21

Dw2=434±10

24.4±1.1

1.6±0.1

12.6±1.1

500 nM 2

Dw=250±4

Dw1=417±12

Dw2=229±4

12.8±0.5

1.5±0.1

20.9±3.6

Dw=386+8

Dw1=557+8

Table 4.4 Summary of kinetics of EF-G promoted translocation at different next TC
complex concentrations.
a
Dwell time of total events
b
Dwell time of Group I traces
c
Dwell time of Group II traces
d
Transition rates are fitted by using the three FRET states model
1
Cognate Phe-tRNAPhe
2
Cognate Lys-tRNALys
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Figure 4.20 Global fitting of synchronization traces at different next TC complex
concentrations. FRET between EF-G693-Cy3 and PRE-ItRNA-Cy5 (top) or PRE-IItRNA-Cy5
(bottom) in TAM15 buffer with 0, 100 or 500 nM next round TC. Fitting results are listed
in Table 4.4.
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Figure 4.21 FRET distribution of EF-G693-Cy3:PREtRNA-Cy5 under different buffer
conditions. FRET results between EF-G693-Cy3 and PRE-ItRNA-Cy5 (top) or PRE-IItRNA-Cy5
(bottom) in WB buffer, TAM15 buffer and Polyamine buffer with 100 nM next round TC
are studied. FRET distribution is plotted and two peak values are fitted by Gaussian
function. The detailed fitting results, including standard deviation of the peak values and
percentages of high FRET state are listed in Table 4.5.
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Fitted Peak of Total

Complex
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FRET distribution
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High FRET
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41%

20%

67%

18%

19%

22%

Table 4.5 Summary of FRET distributions of EF-G693-Cy3:PREtRNA-Cy5 at different
buffer conditions. The experiments were performed in WB buffer, TAM15 buffer and
Polyamine buffer with 100 nM next round TC.
a
SD of FRET distribution
b
The intersect FRET value of the two Gaussian fitted curve (E = IS) is obtained. High
FRET percentage is calculated by using the number of events (E > IS) divided by the
number of total events.
c
Standard error of the fitted peak value
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d
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e

Transition rate (s-1 )
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k

k
1
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k
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b
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Dw2=186±4

26.1%
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15
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PRE-II
MFK
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Table 4.6 Summary of kinetics of EF-G promoted translocation at different buffer
conditions.
a
Dwell time of total events
b
Dwell time of Group I traces
c
Dwell time of Group II traces
d
Percentage of Group I is calculated by using the number of traces from Group I divided
by the number of total events
e
Transition rate constants are fitted by the three-state model.
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Figure 4.22 Global fitting results of postsynchronized traces at different buffer
conditions. FRET results between EF-G693-Cy3 and PRE-ItRNA-Cy5 (top) or PRE-IItRNA-Cy5
(bottom) in WB buffer, TAM15 buffer or polyamine buffer with 100 nM next round TC
are fitted separately. Detailed fitting results are listed in Table 4.6.
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Figure 4.23 FRET distribution of EF-G693-Cy3:PREtRNA-Cy5 with VIO. EF-G693-Cy3
interaction with PRE-ItRNA-Cy5 (left) or PRE-IItRNA-Cy5 (right) in different buffer conditions
with 100 nM next round TC and 100 µM VIO. FRET distributions are plotted, with two
major peaks indicated in the Figures. The detailed fitting results, including standard
deviation of the peak values and the percentages of high FRET states are listed in Table
4.7.
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Table 4.7 Summary of FRET distributions of EF-G693-Cy3:PREtRNA-Cy5 with VIO.
FRET between EF-G693-Cy3 and PRE-ItRNA-Cy5 or PRE-IItRNA-Cy5 are studied under
different buffer conditions with 100 nM next round TC and 100 µM VIO.
a
Dwell time of total events
b
SD of FRET distribution
c
High FRET percentage is calculated by using the number of events (E > 0.4) divided by
the number of total events
d
Standard error of the fitted peak value
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Figure 4.24 VIO suppresses FRET conversions. A, B. Postsynchronized traces under
standard conditions in the presence of 100 µM VIO are obtained by aligning all FRET
traces at the beginning (black) or at the end (red) and plotted as a function of time. C, D.
ΔFRET distribution of EF-G693-Cy3:PRE-ItRNA-Cy5 (left) and EF-G693-Cy3:PRE-IItRNA-Cy5
(right) in TAM15 buffer with 100 µM VIO. FRET events which last longer than 6 frames
are selected. The first and last three frames are averaged separately, defined as initial and
final FRET, respectively. The differences between final and initial FRET are calculated
and delta FRET distributions are plotted.
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Figure 4.25 FRET distribution of EF-G693-Cy3:PREtRNA-Cy5 with Spc. EF-G693-Cy3
interaction with PRE-ItRNA-Cy5 (top) and PRE-IItRNA-Cy5 (bottom) under TAM15 buffer with
100 nM next round TC and 5mM Spc. A, C. FRET distributions are plotted with two
major peaks. B, D. Dwell time distributions are each fitted by a single exponential y =
Aexp(-kt). The detailed fitting results, including standard deviations of peak values and
the percentages of high FRET state are listed in Table 4.8.
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Complex

PRE-I
MVF
PRE-II
MFK

Buffer

TAM15

TAM15

Fitted Peak of Total

a

σ(SD)

FRET distribution
Peak1=0.19±0.01c

1=

0.07

Peak2=0.38±0.02

2=

0.17

Peak1=0.23±0.01

1=

0.08

Peak2=0.45±0.02

2=

0.20

b

High FRET ratio

51%

32%

Table 4.8 Summary of FRET distributions of EF-G693-Cy3:PREtRNA-Cy5 with Spc.
FRET between EF-G693-Cy3 and PRE-ICy5 or PRE-IICy5 is obtained under TAM15 with 100
nM next round TC and 5 mM Spc.
a
SD of FRET distribution
b
The intersect FRET value of the two fitted Gaussian curves (IS) is obtained. High FRET
percentage is calculated by using the number of events (E > IS) divided by the number of
total events.
c
Standard error of the fitted peak value

174

Figure 4.26 FRET state analysis of EF-G693-Cy3:PREtRNA-Cy5 with Spc. FRET between
EF-G693-Cy3 and PRE-ItRNA-Cy5 (top) or PRE-IItRNA-Cy5 (bottom) is obtained under TAM15
buffer with 100 nM next round TC and 5mM Spc. A, C Postsynchronized traces are
calculated by synchronizing all FRET events at the beginning (black) or at the end (red)
and plotted as a function of time. B, D FRET events which last longer than 6 frames are
selected. The first and last three frames are averaged separately, defined as initial and
final FRET, respectively. The differences between final and initial FRET values are
calculated and delta FRET distributions are plotted.
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Figure 4.27 Global fitting results of postsynchronized traces of EF-G693-Cy3:PREtRNACy5
with Spc. EF-G693-Cy3 interactions with PRE-ItRNA-Cy5 (left) and PRE-IItRNA-Cy5 (right)
were studied in TAM15 buffer, 100 nM next round TC and 5 mM Spc.

Figure 4.28 Kinetic models of EF-G catalyzed translocation.
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CHAPTER V SMFRET

STUDY OF BIFUNCTIONAL

RHODAMINE LABELED EF-G
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Abstract
Elongation factor G (EF-G) catalyzes translocation of mRNA, A- and P-site bound
tRNAs on the ribosome during the polypeptide elongation cycle. Previous studies show
that EF-G has significant conformational flexibility with different conformations
observed for EF-G·GTP and EF-G·GDP forms (Agirrezabala et al., 2009). Upon binding
to the ribosome, EF-G undergoes large conformational changes as it transitions from
bound EF-G·GTP to bound EF-G·GDP·Pi and to bound EF-G·GDP that include both
distance displacement and orientation changes. To understand how these two different
movements occur on the ribosome, bifunctional rhodamine labeled EF-G derivatives
(BR-EF-G) were utilized to compare the timing of changes in EF-G orientation on the
ribosome, as measured by single molecule polarized total internal reflection fluorescence
(polTIRF) microscopy (Chen et al., manuscript in preparation) with changes in EFG:tRNA FRET efficiency measurement, presented below. In our work, Phe-tRNAPhe was
labeled with Cy5 and six EF-G derivatives were labeled with a bifunctional
tetramethylrhodamine (BR). Four of the six mutants showed measurable BR:Cy5 FRET,
with dwell times of 150 - 350 ms, depending on which mutant was used. A major FRET
change during EF-G occupancy of the ribosome was observed for only one BR-EF-G, as
determined from synchronization analysis, FRET distributions, and transition heat
contour maps. Interestingly, for the four BR-EF-Gs showing FRET, FRET changes
during EF-G occupancy were larger if the BR group was located closer to the EF-G hinge
region, suggesting that parts of Domain IV of EF-G, which penetrate to the decoding
region of the ribosome, move together with the A-site tRNA during translocation.
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5.1 Introduction
EF-G.GTP first binds to the GTPase activation center (GAC) of a pretranslocation
(PRE) complex, followed by a fast GTP hydrolysis (k = 170 s-1). The tip of Domain IV on
EF-G is believed to penetrate to the A-site during translocation. At the same time, the
interactions of EF-G with tRNAs and mRNA are retained to help to maintain the reading
frame (Pulk et al., 2013; Tourigny et al., 2013; Zhou et al., 2013). The translocation
movements of tRNA and mRNA occur at the same rate and according to the most recent
research, this movement is also coupled with the back ratcheting of the ribosome (Chen
et al., 2013a). As the EF-G.GDP form has a much lower affinity to the ribosome, after Pi
release, EF-G.GDP dissociates from the ribosome spontaneously (Rodnina et al., 1997).
The conformational changes during EF-G residence on the ribosome can be described as
a hinge-like motion of Domains III, IV and V relative to Domains I and II, directly
confirmed by the structural results (Fig 5.1).
In Chapter 4, we identified time-dependent FRET changes between EF-G693 and the
A-site tRNA or L11 during translocation, which revealed important insights regarding the
dynamics of distance changes between one position on C-terminal domain (CTD) of EFG (N693C-EF-G) and the D-loop of tRNA (position 16/20) during translocation. Here,
we extended such measurements to six different BR-labeled EF-G derivatives. The
results obtained provide a more comprehensive view of relative EF-G:tRNA motion
during translocation, and ultimately will be useful in comparing the timing of changes in
EF-G:tRNA distance to changes in EF-G orientation on the ribosome during translocation.
The latter, which is carried out using single molecule polarized total internal reflection
fluorescence (polTIRF) microscopy, employs the same six BR-labeled EF-G derivatives
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(Chen et al., manuscript in preparation). These derivatives are designed to diminish the
free rotation of the dye relative to EF-G. For this purpose, two engineered cysteines (Cys)
located within the same -helix seven residues apart are cross-linked with BR (Fig 5.2).
5.2 Results
5.2.1 The design of the experiment
PRE-II complex containing Cy5 labeled Phe-tRNAPhe, hereinafter denoted PRE-IICy5,
was prepared as described (Section 2.2.4.4) and attached to the slide surface via a 5’ and
3’ double biotin labeled mRNA (MFV) to restrict ribosome free rotation (Fig 5.3, Fig 5.4).
To keep the results of polTIRF and smFRET-TIRF comparable to one another, the
standard buffer condition in our lab (TAM15 buffer) was used. Also, 20 nM next TC (WTVal-TC) and 10 nM Cy5-Phe-TC were added to reduce the likelihood of EF-G binding to
the POST complex and carry out multiple rounds of translocation. All experiments were
performed at 21 °C with a frame rate of 10 ms/frame.
5.2.2 EF-G mutant selections
Six BR-EF-G derivatives which showed full translocation activity (Chen et al.,
unpublished results) were screened for FRET with the A-site Cy5 labeled tRNA,
including BR-EF-G429-436 (Domain III), BR-EF-G630-637 (Domain V), BR-EF-G467-474
(Domain III), BR-EF-G555-562 (Domain IV), BR-EF-G599-606 (Domain IV) and BR-EFG692-699(CTD). The latter four all gave FRET with the A-site bound fMet-Phe-tRNAPhe
(Cy5) and were selected for further studies. Each of the labeled sites fell within -helices
that were solvent-exposed and contained amino acids that were not strongly conserved.
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5.2.3 Characterization of the EF-G:tRNA FRET interactions
5.2.3.1 FRET efficiency distributions and BR-EF-G dwell times
For each of the four BR-EF-Gs giving FRET with the A-site bound fMet-PhetRNAPhe (Cy5), binding to PRE-IItRNA-Cy5 led to a simultaneous increase of BR and Cy5
fluorescence. FRET efficiency distributions (Fig. 5.5) were fitted with Gaussian function
and all BR-EF-G dwell times (Fig 5.6) were fitted with a double exponential decay.
FRET efficiencies were fitted by two major peaks except for BR-EF-G599-606 as only one
peak was obtained. Among these four EF-G derivatives, FRET efficiencies were largest
for BR-EF-G599-606 and lowest for BR-EF-G555-562. FRET efficiencies of BR-EF-G467-474
and BR-EF-G692-699 were similar but a high FRET proportion was more prominent in BREF-G692-699 mutant. BR-EF-G467-474 and BR-EF-G555-562 showed comparable FRET dwell
time with values of τ1= 33 ± 9 ms, τ2= 123 ± 8 ms and τ1= 16 ± 2 ms, τ2= 182 ± 3 ms,
respectively, whereas τ2 for EF-G692-699 was much longer with a value of 335 ± 9 ms. The
differences in dwell times among different EF-G derivatives are likely due to the position
where the dye is attached and all of the dwell time obtained in this work is similar to
previous characterized dwell time of translocation (Chen et al., 2013a; Munro et al.,
2010).
5.2.3.2 Characterization of BR-EF-G:tRNA FRET efficiency change
Following the logic employed in analyzing the interaction of EF-G693-Cy3 with PRE-I
and PRE-II (Section 4.2.4.3), we utilized synchronization analysis (Fig 5.7), ΔFRET
distribution (Fig 5.8) and transition heat contour maps (Figure 5.9) to determine whether
BR-EF-G:tRNA

FRET

efficiency

showed

changes

during

translocation.

Postsynchronized traces of both BR-EF-G467-474 and BR-EF-G692-699 presented a small
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FRET change, while the other two mutants only had one constant FRET value over the
entire FRET duration. ΔFRET distributions were plotted, and although the majority of the
events still showed no significant FRET changes, for BR-EF-G692-699, a certain proportion
of events was observed located in x < 0 region with a negative FRET change (left side of
the dashed line in Fig 5.8 D). In contrast, this population was not prominent in BR-EFG467-474 mutant, likely due to only a low proportion of traces with large FRET changes. As
discussed in Chapter 4, the FRET events of BR-EF-G692-699 mutant were further
segmented into two groups to study the heterogeneity of EF-G:tRNA interactions. We
denoted the group of traces with large decreased FRET (ΔFRET < - 0.2) for the BR-EFG692-699:PRE-IItRNA-Cy5 FRET pair as Group I. All the other traces were placed in Group II
(ΔFRET > - 0.2). The dwell time averaged 408 ± 19 ms for Group I and 372 ± 10 ms for
Group II (Fig 5.10). This small difference is not as large as what was obtained for EFGCy3-693 (543 ± 19 ms for Group I and 434 ± 10 ms for Group II, Section 4.2.4.3).
5.2.3.3 Initial and Final FRET distributions for the BR-EF-G692-699:tRNA pair
We next examined the distributions of initial and final FRET values for the BR-EFG692-699:tRNA pair, which were calculated as the average values of the first three and last
three frames of the FRET events, respectively (Fig 5.11). A clear decrease was observed
for the final FRET as compared to the initial FRET efficiencies, with FRET values of
0.27 ± 0.01 and 0.47 ± 0.01 for initial FRET shifting to 0.23 ± 0.01 and 0.37 ± 0.04 for
final FRET. Also, the initial FRET distribution was broader compared to the final FRET
distribution. Detailed analysis was applied to postsynchronized traces to characterize the
kinetics of tRNA translocation
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5.2.3.4 Translocation kinetics of Group I for the BR-EF-G692-699:tRNA pair
Following the procedure described in Section 4.2.4.7, we fit the postsynchronized
traces in Group I to characterize the kinetics of BR-EF-G692-699 catalyzed translocation.
Global fitting was applied to postsynchronized traces using two-state or three-state
models (Fig 5.12). A better fit to the raw data was obtained using the three-state model.
Accordingly, the results obtained from the three-state model will be used for the later
discussion.
The fitted results showed that in Group I, FRET events started with a high FRET
value of 0.53 ± 0.01, proceeded via an intermediate FRET of 0.28 ± 0.01, and finally
disappeared with a low FRET of 0.24 ± 0.01, corresponding to a distance change from
about 52Å to 62 Å and then to 64 Å. The transitions from 0.53 to 0.28, 0.28 to 0.24, and
0.24 to zero proceeded with rate constants of 45.5 ± 1.7 s-1, 2.5 ± 0.1 s-1, and 24.8 ± 2.2
s-1 (Table 5.3). These results are similar to what we found for EF-GCy3-693 catalyzed
translocation (Section 4.2.4.7 - FRET states: 0.49, 0.31, 0.26; rate constants 24.4 ± 1.1 s-1,
1.6 ± 0.1 s-1, 12.6 ± 1.1 s-1), although the rate constants for BR-EF-G692-699 are 1.5 - 2
times larger. The slower rate constants for EF-GCy3-693 might be due to interaction of the
singly tethered Cy3 dye with the ribosome. The double tethered BR dye would be
expected to interact much less with the ribosome. The smallest rate difference between
the two labeled EF-Gs is in the rate limiting step, which is accompanied by only a small
FRET change. This step, which presumably involves large movements of tRNA and/or
mRNA but only shows a small relative FRET change between labeled positions on EF-G
and the A-site tRNA, might be less influenced by differences in dye-ribosome interaction.
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5.2.3.5 FRET and BR placement within EF-G
The results presented in Fig 5.13 could be used to address the question of how the
extent of negative FRET change correlated with the position of BR cross-linking to the
EF-G molecule. For each BR-EF-G, the measured variable D, defined as the number of
traces showing a ≥ 0.2 decrease in FRET efficiency minus the number of traces showing
a ≥ 0.2 increase in FRET efficiency, was divided by the total number of FRET recordings
(T) (Table 5.4). This results in the following ordering of the percentage of net negative
FRET changes: EF-G692-699 (CTD) > BR-EF-G467-474 (Domain III) > EF-G599-606 (Domain
IV) or BR-EF-G555-562 (Domain IV), supporting the conclusion that negative FRET
changes were larger if the BR group was located closer to the EF-G hinge region.
5.3 Discussion
In Chapter 4, we proposed a kinetic model of EF-G:tRNA interaction during
translocation with the FRET efficiencies and rate constants of each state characterized for
the first time. This model suggests that EF-G:tRNA FRET proceeds from High to INT to
Low FRET, which correspond to FRET values of EF-G:tRNA pair when tRNAs are in
classic, hybrid or POST-like states. This kinetic model is further confirmed by analyzing
post-synchronized FRET between the A-site tRNA and bifunctional rhodamine labeled
EF-Gs(BR-EF-Gs) located at the IV:V interface. The global fitting results of postsynchronized FRET of BR-EF-Gs:tRNA suggest that the FRET efficiency starts with a
high FRET value, and proceeds to an intermediate value, to a low FRET value. Similar as
what was obtained in Chapter 4, the transition rate from INT to Low is the rate limiting
step, while only a small FRET change occurs during this process. However, the transition
rates of BR-EF-Gs:tRNA pair are comparably faster ( ~ 2 fold ) than those of Cy3-EF-
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G:tRNA (Table 5.1, Table 4,4). This difference could be due to the difference in the
labeling strategies. The BR dye on EF-G is more restricted and has less freedom of
rotational movements. In contrast, Cy3 dye is only singly attached to EF-G. When it is
tethered onto the ribosome, more contacts could be formed between the dye and
ribosomal proteins or rRNAs, which are likely to extend EF-G lifetime on the ribosome.
Both postsynchronization analysis and delta FRET distributions (Fig 5.7, Fig 5.8)
show that larger changes in FRET efficiency are found when the BR group is located
closer to the EF-G hinge region (Agirrezabala et al., 2009; Agrawal et al., 1998; Frank
et al., 2007; Valle et al., 2003) about which Domains III-V move relative to Domains I
and II, than when the BR group is in a part of Domain IV that extends into the A-site
decoding center. During translocation, both A-site tRNAs and Domain IV of EF-G are
believed to undergo large distance displacements in the decoding center (Agirrezabala et
al., 2009). Our present results of FRET changes detected by BR-EF-Gs and previous
structural information about the large distance displacements of tRNA and EF-G together
suggest that Domain IV, which extends into the decoding center, moves together with the
A-site tRNA during translocation. Thus, we detect no relative movement between
Domain IV of EF-G and the A-site tRNA during translocation. In contrast, other parts of
EF-G which are located closer to the hinge region, do not undergo such large movement.
The resulting large distance changes between those domains and peptidyl-tRNA during
translocation result in the significant FRET efficiency changes we observe during
translocation.
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5.4 Conclusion
By using bifunctional tetramethylrhodamine labeled EF-G derivatives, restricting the
free rotation of dye attached to EF-G, we were able to study the relative movements
between EF-G and the A-site peptidyl-tRNA. Our data suggest that during EF-G
catalyzed translocation, some parts of Domain IV of EF-G move together with the
peptidyl-tRNA, so that the EF-G:tRNA FRET efficiency doesn’t change (Fig 5.2). In
contrast, when the BR group is located closer to the EF-G hinge region, at which position,
Domains III, IV and V undergo a large movement relative to Domains I and II during
translocation (Agirrezabala et al., 2009), FRET efficiency decreases, consistent with a
growing distance between those parts of EF-G and peptidyl-tRNA.
Fitting results by using two-state or three-state models suggest that an intermediate
state existed in our BR-EF-G:Cy5-tRNA FRET interaction. The fitted rate constants of
BR-EF-G692-699 are larger than those for EF-GCy3-693. This is likely due to the free rotation
of the fluorophore in EF-GCy3-693, which could, by forming contacts with parts of the
ribosome, extend EF-G lifetime on the ribosome. The smallest rate difference between
the two labeled EF-Gs is in the rate limiting step which only shows a small EF-G:tRNA
FRET change, suggesting that tRNA and mRNA movement at the decoding center may
occur at this stage.
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Figure 5.1 Comparison of structural changes observed in EF-G [from (Agirrezabala,
et al., 2009)]. The conformations observed in EF-G/eEF2 by means of cryo-EM
(ribosome-bound forms) and X-ray crystallography (in solution) can be summarized as
follows: EF-G in complex with GTP in solution (red), before interacting with the
ribosome, as seen in the crystal structure of the EF-G analog EF-G-2 (PDB code: 1WDT).
EF-G•GTP•ribosome conformation was determined by cryo-EM using the nonhydrolyzable GTP analog GDPNP (PDB code: 1PN6). The conformational changes in
ribosome-bound EF-G, upon GTP hydrolysis, are likely similar to those described for
eEF2•80S complexes in Taylor et al. (2007). A comparison of the complexes before
(yellow) and after GTP hydrolysis (blue, PDB code: 2P8Y). Conformational changes of
EF-G•GDP from the ribosome-bound conformation (blue), determined by cryo-EM (PDB
code: 2P8Y), to the solution structure (pink), determined by X-ray crystallography (PDB
code: 1EFG), include a movement at the tip of domain IV by ~43 Å. A comparison of the
GDP-bound conformation (pink) of EF-G with the GTP-bound conformation (red)
reveals a shift at the tip of domain IV of the factor by ~25 Å. The presence of GTP also
reveals an ordered Switch I loop and a different conformation of the Switch II loop.
Altogether, these rearrangements likely are the basis of a much higher affinity of the
pretranslocational ribosome for the GTP-bound conformation of EF-G.
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Figure 5.2 Carton figures of EF-G and cross-linked bifunctional rhodamine. EF-G
(red), A-site tRNA (purple) and P-site tRNA (yellow). Mutated sites on EF-G are
identified by amino acid number and domain labeled.
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Figure 5.3 Cartoon of the single molecule experiment setup of BR-EF-G. Cy5 labeled
PRE complex with tRNACy5 was attached to the slide surface via a double biotin labeled
mRNA. Then bifunctional rhodamine labeled EF-G was injected into the system. A green
laser (532 nm) was illuminated to excite rhodamine fluorophore directly.
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Figure 5.5 FRET distribution of BR-EF-G:PRE-IItRNA-Cy5. Sample was prepared in
TAM15 buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-TC and
1mM GTP. FRET efficiency distributions are fitted by Gaussian function:
y= y0 + (

)+(

).
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Figure 5.6 FRET dwell time distribution of BR-EF-G:PRE-IItRNA-Cy5. Sample was
prepared in TAM15 buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-PheTC and 1mM GTP. Dwell time distribution is fitted by double exponential decay:
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EF-G derivative
(Domain)

Mutant sites

FRET efficiency

Peak 1

High
FRET
percentage

Peak 2

FRET dwell time
(ms)
t1

t2

0.26

33 ± 9

123 ± 8

0.28 ± 0.02
(0.13)

0.24

17 ± 2

162 ± 3

0.33 ± 0.01
(0.16)

----

----

46 ± 5

248 ± 10

0.20 ± 0.01
(0.09)

0.31 ± 0.01
(0.15)

0.48

52 ± 9

334 ± 15

467-474

2

BR-EF-G
(III)

D467C,K474C, C114D,
C266A, C397S

0.17 ± 0.01
(10.08)

0.29 ± 0.01
(0.17)

BR-EF-G555-562
(IV)

K555C, K562C, C114D,
C266A, C397S

0.14 ± 0.01
(0.06)

BR-EF-G599-606
(IV)

I599C, K606C, C114D,
C266A, C397S

BR-EF-G692-699
(CTD)

S692C, I699C, C114D,
C266A, C397S

Table 5.1 FRET distributions and dwell time of BR-EF-Gs:PRE-IItRNA-Cy5 FRET
pair. Sample was prepared in TAM15 buffer and contained BR-EF-Gs, 20 nM WT-Val-TC,
10 nM Cy5-Phe-TC and 1 mM GTP at 21 o C.
1
SD of FRET distribution
2
Standard error of the fitted peak
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Figure 5.7 Postsynchronized analysis of BR-EF-G:PRE-IItRNA-Cy5. Sample was
prepared in TAM15 buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-PheTC and 1mM GTP. Postsynchronized traces are obtained by aligning all FRET events at
the beginning (black) or at the end (red) and plotted as a function of time.
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Figure 5.8 ΔFRET di t i uti ns of BR-EF-G:PRE-IItRNA-Cy5. Sample was prepared in
TAM15 buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-Phe-TC and 1
mM GTP. The initial and final FRET are calculated as the averaged results of the first
three frames and last three frames, respectively. ΔFRET distribution is plotted with a bin
size of 0.02.

194

Figure 5.9 Transition density contour map of BR-EF-G:PRE-IItRNA-Cy5. Sample was
prepared in TAM15 buffer and contained BR-EF-Gs, 20 nM WT-Val-TC, 10 nM Cy5-PheTC and 1mM GTP. The initial and final FRET are calculated as the averaged results of
the first three frames and last three frames, respectively. Initial and final FRET values are
plotted as two-dimensional transition density contour maps.
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Figure 5.10 Dwell time distributions of Groups I and II traces. Sample was prepared
in TAM15 buffer and contained BR-EF-G692-699, 10 nM Cy5-Phe-TC, 20 nM WT-Val-TC
and 1mM GTP. Dwell time distributions of Group I and Group II were each fitted by a
single exponential decay.
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Figure 5.11 Initial and final FRET distributions. Sample was prepared in TAM15 buffer
and contained BR-EF-G692-699, 10 nM Cy5-Phe-TC, 20 nM WT-Val-TC and 1mM GTP.
The initial and final FRET are calculated as the averaged results of the first three frames
and last three frames, respectively. Initial and final FRET distributions are plotted with a
bin size of 0.02. The proportion of FRET events on each sides of the dashed line are
indicated in red. The detailed fitting results, including standard deviation of the peak
value and percentage of high FRET state are listed in Table 5.2.

Complex

PRE-II MFK

Initial FRET
PRE-II MFK

Final FRET

Buffer

TAM15

TAM15

Fitted Peak of Total

b
a

σ(SD)

FRET distribution

High FRET
percentage

Peak1=0.27±0.01

1=

0.12

Peak2=0.47±0.02

2=

0.14

Peak1=0.23±0.01

1=

0.07

Peak2=0.37±0.04

2=

0.09

19%

38%

Table 5.2 Statistics of fitted FRET peaks of BR-EF-G:PRE-IItRNA-Cy5. Sample was
prepared in TAM15 buffer and contained BR-EF-G692-699, 10 nM Cy5-Phe-TC and 20 nM
WT-Val-TC.
a
SD of FRET distribution
b
The intersect FRET value of the two fitted Gaussian curves (IS) is obtained. High FRET
percentage is calculated by using the number of events (E > IS) divided by the number of
total events
c
Standard error of the fitted peak
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Figure 5.12 Global fitting results of Group I traces of BR-EF-G:PRE-IItRNA-Cy5 pair.
Sample was prepared in TAM15 buffer and contained BR-EF-G692-699, 10 nM Cy5-Phe-TC,
20 nM WT-Val-TC and 1mM GTP. Postsynchronized traces are obtained by aligning all
FRET traces at the beginning (black) or at the end (red) and plotted as a function of time.
Both two-state (A) and three-state (B) models are applied. Detailed fitting results are
listed in Table 5.3.

Complex

Buffer

BR-EF-

Transition rate (s-1 )

Fitting
model

k

k

Two state

26.2±0.7

1.6±0.1

Three state

45.5±1.7

2.5±0.1

1

2

FRET state
k

3

E1

E2

E3

G692-699
PRE-

15

TAM

-----

0.54±0.01 0.25±0.01

-----

tRNA-Cy5

II

15

TAM

24.8±2.2 0.53±0.01 0.28±0.01 0.24±0.01

Table 5.3 Global fitting results of Group I traces of BR-EF-G:PRE-IItRNA-Cy5 pair.
Sample was prepared in TAM15 buffer and contained BR-EF-G692-699, 10 nM Cy5-Phe-TC,
20 nM WT-Val-TC and 1mM GTP. Fitting results of two-state and three-state models are
listed.
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Figure 5.13 Initial and final FRET distributions of BR-EF-G:PRE-IItRNA-Cy5 pair.
Sample was prepared in TAM15 buffer and contained BR-EF-Gs, 10 nM Cy5-Phe-TC, 20
nM WT-Val-TC and 1mM GTP. The initial and final FRET was calculated as the
averaged results of the first three frames and last three frames respectively. Initial and
final FRET distributions are plotted with a bin size of 0.02.
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PRE-II

BR-EF-G467-474
(III)

BR-EF-G555-562
(IV)

BR-EF-G599-606
(IV)

BR-EF-G692-699
(CTD)

Total events (T)

759

3716

1527

1702

Number of events
ΔFRET < - 0.20

55

115

138

191

Number of events
ΔFRET > + 0.20

20

57

100

62

Difference
number
of events (D)

35

58

38

129

4.6%

1.5%

2.4%

7.6%

Percentage
(D/T)

in

Table 5.4 Stati ti al tudi
f ΔFRET of BR-EF-G:PRE-IItRNA-Cy5 pair. Sample was
prepared in TAM15 buffer and contained BR-EF-Gs, 10 nM Cy5-Phe-TC, 20 nM WT-ValTC and 1mM GTP. The first three frames and last three frames are averaged separately,
defined as initial and final FRET. The difference between final and initial FRET is
denoted ΔFRET.
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